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ABSTRACT
As very little information was available on mercury sensitivity testing, the first 
aim was to determine the most suitable agar and concentration of mercuric 
chloride to use in this project. The primary objective o f the study was to 
determine whether mercury released from amalgam fillings could increase the 
prevalence o f mercury-resistant bacteria in the oral flora of children. This was 
achieved through cross-sectional and longitudinal studies. The second aim was to 
determine whether changes in mercury resistance correlated with changes in the 
incidence o f antibiotic resistance. The final aim was to determine whether 
individual mercury-resistant isolates contained the merA gene.
In the cross-sectional study, saliva and plaque samples were collected from 
patients with and without amalgam fillings. No significant differences in the 
proportion o f mercury-resistant bacteria were detected between the two groups. 
One hundred and thirty nine mercury-resistant bacteria were isolated and 
41% (with amalgam) and 33% (without amalgam) o f these were also resistant to 
one or more antibiotics. Resistance to tetracycline was most common.
Sixteen patients were enrolled into the longitudinal study. The proportions of 
mercury-and antibiotic-resistant bacteria were determined on 3 separate occasions 
(2 pre-amalgam and 1 post-amalgam). There was not a statistically significant 
change in the incidence of mercury- or antibiotic-resistant bacteria during the 
month after the installation o f the amalgam fillings. However, a linear association 
between the number o f surfaces and proportion o f mercury-resistant bacteria was
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observed. Eighty eight mercury-resistant bacteria were isolated and 
27% (pre-amalgam) and 40% (post- amalgam) o f these were resistant to one or 
more antibiotics. Resistance to erythromycin was most common.
One hundred and thirty two mercury-resistant bacteria were screened for the 
merA gene using PCR and 2 sets o f primers. Sixty three percent o f the 
streptococci were found to contain the merA gene. Coagulase-negative 
staphlyococci, Rothia dentocariosa and Neisseria species contained the 
merA gene, while Staphylococcus aureus and Pseudomonas stutzeri did not. All 
sequenced amplicons were found to be up to 95% identical to the 
Bacillus cereus RC607 merA gene.
The results of this study have failed to demonstrate any definitive link between 
the presence of mercury amalgam in teeth and the presence, or proportion, o f 
mercury- or antibiotic-resistant bacteria in the oral cavity o f children.
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Chapter One 
Introduction
1.0 Introduction
1.1 The Oral Microflora
The oral cavity is a highly varied environment with diverging environmental 
determinants. This results in a complex resident microbiota consisting of a wide 
range of bacterial genera, as well as viruses, yeasts and sometimes protozoa 
(Schuster, 1999). Although the ecological conditions within the mouth are constantly 
changing, throughout adulthood the resident oral micro flora remains relatively stable 
(Liljemark & Bloomquist, 1996). However, transient fluctuations in the oral flora 
often occur during certain circumstances. These include changes in saliva flow rates, 
variations in the frequency and types of foods eaten, tooth-brushing and antibiotic 
therapy (Joyston-Bechal et al, 1992, Epstein et al, 1998). Permanent changes in the 
mouth, such as the extraction of teeth, the insertion of protheses (dentures) and dental 
treatment (fillings) can also result in a more permanent change in the resident oral 
flora (Wilson, 1998, Lockhart et al, 1999).
The oral ecosystem encounters most variation during childhood. The oral cavity of 
the foetus in the womb is normally sterile, but after birth is quickly colonised by 
organisms deriving from the mother and other individuals in close proximity to the 
child (Alaluusua, 1991, Li & Caulfield, 1995). During feeding the mouth is regularly 
inoculated with microorganisms resulting in the establishment of pioneer species 
(Mohan et al, 1998). The neonatal oral cavity offers only epithelial (mucosal)
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surfaces for colonisation and the predominant organism found within a newborn’s 
mouth is Streptococcus salivarius, an organism which is present on the tongue 
dorsum in adulthood (McCarthy et al, 1965, Smith et al, 1993). Once the pioneer 
species have become established, the oral environment changes due to the metabolic 
activity of the organisms, resulting in conditions suitable for colonisation by a 
succession of other organisms. These pioneer populations are generally aerobes and 
facultative anaerobes, including streptococci, staphylococci, Neisseria and 
Veillonella species (Pearce et al, 1995, Bloomquist et al, 1996). With increasing age 
there is an increase in non-sporulating anaerobes, filamentous forms and yeasts such 
as Actinomyces, Lactobacillus, Rothia, Fusobacterium, Bacteroides, Leptotrichia, 
Corynebacterium and Candida (McCarthy et al, 1965, Hannula et al, 1999). Teeth 
provide a wide range of habitats for microorganisms and at 6-10 months o f age the 
central incisors erupt presenting a habitat for organisms with a high affinity for hard 
surfaces. After tooth eruption, the environment of the oral cavity becomes similar to 
that of an adult. Initially, Streptococcus sanguinis and mutans streptococci 
(S. mutans and S. cricetus) colonise the tooth. The development of teeth also results 
in the presence of gingival crevicular fluid (GCF), a serum-like exudate, producing a 
nutrient source for organisms (Berkowitz et al, 1975, Morhart & Fitzgerald, 1976, 
Smith et al, 1993). The gingival crevice has a low oxygen concentration and is 
therefore populated by anaerobic organisms such as spirochaetes and black-pigmented 
anaerobes (Marsh & Bradshaw, 1997, Tanaka et al, 1998). Primary dentition is 
usually complete by 3 years of age, while permanent teeth begin to develop at the age 
of 6 years (Bishara et al, 1988, Ranly, 1998). Permanent tooth eruption is usually
complete by 19 years of age, although the third molars (wisdom teeth) may not erupt 
at all (Daito et al, 1992). After the secondary teeth have erupted the oral flora 
generally remains stable. However, hormonal changes that occur during adolescence 
and pregnancy can result in these hormones entering the gingival crevice and an 
increase in the number of spirochaetes and black-pigmented anaerobes 
(Bailit et al, 1964).
During adulthood the bacterial populations exist in harmony with the host, remaining 
relatively stable unless major physiological changes are encountered. Complete loss 
of teeth results in a reduction or the elimination of spirochaetes and a reduction in 
lactobacilli, yeasts and S. sanguinis while wearing dentures can promote the 
colonisation of Candida albicans, but eliminate S. sanguinis
(Socransky & Manganiello, 1971, Millsap et al, 1999). In addition, oral candidiasis is 
more common in the elderly due to changes in the oral mucosa, malnutrition and trace 
element deficiencies, while antibiotic therapy often results in an increase in the 
presence of yeasts (Hannula et al, 1999, Lockhart et al, 1999). Dietary habits can also 
perturb the balance o f the oral microflora. A diet high in carbohydrates can result in 
an increase in aciduric and cariogenic organisms in the mouth such as mutans 
streptococci and lactobacilli (van Houte, 1994).
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1.2 Plaque formation
After tooth eruption, several organic deposits may form on the surface of teeth. These 
deposits include pellicle, materia alba, plaque and calculus and also form soon after 
tooth-brushing. Pellicle forms first and occurs when salivary proteins adsorb to the 
hydroxyapatite (enamel) surface of teeth (Lie, 1978). This results from electrostatic 
ionic interactions between phosphate groups and calcium ions on the enamel surface 
and oppositely-charged groups in the salivary macromolecules (Gristina, 1987, 
Dowd, 1999). The resulting pellicle is heterogenous with a thickness of lOOnm at 
2 hours and 500-1 OOOnm at 24-48 hours. The pellicle is very tenacious and initially 
attracts coccal organisms such as streptococci to the tooth surface through 
hydrophobic interactions and electrostatic forces (Jenkinson & Lamont, 1997). At 
this point, the pellicle has now become plaque. Streptococcus sanguinis is a 
prominent organism amongst the earliest colonisers of the tooth surface, deriving 
from saliva (Socransky et al, 1977). This organism initially adheres to small 
irregularities and fissures that are relatively sheltered from oral cleansing forces 
(saliva). Other pioneer organisms include Neisseria species, Streptococcus oralis and 
Streptococcus mitis (Figure 1.1). If the plaque accumulates undisturbed, the 
proportions of organisms present in the biofilm changes. Between 0-7 days,
streptococci are the predominant organisms, but by day 14 the oxidation-reduction 
potential has decreased and anaerobic rods and filamentous organisms predominate 
(Listgarten et al, 1975). Another important mechanism that encourages species 
diversity and allows plaque build up is coaggregation between organisms
(Hughes et al, 1988). Carbohydrate-binding proteins known as lectins are found on 
bacterial surfaces and interact with complementary carbohydrate-containing receptors 
on other microorganisms (Herp et al, 1988). Intra-generic and inter-generic 
coaggregation between the pioneer Streptococcus species and Actinomyces species 
results in further bacterial accumulation in plaque (Jenkinson, 1994). This results in 
further inter-generic coaggregation between the primary colonisers and other genera.
Figure 1.1: A Bacterial Matrix (Plaque)
The organisms in dental plaque are embedded in an organic matrix, which accounts 
for approximately 30-70% of the total plaque volume (Socransky et al, 1963). The 
organic matrix consists of salivary glycoproteins and extracellular polysaccharides 
produced by the bacteria found within the biofilm (De Jong & Van der Hoeven, 1987, 
Bowden & Li, 1997). Organisms such as S. mutans produce several types of 
extracellular polysaccharides, known as dextran (a glucan), from dietary sucrose 
(Morhart & Fitzgerald, 1976, Ruby et al, 1978, Kuramitsu & Wondrack, 1983).
Dextran has been shown to be an important parameter in holding this species together 
in vitro and in vivo (Jordan & Keyes, 1966, Gibbons, 1968). Other organisms such as 
S. salivarius, convert dietary sucrose into fructan (levan), which is used as an energy 
source by other organisms (Ebisu et al, 1975, Kelstrup, 1981, Ceming, 1990). 
Although most work on the origin o f plaque matrix carbohydrates has been confined 
to streptococci, other genera such as Neisseria, Actinomyces, Lactobacillus and 
Micrococcus mucilagenosus are also known to produce extracellular materials that 
contribute to the plaque matrix (Bowden, 1969, Ceming, 1990).
The organisms found in dental plaque live in close proximity to each other and 
although often beneficial to each other, can also be antagonistic 
(Vemazza & Melville, 1979, Shapiro, 1996, Tompkins et al, 1997). Antagonistic 
factors include essential nutrient depletion and the accumulation of inhibitory and 
toxic by-products, such as bacteriocins, hydrogen peroxide and organic acids. 
Organic acids reduce the pH and these acidic conditions can lead to the development 
of caries (Shapiro, 1996, Tompkins et al, 1997, Barnard & Stinson, 1999).
Antagonistic factors and nutrient competition leads to environmental heterogeneity, 
which allows organisms with different growth requirements to grow within the 
biofilm, and also ensures synergistic co-existence of different species 
(Sundqvist, 1994). For example, some oral spirochaetes require spermine, spermidine 
and putrescine, which are provided by Gram-positive rods and fusobacteria 
(Loesche, 1968, Deyloff & Sanders, 1980). Veillonella and oral diphtheroids produce
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vitamin K, which is an essential growth requirement for the black-pigmented 
anaerobes (Mayrand et al, 1980, Shah & Collins, 1983).
The quantitative composition o f plaque can vary quite markedly at different areas in 
the mouth and at different sites on the same tooth (Socransky et al, 1977). For 
example, gingival crevice plaque has a low oxidation-reduction potential, resulting in 
high species diversity, especially of anaerobes, although the total number of bacteria 
can be low (Mettraux et al, 1984). In addition, anatomical factors, such as 
malalignment, may predispose areas of the mouth to excessive plaque accumulation 
(Quirynen, 1994). Similarly orthodontic or prosthetic appliances may interfere with 
oral hygiene procedures and encourage plaque formation (Chadwick, 1994, 
Heintze et al, 1996).
The plaque biofilm can protect organisms within it from saliva, mastication and 
antimicrobials (Marsh, 1989, Bowden & Li, 1997). The matrix acts as a 
diffusion-limiting barrier and the sensitivity of a biofilm-associated organism to 
antibiotics and disinfectants is reduced when compared to the same organism in 
suspension (Wilson, 1996).
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1.3 The Oral Microflora and Caries
1.3.1 Dental Caries
The plaque matrix also plays an important role in caries development since harmful 
bacterial products such as lactic acid are retained in high concentrations at particular 
sites where they can initiate caries (McNee et al, 1982). Dental caries is the most 
common disease in man, although its prevalence and incidence is decreasing in 
developed countries, but increasing in developing countries where consumption of 
dietary carbohydrates has increased (Newbrun, 1992, Woodward & Walker, 1994, 
Ismail et al, 1997).
Organisms associated with caries formation are mutans streptococci and lactobacilli 
(Schuster, 1999). These organisms possess the ability to rapidly transport sugars and 
convert them to acid and they can also tolerate acidic conditions for prolonged 
periods and are able to continue to metabolise and multiply at low pH 
(Bender et al, 1986, Belli & Marquis, 1991, Miyagi et al, 1994, 
Bradshaw & Marsh, 1998).
Cariogenic organisms are usually found in small numbers in plaque at neutral pH, but 
when the frequency of fermentable carbohydrate intake increases, the pH decreases 
and the number of cariogenic organisms increase. The decrease in pH results in 
enamel demineralisation (loss of hydroxyapatite crystal s)(Figure 1.2)
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(Featherstone, 1999). In the presence of fluoride, demineralisation can be reversed 
and lead to remineralisation (Winston & Bhaskar, 1998, Featherstone, 1999). 
Additionally, depending on the fluoride concentration and pH of the environment, 
fluoride can exert bactericidal or anti-enzymatic properties. In the dental clinic, 
topical applications of fluoride (>1% fluoride) have been shown to be toxic to mutans 
streptococci (Kay & Wilson, 1988, Marquis, 1995). In oral streptococci, lower 
concentrations of fluoride can inhibit enzymes involved in acid production and in the 
transport and storage of glucose and its analogues (Hayes, 1994). The topical 
application of antimicrobial agents such as chlorhexidine and triclosan can disrupt the 
ecology of the microflora, although the aims of most agents are anti-plaque rather 
than anti-caries (Johnson, 1993, Marsh, 1993, Bouwsma, 1996, Gaffar et al, 1997, 
Guggenheim et al, 1997). Once the enamel has been demineralised and penetrated, 
bacteria can gain access directly to the dental tubules and infect the surrounding tissue 
(Michelich et al, 1980, Gutierrez et al, 1990). If demineralisation continues, the 
lesion progresses and a cavity will form, which can result in dissolution of the enamel 
and transport of the calcium and phosphate ions from the enamel into the surrounding 
environment (Ingram, 1990). If the lesion is not treated, the cavitation spreads into 
dentine, often destroying the dental pulp (Figures 1.2 & 1.3). This results in pain and 
the patient will usually seek treatment.
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a b c
Figurel.2: Demineralisation and remineralisation
a) Healthy tooth enamel rods before the acids onslaught, b) Enamel rods 
demineralised, or broken down, by acid, c) Enamel rods remineralised or rebuilt by
fluoride and minerals in saliva
a b e d
Figure 1.3: Cavity formation
a) Tooth decay begins on biting surfaces, between teeth and on exposed roots,
b) Untreated, the cavity becomes larger, c) Decays spreads beneath the enamel 
destroying the tooth surface, d) Decay enters the pulp and an abscess may occur
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1.3.2 Restoration of the Caries Lesion
As early as the 7th century, the Chinese used a ‘silver paste’ containing mercury to fill 
decayed teeth (Lorscheider et al, 1995a). Amalgam fillings have now been an 
accepted part of dental therapeutics for more than 150 years, constituting 
approximately 75% of all restorative materials used by dentists (Leinfelder, 1991). 
The reasons for its popularity include ease of manipulation, relatively low cost and 
long clinical service life, wearing at a rate similar to that of teeth (Leinfelder, 1991). 
In addition, hypersensitivity to mercury is extremely rare (Burrows, 1986). However, 
dental amalgam also has some drawbacks; it is not tooth-coloured and does not easily 
bond to teeth (Figure 1.4)(Ferracane, 1995). The greatest concern is that amalgam 
contains mercury, which, if not handled properly, can be a safety hazard to the dental 
staff and patient (Curtis & Brown, 1992, Kostyniak, 1998).
Figure 1.4: Mercury Amalgam Fillings
Amalgam fillings contain a weight composition that is approximately 50% mercury, 
35% silver, 13% tin, 2% copper and trace amounts of zinc (Hahn et al, 1989). A 
newly-placed multisurface dental silver filling involving an occlusal (grinding) 
surface of a molar tooth contains between 750-1000mg mercury (Hahn et al, 1989). 
It was once believed that the long-term danger to the patient from mercury vapour 
was remote. Several days after placement, the mercury component o f dental amalgam 
becomes inert, exposing the patient to 1-lOpg Hg per day (Lyttle & Bowden, 1993a, 
Lorscheider et al, 1995b). However, studies have shown that tooth-brushing, bruxism 
(tooth grinding) and gum chewing, especially ‘nicotine gum’, results in a substantial 
increase in mercury vapour found in the mouth (Vimy & Lorscheider, 1995a, 1995b). 
Studies have also shown that plaque may increase mercury release, as bacterial 
metabolism results in the production of acids which corrode amalgam 
(Moberg, 1988). Furthermore, symptoms such as fatigue, anxiety, irritability, temper 
outbursts, stress intolerance, indecision, headaches, depression and a metallic taste in 
the mouth have been linked to amalgam fillings (Siblerud et al, 1994). However, 
taking these concerns with other biological and environmental safety issues, it has 
been concluded that dental amalgam presents an acceptable risk-to-benefit ratio when 
used properly (Corbin & Kohn, 1994, Lorscheider, 1995b).
Mercury amalgam is not the only option available to treat dental caries. Amalgam 
fillings are preferentially used for the restoration of posterior teeth, while composite, 
ceramics and hybrid glass-ionomer restorative materials can be used for small class V 
restorations (Tyas, 1995). With increasing toxicity concerns and aesthetic
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considerations, the number of white restorations is significantly increasing 
(Geurtsen, 1998, Hse et al, 1999). However, these materials are often expensive and 
can only be used for small fillings. Furthermore, they are not resistant to mechanical 
wear, so can only be used in areas where chewing stress is low (Ferracane, 1995). 
Additionally, they can shrink which can lead to micro-leakage and secondary caries. 
The success o f the filling depends on the technique employed and, for ceramic inlays, 
healthy tooth substance must be removed to prevent undercut before the filling can be 
placed (Rykke, 1992, Ferracane, 1995). Another option is gold fillings. However, 
they are expensive and, although not as toxic as mercury, gold is absorbed by the 
body (Rykke, 1992).
1.4 Antimicrobial Activity of Mercury and its Compounds
In addition to treating tooth decay, mercury compounds have been widely used for 
centuries as disinfectants and antiseptics and as an antimicrobial to treat diseases such 
as syphilis and leprosy (Blancou, 1995). The use of mercury compounds in medicine 
has now decreased, although a number of organic derivatives of mercury are used as 
bacteriostatic and fungistatic agents in vaccine and contact lens preservatives 
(Winder et al, 1980, Halsey, 1999). Until recently, mercury salts were used 
extensively in the preservation of wood, textiles, paints and leather, as diuretics such 
as Mersalyl, Meralunde, Chlormerodrin, Mercuramide and Mercaptomerin, in 
teething powders and also as disinfectants in hospitals (Clarkson, 1990, 
Lorscheider & Vimy, 1991).
Mercury is toxic to both eukaryotic and prokaryotic cells since it has a high affinity to 
bind to thiol groups in proteins (Berg & Miles, 1978, Delnomdedieu & Allis, 1993). 
Organomercurials and inorganic mercury also possess the ability to pass through 
biological membranes. These properties result in the inactivation of enzymes and 
damage to membranes. Mercuric ions also bind to nucleotides and lipids and are 
genotoxic.
1.5 Mercury Resistance
1.5.1 Summary of Previous Work
The presence of mercury in the environment, such as the hospital, environmental 
contamination, and factories (battery manufacture) is believed to lead to the selection 
of mercury-resistant bacteria (Timoney et al, 1978, Porter et al, 1982).
The mercury resistance locus was the first of twelve distinct bacterial 
plasmid-determined metal resistance loci to be described (Summers et al, 1993, 
Liebert et al, 1997). The other metals include arsenic, antimony, boron, cadmium, 
chromium, cobalt, copper, nickel, silver, tellurium and zinc 
(Silver & Walderhaug, 1992, Silver & Ji, 1994, Silver, 1996, Silver & Phung, 1996, 
Silver, 2003). Unlike mercury, many of these resistance loci are found predominantly
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in organisms isolated from soil and industrial waste rather than in commensal and 
pathogenic bacteria isolated from humans and primates (Summers et al, 1993).
Bacterial mercury resistance has been studied for decades in laboratories across the 
world in both environmental and clinical organisms (Moore, 1960, Hall, 1970a, 
Wireman et al, 1997). Most projects have studied links between mercury and 
multiple antibiotic resistances, especially in clinical isolates. Moore carried out one 
o f the first studies in the 1960s and observed that Staphylococcus aureus strains were 
either resistant or sensitive to a discriminating concentration of mercury salts 
(Moore, 1960). He found that phage-types of staphylococci associated with hospital 
epidemics were more often mercury-resistant than non-epidemic strains. In this 
study, Moore found a close correlation between resistance to mercury salts and to 
antibiotics in general, but to no antibiotic in particular. He found that 
mercury-resistant strains o f the same phage-type had different antibiograms, thus 
indicating that mercury resistance and specific antibiotic resistance were independent. 
In later studies, a high correlation between high penicillinase activity, resulting in 
penicillin resistance, and mercury resistance was observed (Richmond & John, 1964, 
Dyke et al, 1970). These studies also showed co-transduction of both mercury and 
penicillin resistance to sensitive Staph, aureus (Richmond & John, 1964).
Hall found that mercury resistance at University College Hospital London was 
common in antibiotic-resistant strains of Staph, aureus, although the correlation was 
not as high as that observed by Moore (Hall, 1970b). Hall found that the number of
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mercury-resistant Staph, aureus isolated from different hospital wards varied 
depending on the ward type. For example, of the Staph, aureus isolated from nose 
and wound swabs taken from patients in casualty and outpatient departments only 
9% and 20% of the organisms were resistant to mercury. However, 31% and 33% of 
the Staph, aureus isolated from the surgical and medical wards were
mercury-resistant. Mercury resistance was found to be common in patients who had 
been staying long-term in the hospital and rare in patients newly admitted or staying 
short-term in the hospital.
Since Moore’s work 4 decades ago, mercury resistance has been studied in both 
Gram-negative and Gram-positive species, aerobic and anaerobic organisms, and has 
been detected in many different genera, such as Streptococcus, Staphylococcus, 
Clostridium, Actinomyces, Pseudomonas, Actinobacillus, Salmonella and Bacteroides 
(Nakahara et al, 1977a, Porter et al, 1982, Khor & Jegathesan, 1983,
Rudrik et al, 1985, Avila-Campos et al, 1989, Lyttle & Bowden, 1993a).
Rudrik studied obligately anaerobic isolates from both clinical specimens and sewage 
sludge. In the study, 200 clostridia isolated from the faeces o f hospitalised patients 
and 90 organisms (mainly Enterobacteriaceae) from sewage sludge were screened for 
mercury resistance (Rudrik et al, 1985). The minimum inhibitory concentrations
(MIC) of mercuric chloride (HgCh), phenylmercuric acetate (PMA) and
ethylmercurithiosalicylate (EMSA) for 23 Clostridium perfringens strains, 5 members 
of the Enterobacteriaceae family and 2 Bacteroides ruminicola ssp brevis were
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determined using agar dilution. The MICs of the organomercurial compounds, 
EMSA and PMA, were generally lower than the MICs obtained from the inorganic 
mercury compound, HgCh, suggesting the organisms were resistant to inorganic 
mercuric compounds only. The MICs determined that 3 C. perfringens isolates, 
one B. ruminicola ssp brevis isolate and all 5 enterobacteriaceae isolates were 
resistant to HgCh although none of these isolates appeared to be resistant to either 
organomercurial. In this study, none of the resistant anaerobes were shown to contain 
plasmids, while the resistant facultative isolates (Enterobacteriaceae) contained 
several plasmids. However, although the data suggested chromosomally-determined 
mercury resistance, the presence of large plamids or a transposon could not be ruled 
out. The aerobic organisms showed inducible mercury resistance while the anaerobic 
organisms did not show inducible mercury resistance. Additionally, the anaerobic 
organisms did not demonstrate multiple antibiotic resistance, although the 
Enterobacteriaceae showed resistance to kanamycin, ampicillin, tetracycline and 
cephalothin.
Avila-Campos and co-authors have worked on mercury resistance in various 
microbial genera (Avila-Campos et al, 1989, Avila-Campos et al, 1991a, 
1991b). In 1989 the group published a paper in which 
41 Actinobacillus actinomycetemcomitans strains resistant to mercuric chloride were 
isolated (Avila-Campos et al, 1989). Actinobacillus actinomycetemcomitans is an 
indigenous micro-organism of the human oral cavity but is often associated with 
periodontal disease, especially in children and young adults. The level of resistance
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to mercuric chloride was determined by agar dilution, allowing the determination of 
the MIC, which was found to be 4pg/ml for all 41 isolates. However, the group stated 
that this MIC value may not be indicative of a mercury resistance gene, but this 
organism may have intrinsic resistance. In 1991, the group published another paper in 
which the stability o f the mercuric chloride resistance of Bacteroides fragilis strains 
isolated from human and marmoset (Callothrix penicillata) faeces were tested 
(Avila-Campos et al, 1991a). In previous studies, B. fragilis has been shown to be 
resistant to several antibiotics and heavy metals which can be transferred to other 
intestinal bacteria including Gram-negative facultative anaerobes such as the 
Enterobacteriaceae (Wallace et al, 1981). Avila-Campos and co-authors determined 
the MIC of 5 Bacteroides species by the agar dilution method. All 5 strains tested 
had an MIC value greater than 2pg/ml, the breakpoint value for mercuric chloride as 
determined by the authors, suggesting that the strains were all resistant to mercuric 
chloride. The 5 strains were subcultured for 24 hours in the absence of selective 
pressure (eg mercuric chloride) and the MIC determined. This procedure was 
repeated up to 10 times and it was found that after 10 subcultures the MICs remained 
the same, suggesting that mercury resistance is stable in Bacteroides species. This 
agrees with previous work by Rudrik’s group which suggested that mercury resistance 
in Bacteroides species was not plasmid-mediated, while Riley and Mee found that 
heavy metal resistance in Bacteroides was intrinsic rather than plasmid-mediated 
(Riley and Mee, 1982, Rudrik et al, 1985).
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Lyttle and Bowden tested selected strains of oral streptococci and Actinomyces for 
their ability to grow in the presence of mercury (Lyttle & Bowden, 1993b). They 
found that streptococci were more resistant to mercury than Actinomyces and that the 
resistant streptococci adapted to growth in concentrations of mercury greater than on 
initial isolation. Previous work by these authors showed that oral microbes may play 
an active role in mercury release from dental amalgam (Lyttle & Bowden, 1993a). 
They found that biofilms of S. mutans facilitated the liberation of mercury from 
freshly prepared amalgam in vitro.
1.5.2 Mercury Resistance Mechanisms
Various mechanisms leading to mercury resistance have been described. Anaerobic 
organisms such as Clostridium cochleareum have the ability to convert mercuric 
chloride to insoluble mercuric sulphide (HgS) by reaction with hydrogen sulphide 
(H2S) (Pan-Hou & Imura, 1981). Detoxification o f mercury has also been seen in 
aerobic mercury-resistant strains of Bacillus firmus, Bacillus pumilus, 
Klebsiella aerogenes NCTC 418 and Klebsiella pneumoniae M426 
(Belliveau et al, 1991, Essa et al, 2002). Certain anaerobic organisms possess the 
ability to methylate the mercuric ion (Hg2+) to methylmercury (CfLHg*). 
Methylmercury is volatile and has a very low vapour pressure leading to the 
compound dissipating from the microbial environment. However, this mechanism is 
peculiar since methylmercury is more toxic than inorganic mercury salts 
(mercuric ions)(Hobman & Brown, 1997). Another study has shown that an
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Enterobacter aerogenes strain displays a reduced uptake of Hg2+ ions 
(Hobman & Brown, 1997, Essa et al, 2002).
However, the most widely reported and studied mechanism of mercury resistance in 
bacteria is the enzymatic reduction of divalent mercuric ions (Hg2+) to the metallic 
form (Hg°). This reaction is catalysed by the cytoplasmic flavoenzyme mercuric 
reductase (MerA)(Hart et al, 1998). The mercuric reductase gene is incorporated in a 
multigene operon; where the additional genes are involved in regulation of the system 
(merR and merD) and in transport o f toxic Hg2+ to the reductase (merT, merC, merE 
and merF). At present, the best-understood metal resistance loci is that conferring 
resistance to mercury compounds (Silver & Walderhaug, 1992). Generally, the 
mercury operon is plasmid encoded, although there are a few exceptions in which the 
genes are found on the chromosome, such as the Bacillus broad-spectrum and 
Thiobacillus ferrooxidans narrow-spectrum resistance operon 
(Silver & Walderhaug, 1992). Narrow-spectrum resistance is seen in organisms that 
only have the ability to reduce inorganic mercuric compounds (Hg2+) to Hg° and these 
organisms have a limited range of resistance to organomercurials (Summers, 1986). 
Some organisms possess broad-spectrum resistance and are able to biotransform both 
inorganic mercury and a wide range of organomercurials, such as phenylmercuric 
acetate, methylmercury and /rara-hydroxymercurobenzoate (/?-HMB) 
(Summers, 1986, Hobman & Brown, 1997). These organisms possess an 
organomercurial lyase enzyme which catalyses the cleavage of the organic bond, 
C-Hg, to yield Hg2+ and an organic moiety. Mercuric reductase then reduces Hg2+ to
metallic mercury. Broad-spectrum resistance is rarely encountered in Gram-negative 
organisms (Summers, 1986).
1.5.3 Organisation of Mercury Resistance Genes
The mer operon of Gram-negative bacteria have been studied more extensively than 
those from Gram-positive bacteria, but both possess genes required for regulation, 
transport and mercury reduction (mercury reductase)(Figure 1.5) 
(Silver & Phung, 1996, Osborn et al, 1997). The merB gene (broad-spectrum 
resistance) is more common in Gram-positive bacteria than Gram-negative bacteria.
The mer operon is often a component of transposons and integrons (Misra et al, 1984, 
Kholodii et al, 1993, Liebert et al, 1999). The first mer operon to be studied was 
found on Tn21, which is present within the multidrug resistant conjugative plasmid 
NR1 (R100) of Shigella flexneri. Tn21 also contains the class I integron In2, which 
encodes resistance to sulphonamides (sut) and streptomycin/spectinomycin (aadA). 
The presence of the integron enables the organism to acquire further 
antibiotic resistance genes (Hobman et al, 2003)(Chapter 1.9.1).
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2RSH
MerA
RSH(MerB)
Figure 1.5: Model of a typical Gram-negative mer operon and mercury reduction. 
The symbol •  indicates a cysteine residue (Barkay et al, 2003)
The first gene found within the mercury operon is merR, which encodes a trans-acting 
repressor/activator protein, which regulates the expression of the operon 
(Figures 1.5 & 1.6)(Zeng et al, 1998). In Gram-negative organisms, with the 
exception of the marine bacterium Pseudomonas haloplanktis, merR is transcribed
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divergently from the structural genes (merTPCAD). Low G+C Gram-positive 
bacteria have similar sets of genes, although merR is transcribed in the same direction 
as the other genes of the operon (Laddaga et al, 1987, Wang et al, 1989). However, 
merR from operons o f Streptomyces (high G+C Gram-positive) are transcribed 
divergently from structural genes (Barkay et al, 2003). This gene is separated from 
the other mer genes by a short sequence of a cis-acting operator-promotor element 
(merO/P). The MerR regulator is the archetype of a family of regulatory proteins, 
which include SoxR, TipAL, NolA, BmrR and BltR (Brown et al, 2003a). In the 
absence of Hg2+ and MerR, RNA polymerase preferentially transcribes from the merR 
promotor, increasing the amount of MerR in the cell. In the continued absence of 
Hg2+, MerR binds to the merO/P and the DNA becomes bent and unwound at the 
operator sequence. RNA polymerase is able to bind to the promotor site and forms 
distortion of the O/P region, which maintains repression of the promotor 
(Barkay et al, 2003). When Hg2+ is present, it binds to one of the two binding sites of 
merR, provoking an allosteric change and merR forms an activating conformation 
(Zeng et al, 1998). MerR binds tightly to the operator, causing DNA distortion at the 
centre of the operator and straightens the helix backbone. This allows access o f the 
RNA polymerase to the -35 and -10 transcriptional start site (Brown et al, 2003a).
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Figure 1.6: Mercury operons from Gram-negative (below line) and Gram-positive 
(above line) bacteria. Arrows indicate the direction of translation of each gene
product (Barkay et al, 2003)
A second regulatory protein, MerD, is found downstream from the promotor on the 
mercury resistance operon. The sequence similarity between MerR and MerD at the 
NH2-terminus, which spans the putative DNA-binding domain, suggests that MerD 
can also bind to an operator site (Mukhopadhyay et al, 1991). The group showed that 
insertion mutations and deletion of the merD gene led to greater mercury sensitivity 
for the host cell (Mukhopadhyay et al, 1991). Expression of merD is dependent on 
transcription of the mer operon, suggesting that the second regulator only 
down-regulates expression of the operon (Mukhopadhyay et al, 1991).
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Once the operon is induced, MerP is secreted into the periplasm and may act as a 
‘sponge’, binding Hg2+, which has entered the periplasm via cation-selective porins 
found in the outer membrane. Binding the Hg prevents it from reaching sensitive 
targets either in the cell wall or the cytosol. The binding of Hg2+ to MerP has been 
described as a ‘baseball’ model, where Hg2+ is initially bound by a pair of cysteines
^  i
followed by sequential passing of Hg from ‘glove to glove’, cysteine pair to cysteine 
pair. Finally, the Hg2+ is passed onto a cysteine pair found in the periplasmic region
i
of the MerT transport protein. The Hg then passes to another cysteine pair found in 
the cytoplasmic loop of the MerT, thus crossing the inner membrane. Finally the 
mercury ion is passed to a cysteine pair in the aminoterminal domain of the mercuric 
reductase, which is found in the cytoplasm of the bacterial cell (Hamlett et al, 1992). 
The mercuric reductase protein is very specific for mercuric and mercurous ions, and 
no other metal ion is known to be oxidised or reduced significantly by the enzyme 
(Misra, 1992). Mercuric reductase belongs to the pyridine nucleotide-disulphide 
oxidoreductase protein family, of which glutathione reductase (GR),
lipoamide dehydrogenase (LPD) and thioredoxin (TR) are members 
(Hobman & Brown, 1997, Brown et al, 2003a). MerA functions as an 
oi2 homodimer and two pairs of cysteine residues, a redox-active pair (Cys207 and 
Cys212) from one subunit of MerA and a carboxyl-terminal pair (Cys628 and 
Cys629) from the other unit o f MerA, form the catalytic site (Distefano et al, 1990, 
Liebert et al, 1999). MerA uses two hydrides from two NADPH molecules for the
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reduction of FAD, which in turn reduces Hg2+ bound to the redox-active cysteines of 
the enzyme (Equation l.l)(Figure 1.7)(Schiering et al, 1991).
NADPH + Hg2+ = NADP+ + H+ + Hg°
Equation 1.1: Reduction of Hg2+ via the reduction of FAD
C-terminal segment
Hi  sential path way 
fo r  bulky HgtSR)-* 
substrates.
Sm all HgX2 can m  
rapidly enter under 
C-terminal segment
Figure 1.7: Dimeric structure of MerA (Barkay et al, 2003)
Some environmental organisms possess the mercuric reductase gene but are
mercury-sensitive, suggesting that some of the genes for mercury resistance may be
more widespread than the numbers of resistant organisms isolated by mercury
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selection show (Bogdanova et al, 1992). These organisms may not possess the 
transport genes required for mercury reduction (Bogdanova et al, 1992).
While the function of the MerR, MerT, MerP and MerA have been well-studied, 
MerC, MerE, MerF and MerG have received less attention (Brown et al, 2003b). 
These genes are not found in all mer operons. MerC and MerF are both transport 
proteins (Liebert et al, 1999, Brown et al, 2003b, Nascimento & Chartone-Souza, 
2003). Very little is known about MerE, but it is thought to be located in the inner 
membrane of some broad-spectrum mercury-resistant organisms (Barkay et al, 2003, 
Nascimento & Chartone-Souza, 2003). MerG is frequently found in the periplasm of 
broad-spectrum resistant organisms and prevents the entry of organomercurials 
(Barkay et al, 2003).
Nearly all Gram-positive bacteria that exhibit mercury resistance show 
broad-spectrum resistance, while only 10% of mercury-resistant Gram-negative 
bacteria possess the organomercurial lyase enzyme (Barkay et al, 2003). This enzyme 
is encoded by the merB gene and is able to break the organic bond in 
organomercurials (Schottel et al, 1974). Organomercurial lyase is a small monomeric 
protein (22kDa) and has broad substrate specificity for primary, secondary and tertiary 
alkyl mercuric halides, and for alkyl, vinyl and aryl mercuric halides 
(Begley et al, 1986). Both in vivo and in vitro organomercurial lyase has a low 
turnover relative to mercuric reductase, thus preventing the accumulation of toxic 
inorganic Hg2+ in the cell. The enzyme is found in the cytoplasm and binds to a thiol
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compound of the organomercurial (Begley et al, 1986). The organomercurial lyase 
forms a complex with the thiol (RHgSR’) and this organomercurial-thiolate complex 
binds to an active cysteine thiolate site found on the enzyme. This leads to the 
breakage of the C-Hg bond by a proton found in MerB, forming a C-H bond and the
4-organic (R) group is released. The free Hg bonds covalently with another cysteine 
residue until it is released by excess soluble thiol and making it available to mercuric 
reductase (Barkay et al, 2003).
The amino acid sequences of proteins found on the mercury operon 
(regulation, transport and reduction) have been compared between Gram-positive and 
Gram-negative organisms. There seems to be high evolutionary conservation 
suggesting that mercury resistance is an ancient genotype. However, although 
resistance to mercury compounds was first found on plasmids in Gram-positive 
bacteria, the phenomenon has been less extensively studied in this class than in the 
Gram-negative bacteria (Dyke & Richmond, 1967).
1.6 Link between Mercury and Antibiotic Resistance
The possibility of bacteria developing antibiotic resistance was first suggested by 
Alexander Fleming seven decades ago in his published description of the discovery of 
penicillin (Fleming, 1929). In most studies, it has been found that over time the 
number of antibiotic-resistant bacteria has increased and older strains are likely to be 
less resistant than recent strains. A study involving bacteria isolated from the
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‘pre-antibiotic’ era found that a high percentage of these organisms carried 
conjugative plasmids that allowed the transfer of DNA from one bacterium to 
another. In this study, Hughes and Datta investigated the Murray collection, a 
collection of 433 bacterial strains isolated at the beginning of the 20th century before 
antibiotic therapy was available (Hughes and Datta, 1983). They found little 
resistance to antibiotics and to other antimicrobial agents. Only 3 organisms were 
resistant to mercuric chloride and all 3 were found to possess a plasmid that contained 
the mer operon (Essa et al, 2003). In this study the authors concluded that 
conjugative plasmids were as common in Enterobacteriaceae before the medical use 
of antibiotics as they are in antibiotic-sensitive strains from the present day. Before 
this study it was believed that the use of antibiotics encouraged the spread of plasmids 
(Hughes & Datta, 1983).
For many decades, researchers have studied links between antibiotic and mercury 
resistance. Richmond and John discovered that genes encoding mercury resistance 
were plasmid-mediated (Richmond & John, 1964). They isolated a Staph, aureus 
strain from a clinical setting that was resistant to penicillin and mercury salts and a 
chance observation showed that the loss of penicillinase synthesis was accompanied 
by the loss of resistance to mercury salts. The correlated loss of penillinase and 
mercury resistance suggested that the two characters might be closely linked 
genetically. Using transduction experiments, they concluded that the genes
controlling penicillinase synthesis and mercury resistance were closely linked. 
Relating to previous work by Novick, where penicillinase genes were
plasmid-encoded, Richmond and John concluded that the penicillinase and mercury 
resistance were on the same plasmid (Novick, 1963, Richmond & John, 1964).
The presence of mercury in the environment has led authors to believe that this can 
lead to selection pressure, resulting in the emergence and persistence of 
mercury-resistant organisms. Porter found that the frequency of Hg2+ resistance was 
only 2% for Staph, aureus and 9% for Escherichia coli in a US hospital 
(Porter et aly 1982). However, in a Japanese hospital, where the use of 
organomercurials in hospital liquid detergents and disinfectants was heavy, 
36% Staph, aureus and 57% E. coli strains were mercury-resistant. The number of 
mercury-resistant strains decreased in Japan during later years when the hospital 
ceased using organomercurials for disinfection purposes. The figures reduced to 
10% mercury-resistant Staph, aureus and 29% mercury-resistant Escherichia coli. 
During this study the antibiotic susceptibilities of mercury-resistant strains were 
determined. However, unlike other studies discussed, the results showed no specific 
antibiotic resistance patterns suggesting that there was no linkage between antibiotic 
and mercury resistance.
Another Japanese study tested clinical isolates for resistance to heavy metals 
(mercury, cadmium, arsenic and lead) and antibiotics (streptomycin, tetracycline, 
chloramphenicol, kanamycin, gentamicin, penicillin, erythromycin and 
josamycin)(Nakahara et al, 1977a). They found that the frequency of heavy metal 
resistance was the same as, or higher than the frequency of drug resistance. Many
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strains were resistant to heavy metals, but remained sensitive to the antibiotics. In 
this study the authors demonstrated conjugation between a mercury-resistant donor 
strain and mercury-sensitive recipient strain. Another paper by these authors 
describes Pseudomonas aeruginosa strains expressing multiple heavy metal 
resistance, including mercury resistance, and multiple antibiotic resistance 
(Nakahara et al, 1977b). However, many isolates were metal-resistant but 
antibiotic-sensitive.
The work of Groves and colleagues challenges the theory about selection pressure 
leading to mercury resistance (Groves et al, 1975). Groves studied mercury resistance 
in organisms isolated from Iraqi farmers and families who lived in an area of severe 
methylmercury poisoning due to the consumption of home-made bread prepared from 
seed grain treated with a methylmercurial fungicide. Staphylococci were isolated 
from the anterior nares of ‘poisoned’ and control populations, which were then tested 
for resistance to mercury, copper and cadmium. In this study staphylococci isolated 
from patients exposed to antibiotics were also tested. The authors found that the 
exposure to methylmercury did not influence the incidence of mannitol-positive 
{Staph, aureus) mercury-resistant strains from the ‘poisoned’ population, whereas 
exposure to antibiotics significantly increased the incidence of strains resistant to the 
mercuric ions. However, in mannitol-negative staphylococci (coagulase-negative 
staphylococci, CNS) the highest incidence of mercury resistance in staphylococci 
occurred in the non-exposed population. Resistance to copper ions was more
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frequently associated with the presence of Staph, aureus whereas the resistance to 
mercuric ions was most frequently found in coagaulase-negative staphylococci.
1.7 Dental Amalgam and Mercury and Antibiotic Resistance in Oral Bacteria
Several groups have investigated whether the dental amalgam used to repair caries 
can provide enough selective pressure to promote the emergence and spread of 
mercury and antimicrobial resistance in the normal human flora (Summers et al, 
1993, Osterblad et al, 1995, Edlund et al, 1996). Edlund and coauthors studied the 
resistance patterns in the oral and intestinal flora from patients that had been exposed 
to mercury due to removal of dental amalgam (Edlund et al, 1996). The fillings were 
replaced with composites, cast gold crowns and inlays. The results were compared 
against microbes isolated from a control group without any history of amalgam 
fillings. Edlund found no differences in the resistance pattern of the oral flora 
between the two groups. However, in the amalgam group there was an increase in the 
relative number of intestinal organisms resistant to mercury, ampicillin, cefoxitin, 
erythromycin and clindamycin, although this was calculated to be not statistically 
significant. In spite of this, a significant correlation between the prevalence of 
mercury resistance and multiple antibiotic resistance in intestinal bacterial strains 
such as E. coli, Bacteroides species and enterococci was observed. In conclusion, the 
study showed that mercury exposure from amalgam fillings did not seem to be a
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major factor in the selection of mercury and antimicrobial resistance in the human 
oral and intestinal flora.
The results of a study by Osterblad and colleagues support the theory that amalgam 
fillings do not provide selective pressure (Osterblad et al, 1995). Three patient 
groups were examined. Group one had never been exposed to dental amalgam 
fillings, a second group had all their amalgam fillings removed, while the third group 
had various numbers of amalgam fillings. Aerobic Gram-negative bacilli were 
isolated from faecal samples and tested for resistance to ampicillin, cefuroxime, 
nalidixic acid, trimethoprim, suphamethoxazole, tetracycline and mercury. It was 
found that the patients with a high concentration of Hg2+ in their faeces did not have a 
higher incidence of mercury- or antibiotic-resistant bacteria. However, multiply 
antibiotic-resistant strains were commonly resistant to mercury. Bacterial conjugation 
experiments were also carried out, resulting in transfer of mercury and antibiotic 
resistance from the donor strain to the recipient. All resistance factors found in the 
mercury-resistant strains, except cefuroxime and nalidixic acid resistance, were 
transferred and sulphamethoxazole together with tetracycline was the most frequently 
transferred resistance. No significant difference in transfer frequency between the 
three subject groups was observed.
In contrast, Summers observed that mercury amalgam provokes an increase in
*
mercury- and antibiotic-resistant bacteria in the oral and intestinal flora of primates 
(Summers et al, 1993). In the first part of the study which involved human
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volunteers, faecal samples were collected from human subjects. The amalgam status 
of each subject was not recorded, but the antibiotic history of each subject was noted. 
Subjects who had a high prevalence of mercury resistance in their intestinal flora and 
had not consumed antibiotics were also more likely to have a high number of strains 
resistant to antibiotics. Subjects with no detectable levels of mercury resistance were 
less likely to have strains resistant to antibiotics. In the second study, resistance to 
mercury and antibiotics were examined in the oral and intestinal flora of 6 adult 
monkeys prior to the installation of amalgam fillings, during the time they were in 
place and after replacement of the amalgam fillings with glass ionomer fillings. 
During this study, the faecal mercury concentrations were monitored. A statistically 
significant increase in the number of mercury-resistant bacteria during the 5 weeks 
following installation of the amalgam fillings and during the 5 weeks following 
replacement with glass ionomer fillings was observed. Some mercury-resistant 
Enterobacteriaceae and enterococci were also resistant to one or more antibiotics 
including ampicillin, tetracycline, streptomycin, kanamycin and chloramphenicol. 
Many of the mercury-resistant Gram-negative strains were able to transfer mercury 
and antibiotic resistance together to recipient strains suggesting that the loci for these 
resistances were genetically linked. This paper is important in that it not only 
supports evidence for a link between amalgam fillings and an increase in mercury and 
antibiotic resistance but is also the first report of mercury resistance in the oral 
streptococci. In addition, this work is very important as it illustrates that the 
commensal flora can act as a reservoir for antibiotic resistance genes, which under 
suitable conditions can be transferred to pathogenic organisms creating
antibiotic-resistant pathogens. Amalgam is the most common restorative material 
used worldwide and the potential impact of this source of mercury could have on the 
composition of the normal human flora is very large because unlike antibiotics, which 
are normally taken only occasionally, once the amalgam is in place, low level mercury 
is released for extended periods.
1.8 Antibiotics
1.8.1 The Discovery of Antibiotics
Antibiotics are low molecular mass substances that are produced as secondary 
metabolites by certain groups of micro-organisms, especially Streptomyces, 
Bacillus and the moulds, Pemcillium and Cephalosporium 
(Brumfitt & Hamilton-Miller, 1988, Demain, 1992, Maplestone et al, 1992, 
Alderson et al, 1993). Most micro-organisms that produce antibiotics are resistant to 
the action of the antibiotic that they produce and it is generally not understood why 
(Maplestone et al, 1992, Stone & Williams, 1992). It may be helpful to study these 
mechanisms to gain a greater understanding of the cellular and molecular basis of 
resistance. The majority of organisms that produce antibiotics also form spores or 
resting structures. It is not fully known why these organisms produce antibiotics but 
production may give them some nutritional advantage ip the habitat by antagonising 
the competition (Messenger & Turner, 1981, Stone & Williams, 1992). Alternatively, 
the antibiotic may act as some sort of hormone or signal molecule associated with
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sporulation, dormancy or germination (Nakano & Zuber, 1990, Marahiel et al, 1993). 
Antibiotic synthesis may require as many as 30 separate enzymatic steps and retaining 
such a large number of genes in the genome has led to the conclusion that either the 
molecule and/or the process is important for the survival of these organisms in their 
natural habitat (Stone & Williams, 1992).
The earliest record of a substance produced by a mould that could apparently kill 
bacteria was made in 1896 by a medical student named Ernest Duchesne. However, 
his work was largely ignored. Then, in 1929, the Scottish physician 
Alexander Fleming observed inhibition of staphylococci on an agar plate 
contaminated by Penicillium notatum. The diffusible substance produced by the 
Penicillium killed many different kinds of bacteria and Fleming realised its potential 
usefulness in treating infections (Fleming, 1929, Brumfitt & Hamilton-Miller, 1988, 
Demain & Elander, 1999). However, the substance appeared very unstable and 
Fleming ceased working on the mould, publishing his last work on penicillin in 1931.
The development and clinical use of antibiotics began with the therapeutic application 
of the synthetic antimicrobials known as sulphonamides in 1935 
(Domagk, 1935, Morris et al, 1998). Prontosil, a hydrochloride salt of 
4’-sulphonamide-2,4-diaminoazobenzene, was originally part of a leather dye 
compound but had the ability to kill bacteria (Figure 1.8). The substance was 
relatively non-toxic and was found to be converted by the body to sulphanilamide.
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Figure 1.8: Chemical structure of Prontosil
World War II was an important impetus to the study of the chemotherapeutic value of 
penicillin. Penicillin was purified and injected into experimental animals, where it 
was found not only to cure infections but also to possess only low toxicity 
(Chain et al, 1940). With the successful testing of penicillin, the age of the use of 
naturally-occurring substances for the treatment of infections was bom and the late 
1940s and early 1950s saw the discovery and introduction into clinical practice of 
streptomycin, chloramphenicol and tetracycline (Schatz et al, 1944, Roberts, 1996, 
Chopra & Roberts, 2001, Stratton, 2002).
1.9 Properties of Clinically Useful Antibiotics
Antibiotics have a cidal (killing) effect or static (inhibitory) effect on a range of 
microbes. Desirable properties of a clinically useful antibiotic are as follows:
1. Non-toxic to the host, without undesirable side effects.
2. Non-allergenic to the host.
3. Harmless to the normal flora of the host.
4. Able to reach the infected region of the body at a desirable
concentration.
5. Inexpensive and easy to produce.
6. Chemically stable.
7. Resistance is uncommon.
Table 1.1 summarizes the 5 basic sites of antibiotic activity. The most common site 
of antibiotic activity is interference with bacterial cell wall synthesis. Obviously, 
these agents are ineffective against wall-less organisms, such as Mycoplasma. 
Antibiotics such as the sulphonamides inhibit folic acid production. Polymyxins 
destroy cytoplasmic membranes of susceptible bacteria by producing a detergent-like 
activity resulting in leakage of the cell contents. Many antibiotics inhibit protein 
synthesis, while others inhibit DNA and RNA synthesis. *
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1.9.1 Antibiotic Resistance
Bacteria have been in existence for more than 3 billion years. Antibiotic resistance 
was well established long before the clinical use of antibiotics as a means of survival 
for bacteria exposed to antimicrobials produced by microbes in the surrounding 
environment (Holland, 1998). Surveillance of antimicrobial resistance began 60 years 
ago when the use of antimicrobial agents began and it was not long before 
microbiologists noted an increase in bacterial resistance to the antibiotics. For 
example, when penicillin was first introduced to the clinic, less than 1% of 
Staph, aureus were resistant. After a few years the proportion rose to 8% and at 
present more than 80% of clinically isolated Staph, aureus are resistant to penicillin 
(Ebrahim, 1995).
Antimicrobial resistant micro-organisms possess either intrinsic resistance or acquired 
resistance. Intrinsic resistance, or more accurately, insensitivity, is 
chromosomally-mediated and, typically, non-transferable (Huycke et al, 1998, 
Courvalin, 1996). Intrinsic resistance has been recognised since the early days of 
antibiotic therapy and refers to a trait that is present in all the members of a given 
bacterial genus or species. For example, Gram-negative bacteria, in particular 
Enterobacteriaceae, are naturally resistant to macrolides and resistant to glycopeptide 
antibiotics such as teicoplanin and vancomycin. This is due to the inability of the 
large molecules to permeate the outer membrane of the organism (Courvalin, 1996). 
Enterococci are intrinsically resistant to low-level aminoglycosides, such as
gentamicin, and the primary and secondary cephalosporins, while the lactic acid 
bacteria (Lactobacillus, Leuconostoc and Pediococcus) are resistant to glycopeptide 
antibiotics (Woodford et al, 1995). The motile enterococci
(Enterococcus gall inarum, Ent. casseliflavus and Ent. flavescens) possess the vanC 
gene (chromosomal) and consequently show low-level vancomycin resistance, but 
teicoplanin susceptibility (Woodford et al, 1995).
Acquired resistance can either be indigenous, through mutations, or exogenous, due 
to the acquisition of foreign DNA from other organisms (Neu, 1992, 
Courvalin, 1996). Chromosomally-mediated resistance that arises through mutation 
can only be passed on vertically to daughter cells resulting in a gradual spread of 
resistance which is usually low-level (Ebrahim, 1995). This type of resistance is 
usually progressive, evolving from low level through intermediate to high level 
resistance (Roberts, 1998). For example, fluroquinolone resistance in E. coli requires 
several sequential mutations to reach a clinically relevant level of resistance 
(Levy, 1998). Penicillin-resistant Streptococcus pneumoniae emerged after gradual 
progression from reduced susceptibility to high-level resistance 
(Goldstein & Gerau, 1994, Jacobs, 1999). This highlights the importance of constant 
surveillance, where an increasing minimum inhibitory concentration (MIC) is a 
possible indicator of future resistance (Levy, 1998).
Acquisition of exogenous resistance occurs through the exchange of genetic material 
by transformation, transduction or conjugation (Figure 1.9)(Courvalin, 1996).
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Figure 1.9: Gene transfer in bacteria 
a) conjugation, b) transduction and c) transformation (Miller, 1998)
Transduction is limited to closely-related species as a high degree of specificity is 
required in the adsorption step in bacteriophage invasion (Courvalin, 1996). 
Similarly, transformation may be confined to intrageneric transfer (Courvalin, 1996).
In transformation, DNA fragments are transferred into the genome of a 
naturally-transformable recipient organism by homologous recombination 
(Spratt et al, 1992). Transformation accounts for the build up of mosaic genes 
responsible for penicillin resistance by the production of hybrid penicillin-binding
proteins in S. pneumoniae, Neisseria gonorrhoeae and Neisseria meningitidis 
(Spratt et al, 1992).
Conjugation with plasmid transfer of DNA is particularly common among the 
Enterobacteriaceae, Pseudomonas and anaerobic organisms such as Bacteroides 
(Salyers & Shoemaker, 1996). Conjugative plasmids encode the proteins involved in 
their own transfer from a donor cell to a recipient cell (Burrus et al, 2002). These 
include the pili (Gram-negative) or aggregation factor (Gram-positive) needed for 
cell-to-cell contact, plus DNA relaxases (relaxosome), which nicks the orfY site of the 
plasmid (Figure 1.10). This enzyme is also involved in replicating the remaining 
strand in the donor and joining both ends to reform the plasmid. The nicked strand is 
transferred through the pili or mating pore and replicates in the recipient cell 
(Grohmann et al, 2003). Conjugative plasmids can efficiently transfer between 
Gram-positive or Gram-negative bacteria belonging to different genera but not 
between Gram-positive and Gram-negative organisms and vice versa 
(Courvalin, 1994). This is because their host range for replication is more narrow than 
that for transfer, meaning that although conjugation can occur, the DNA cannot 
replicate within the new host.
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9Figure 1.10: Conjugation between Gram-negative bacteria
Since the discovery o f conjugative plasmids, chromosomal conjugative elements have 
been identified and found that, unlike conjugative plasmids, cannot be isolated as 
circular replicative molecules. Site-specific recombinases encoded by these elements 
promote their excision and integration (Burrus et al, 2002). These elements are 
known as conjugative transposons and can transpose both intracellularly and 
intercellularly. They contribute to the spread o f antibiotic resistance genes in several 
clinically important groups of bacteria, including Gram-positive cocci, some 
Bacteroides species and certain Gram-negative bacteria (Speer et al, 1992, 
Salyers et al, 1995, Salyers & Shoemaker, 1996, Smith et al, 1998,
Rowe-Magnus et al, 2002). The best-studied chromosomal conjugative transposon is 
Tn916, found in Ent. faecalis, which carries the vanB gene (Manganelli et al, 1995, 
Burrus et al, 2002). Conjugative transposons differ from conjugative plasmids in that 
the circular intermediate o f a conjugative transposon does not replicate, at least in 
hosts so far investigated (Speer et al, 1992).
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In addition to conjugative plasmids, bacteria may possess transposons, so-called 
jumping genes that have the ability to enter transmissible plasmids or chromosomes 
(Haren et al, 1999). The transposon excises from the chromosome in which it is 
found and forms a covalently-closed circle. A single stranded copy of this circle is 
transferred to the recipient, where it is converted into double stranded DNA, which 
integrates into the DNA of the new host (Salyers & Shoemaker, 1996).
Studies have shown that regions that flank resistance genes in transposons and 
plasmids of Gram-negative bacteria often show high similarity (Olsen, 1999). This 
realisation led to the discovery of integrons. Integrons are natural genetic engineering 
elements that are able to stockpile and express selectable genes. The definitive 
features of integrons are that they encode a site-specific integrase (Inti) and have a 
proximal primary recombination sequence site (attl)(Hall & Collis, 1998). The 
integrase mediates recombination between the attl site and a secondary target called 
an attC site. The 59bp attC sites are found on gene cassettes. These are discrete 
genetic elements that may exist as free, circular, non-replicating DNA molecules 
when moving from one cell to another but are normally found as linear sequences 
within a larger DNA molecule such as a plasmid or bacterial chromosome 
(Bennett, 1999). Gene cassettes normally contain a single gene of approximately 
500-1000bp in length, which usually lacks a promotor. Once integrated with an 
integron, the gene is expressed by the integron’s promotor 
(Rowe-Magnus & Mazel, 2001). Although integrons are unable to self-transpose they
are often found associated with transposons and conjugative plasmids that can serve 
as vehicles for the intra- and inter-species transfer of genetic material. Their impact 
on the development of multi-antibiotic resistance has been considerable 
(Rowe-Magnus et al, 2002).
1.9.2 Selective Pressure
The use of antibiotics in the clinic results in selective pressure, which may give rise to 
an increased incidence of antibiotic resistance. An increasing rate of antibiotic 
consumption in several countries has resulted in a steady rise in the prevalence of 
resistant strains (Austin et al, 1997). In some countries there are a bewildering 
variety of proprietary drugs which contain irrational mixtures of antibiotics and other 
preparations such as vitamins, steroids and stimulants. These mixtures could be 
regarded as similar to the growth promoters often used in animal husbandry 
(Greenhalgh, 1986). Brazil alone has 117 different brands of ampicillin and 
amoxycillin, while Indonesia markets more than 13,000 drug formulations 
(Ebrahim, 1995). Additionally, in certain countries such as Mexico, Spain, Taiwan 
and China, antibiotics can be bought cheaply over-the-counter without a prescription, 
which may result in increased antibiotic consumption and, more importantly, use of 
the wrong drug (Livermore, 1995).
Long-term antibiotic consumption leads to long-term selective pressure, which can 
result in an increased incidence of antibiotic resistance. This is seen in subjects
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taking broad-spectrum antibiotics such as neutropaenic cancer patients and acne 
sufferers, who take fluoroquinolones and tetracyclines, respectively (Eady, 1998). 
Broad-spectrum agents act on a wide range of micro-organisms, resulting in the 
eradication of both pathogenic and commensal organisms. Surprisingly, the use of 
antibiotics by one person can affect other individuals in the immediate and extended 
environment. Studies have shown that the housemates of acne sufferers treated with 
antibiotics also had large numbers of drug-resistant flora on their skin 
(Miller et al, 1996).
Antibiotic resistance is becoming a great concern and the problem is impossible to 
reverse. Once resistance appears it is likely to decline slowly, if at all. There are no 
counter-selective measures against resistant bacteria and the slow loss of resistance is 
linked to poorly reversible genetic and environmental factors. Resistance is becoming 
a greater concern because there are no antibiotics to which resistance has not 
eventually appeared (Levy, 1997). Additionally, despite the intensive research that is 
being conducted by the pharmaceutical industry, only one new class of antimicrobials, 
the oxazolidinones, has been launched since 1972 (Livermore, 2003). The other 
newly introduced antimicrobials are permutations (analogues) of pre-existing 
compounds. Therefore, it is common to see resistance to these new antibiotics even 
before they have been introduced to the clinical environment. A global priority is to 
encourage the development of novel classes of antibiotics. However a major 
limitation is that it can cost up to $300 million to discover a new class of antibiotic 
(Levy, 1997).
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At present there are very few ways in which the emergence of antibiotic resistance 
can be slowed and it is near impossible to decrease. One way is that the general 
public must be better educated and understand that antibiotics are not miracle drugs, 
and that treatment may fail and may even be harmful. In addition, prescribers need to 
remain up to date on diagnosis and treatment of infectious diseases and not succumb 
to patient pressure for antibiotics (Williams & Heymann, 1998).
1.10 Penicillin Resistance
1.10.1 The Penicillins
Penicillin is an example of a p-lactam antibiotic. The P-lactams are potent
bactericidal agents of widespread clinical use and show low toxicity to eukaryotes. 
Antimicrobials belonging to this group include the penicillins (penems), 
cephalosporins (cephems), monobactams and carbapenems. Beta-lactam antibiotics 
have been in clinical use for more than 50 years and the susceptibility o f various 
pathogenic bacteria to these agents has changed dramatically over the years due to 
their widespread and liberal usage (Kotra & Mobashery, 1998).
Beta-lactams inhibit the synthesis of peptidoglycan, a major polymer of the bacterial 
cell wall. The targets for p-lactam antibiotics are cell wall-synthesising enzymes, 
which, due to their ability to bind covalently radiolabelled penicillin, are known as
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Penicillin-binding Proteins (PBP)(Blumberg & Strominger, 1974). PBPs are present 
in nearly all bacteria and vary from species to species in number, size, quantity and 
affinity for p-lactam antibiotics (Georgopapadakou, 1993). The functions of PBPs 
are diverse and include transpeptidase, transglycosylase and carboxypeptidase 
activities (Massova & Mobashery, 1998). The enzymes are localized non-randomly 
on the outer face of the cytoplasmic membrane and are anchored through short 
hydrophobic carboxy- or amino-terminal sequences (Georgopapadakou, 1993). All 
prokaryotes have between 2 and 4 essential PBPs and therefore the p-lactams have 
multiple targets. Inhibition of any of these enzymes can lead to cell lysis, death or 
growth arrest (Georgopapadakou, 1993).
1.10.2 Penicillin Resistance Mechanisms
Micro-organisms resistant to P-lactams exhibit either altered PBPs or produce 
P-lactamases (penicillinases). In addition, some Gram-negative organisms also 
exhibit altered outer membrane permeability (Philippon et al, 1989).
Altered PBPs are more commonly found in Gram-positive than Gram-negative 
bacteria (Georgopapadakou, 1993). The most common example of PBP-mediated 
resistance is methicillin-resistant Staph. aureus (MRSA) 
(Brumfitt & Hamilton-Miller, 1989). Staphylococcus aureus normally has five PBPs 
while methicillin-resistant organisms have an additional 78-kDa PBP, known as 2a or 
2’, which has a low affinity for p-lactams and catalyses a penicillin-insensitive
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transpeptidation (de Jonge et al, 1992). This enzyme is encoded by a chromosomal 
gene known as mecA (Georgopapadakou, 1993). Other Gram-positive organisms 
such as Staphylococcus epidermidis, S. pneumoniae, viridans streptococci and 
enterococci possess altered PBPs (Georgopapadakou, 1993). Resistance to P-lactams 
in Gram-negative bacteria is not commonly associated with altered PBPs, probably 
due to the effectiveness of P-lactamases, coupled with reduced outer membrane 
permeability (Spratt, 1988).
Beta lactamases are the most common cause of bacterial resistance to P-lactam 
antibiotics (Livermore, 1995). The p-lactamases have been classified into 4 groups. 
Beta-lactamases belonging to groups A, C and D possess serine residues, which 
participate in the active site of the enzyme (Kotra & Mobashery, 1998). Class B 
p-lactamases are metalloenzymes and utilize zinc to disrupt the p-lactam ring 
(Livermore, 1995). Beta lactamases are encoded by genes found both chromosomally 
and, more commonly, on plasmids. Examples of these enzymes include 
SHV (sulphydryl variable), TEM (Temoniera) and PSE {Pseudomonas-specific 
enzyme). A range of p-lactam inhibitors have been developed such as clavulanate, 
sulbactam and tazobactam, which render resistant organisms sensitive (Sirot, 1995). 
However, p-lactamase-inhibitor combinations do not reduce the MIC greatly, when 
compared with organisms without the p-lactamase protein.
Extended-spectrum p-lactamases (ESBLs) are mutant enzymes which derive from 
TEM or SHV (Class A) enzymes. They confer variable levels of resistance to
cefotaxime, ceftazidime and other broad-spectrum cephalosporins and monobactams. 
They have no activity against cefamycins and carbapenems (Sirot, 1995). ESBLs 
have been detected in nearly all species of Enterobacteriaceae, such as E. coli and 
Enterobacter aerogenes but are more common in K. pneumoniae (Jacoby, 1994, 
Sirot, 1995). Most EBSLs are found on plasmids and allows resistance to spread 
readily to other pathogens (Sirot, 1995).
1.10.3 Oral Flora and B-lactam Resistance
Beta-lactamase producing strains of Haemophilus, Actinomyces, Veillonella, 
Lactobacillus, Clostridium, Peptostreptococcus, Streptococcus, Bacteroides, 
Neisseria, Moraxella, Eikenella and Capnocytophaga have been isolated from the 
oral flora of humans (Slots, 1979, Moore et al, 1984, Wasfy et al, 1986, 
Lacroix & Walker, 1992, Roberts, 1998, Packer et al, 1999).
1.11 Vancomycin Resistance
1.11.1 The Glvcopeptides
Vancomycin is a glycopeptide antibiotic, isolated from Streptomyces orientalis and, 
along with teicoplanin, inhibits cell wall synthesis in Gram-positive bacteria by 
interacting with the terminal D-alanyl-D-alanine (D-Ala-D-Ala) group of the 
pentapeptide side chains of peptidoglycan precursors (Reynolds, 1989).
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This interaction prevents the transglycosylation and transpeptidation reactions 
required for polymerisation of peptidoglycan. Glycopeptides are large molecules; 
vancomycin has a molecular mass of 1,448 and teicoplanin is 1,900; and thus are 
unable to permeate the outer-membrane of Gram-negative organisms and reach the 
target site. Therefore, nearly all Gram-negative organisms are resistant to 
glycopeptide action, while nearly all Gram-positive organisms are susceptible 
(Woodford et al, 1995). Since the introduction of vancomycin in the 1950’s the 
glycopeptide class of antibiotics has been used to treat diseases caused by 
Gram-positive organisms possessing intrinsic resistance to other agents, as in 
Clostridium difficile and Corynebacterium jeikeium, or acquired resistance, such as 
MRSA.
1.11.2 Vancomycin Resistance Mechanisms
The introduction of new antibiotics into clinical use is usually followed by the fairly 
rapid emergence of bacterial resistance. However, isolates resistant to vancomycin 
were not found until almost 30 years after the introduction of vancomycin to the clinic 
(Woodford et al, 1995). In addition, resistance to vancomycin was reported only 
rarely and appeared to have little clinical significance (Woodford et al, 1995). 
However, in 1988 there were two reports of plasmid-mediated, high-level resistance 
to both vancomycin and teicoplanin in Enterococcus species (Woodford et al, 1995). 
These and subsequent reports alerted microbiologists to the possibility of 
glycopeptide resistance in enterococci and many laboratories began screening for it.
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Recent studies by the National Nosocomial Infections Surveillance programme of the 
Centers for Disease Control and Prevention (CDC) found that up to 10% of 
hospital-acquired enterococci isolated from patients in intensive care units (ICUs) 
were resistant to vancomycin. Treatment of these infections is usually difficult since 
these organisms are also often resistant to other agents such as p lactams and 
macrolides (Bonafede & Rice, 1997).
Enterococci are increasingly prominent nosocomial pathogens and, due to the 
increasing number of vancomycin resistant organisms isolated, many laboratories are 
studying vancomycin resistance. To date, 5 glycopeptide resistance phenotypes have 
been described in enterococci (Woodford, 2001). The two primary clinical important 
phenotypes are VanA and VanB. VanA strains express high-level vancomycin and 
teicoplanin resistance, while VanB strains express low-level vancomycin resistance 
and susceptibility to teicoplanin (Arthur & Courvalin, 1993). The apparent 
susceptibility to teicoplanin is due to teicoplanin being a poor inducer of the VanB 
operon. VanC confers low-level resistance to vancomycin and is an intrinsic property 
of most isolates of Ent. casseliflavus, Ent. flavescens and Ent. gallinarum 
(Woodford et al, 1995, Woodford, 1998).
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1.11.3 Oral Flora and Vancomycin Resistance
Resistance to vancomycin is rarely encountered in viridans streptococci. Resistance 
was first reported in Slovakia in 1996, while vancomycin resistance in enterococci 
had been reported 8 years previously (Uttley et al, 1988, Krcmery et al, 1996a). The 
vancomycin-resistant S. mitis displayed low-level resistance to vancomycin 
(MIC 16-32mg/l) and was sensitive to teicoplanin, suggesting that the organism had 
an enterococcal vanB gene. Since then, studies have shown in vitro transfer of the 
vanA gene from Ent. faecium  to S. sanguinis, resulting in high-level vancomycin 
resistance (MIC 128mg/l)(Leclercq et al, 1989).
1.12 Erythromycin Resistance
1.12.1 The Macrolides
McGuire and coworkers discovered erythromycin in 1952 when studying the 
metabolic products of a strain of Saccharopolyspora erythaea (previously known as 
Streptomyces erythreus), which had been collected from a soil sample from the 
Phillippine Archipelago (Roberts et al, 1999). Erythromycin can be either 
bacteriostatic or bacteriocidal depending on the drug concentration, organism 
susceptibility, organism growth rate and size of inoculum. Erythromycin belongs to 
the macrolide class of antibiotics, which along with the lincosamides and
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streptogramins inhibit protein synthesis by binding to the 50S bacterial ribosomal 
subunit (Weisblum, 1995, Roberts, 1998). Although all 3 classes are structurally 
unrelated, all share overlapping binding sites on the 50S ribosomal subunit. The 
newer derivatives of macrolides possess both Gram-negative and Gram-positive 
antimicrobial activity, although the older derivatives such as erythromycin only show 
activity against Gram-positive bacteria and certain Gram-negative genera such as 
Neisseria, Haemophilus and Bacteroides (Roberts et al, 1999). In addition, 
erythromycin is active against mycobacterial infections (Piddock, 1998).
1.12.2 Erythromycin Resistance Mechanisms
Bacteria possess a number of different mechanisms of resistance to macrolides, 
including efflux, drug inactivation and target site alteration (Roberts, 1998). 
Ribosomal mutation is the most common mechanism and this is carried out by a 
rRNA methylase that post-translationally modifies an adenine residue at position 
2058 of the 23S rRNA (Eady et al, 1990, Roberts, 1998). This leads to a 
conformational change in the ribosome, resulting in cross resistance and prevents 
both macrolides, lincosamides and type B streptogramins (MLSb) from binding to the 
50S ribosomal subunit (Leclercq & Courvalin, 1991a, 1991b, Roberts et al, 1999).
• Ribosomal RNA methylases are encoded by the erm genes (erythromycin resistant 
methylases) and to date more than 30 erm genes have been isolated (Roberts, 1998). 
They have been isolated from a wide variety of species including a number of
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different Gram-positive and a limited number of Gram-negative organisms 
(Table 1.2)(Roberts et al, 1999). The genes have been grouped into families based on 
their DNA and amino acid homology and every new gene isolated from a different 
species is given a new letter designation (Leclercq & Courvalin, 1991a, 1991b). The 
majority of erm genes are highly related to ermB and ermAM  (Roberts, 1998). The 
ermB group was first described in streptococci and has now been isolated from oral 
bacteria such as A. actinomycetemcomitans, Treponema denticola and 
Fusobacterium, Haemophilus, Peptostreptococcus, Porphyromonas and Vellionella 
species (Roberts, 1998). The ErmC methylase has been found in both Gram-negative 
(A. actinomycetemcomitans and Neisseria species) and Gram-positive organisms 
{Lactobacillus and Streptococcus species)(Roberts et al, 1999). The ermA gene has 
been found in staphylococci and ermQ in A. actinomycetemcomitans 
(Weisblum, 1995, Roberts et al, 1999). The erm genes are often chromosomal and 
associated with either transposons or conjugative transposons (Roberts, 1998). They 
are often associated with other antibiotic resistance genes, especially 
tetracycline resistance genes (Roberts et al, 1999). The ermB gene is often linked 
with the tetM  gene, while the ermF gene is often linked with the tetQ gene 
(Roberts et al, 1999).
The efflux mechanism of resistance, designated the M phenotype, causes resistance to 
14-membered (roxithromycin, clarithromycin, oleandomycin, erythromycin and 
dirithromycin) and 15-membered (azithromycin) macrolides (Leclerq, 2002). In 
S. pyogenes, the mefA (macrolide efflux) gene and in S. pneumoniae, the mefE gene
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encodes proteins involved in efflux (Roberts, 1998). In Staph, aureus, the msrA gene, 
and in Staph, epidermidis, the mreA gene, encode proteins involved in efflux 
(Eady et al, 1990, Clancy et al, 1997).
Drug inactivation is a mechanism less commonly observed in organisms, although it 
has been detected in E. coli, Staph, aureus, lactobacilli and coagulase-negative 
staphylococci (Leclerq & Courvalin, 1991a, 1991b). Unlike target-site alternation, 
enzymatic modification of M L S b  antibiotics is highly specific (Roberts, 1998). For 
example, an organism possessing the erythromycin esterase confers resistance to 
erythromycin and other 14-membered macrolides only.
1.12.3 Oral Flora and Macrolide Resistance
Numerous laboratories around the world have looked for macrolide resistance genes 
in the oral flora, especially in viridans streptococci. To date, genes encoding efflux 
proteins (mef) and ribosomal methylases (erm) have been found. Erm genes have 
been found in S. oralis and S. mitis (Table 1.2)(Poutanen et al, 1999, 
Ono et al, 2000). Prevotella, Porphyromonas and Bacteroides have been found to 
possess ermF and strains of the ‘S. millerV group have the ermB gene 
(Arzese et al, 2000, Jacobs et al, 2001, Chung et al, 2002). MefE is found in 
S. oralis, S. mitis and S. salivarius, while m ef A is found in strains of S. oralis 
(Arpin et al, 1999, Ono et al, 2000).
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1.13 Tetracycline Resistance
1.13.1 The Tetracyclines
The development of the tetracycline antibiotics was the result of systematic screening 
of soil specimens collected from many parts of the world for antibiotic-producing 
microorganisms (Brumfitt & Hamilton-Miller, 1988). Chlortetracycline, obtained 
from Streptomyces aureofaciens, was introduced in 1948, and in 1952, a third 
member, tetracycline, was produced semi-synthetically from chlortetracycline 
(Roberts, 1996, Chopra & Roberts, 2001). Tetracyclines are broad-spectrum 
antimicrobials that are active against a wide range of Gram-positive and 
Gram-negative bacteria, cell wall-free mycoplasmas, chlamydiae, rickettsiae and 
protozoan parasites (Roberts, 1998, Chopra & Roberts, 2001). Due to their broad 
spectrum of activity, relative safety and low cost, tetracyclines have been used widely 
throughout the world and are the second most commonly used antibiotic after 
penicillins (Roberts, 1994, 1998). Tetracyclines also possess non-antimicrobial 
properties including anti-inflammatory and immunosuppressive properties, antibody 
production suppression, reduction in leucocyte and neutrophil chemotaxis, reduction 
in phagocytic function of polymorphonuclear leucocytes (PMN), inhibition of lipase 
and collagenase activity and anti-tumour activity (Roberts, 1996). These additional 
properties have led to an increase in the use of tetracyclines, resulting in an increase 
in the overall consumption of the antibiotic and greater exposure of the normal flora 
to the antimicrobial (Roberts, 1998).
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Tetracyclines gain access into the bacterial cell wall by passive diffusion through 
hydrophilic pores in the outer cell membrane and then through the inner cytoplasmic 
membrane by energy-dependent transport (Roberts, 1996). The tetracyclines act by 
blocking the binding of aminoacyl tRNA to the acceptor site (A site) on the ribosome.
1.13.2 Tetracycline Resistance Mechanisms
During the past 20 years resistance to tetracycline has limited their use 
(Roberts, 1994). Resistance to tetracycline is primarily due to the acquisition of 
Tet determinants rather than to mutation of existing chromosomal genes 
(Roberts, 1994). To date, 29 tetracycline resistance determinants (Tet) and 
3 oxytetracycline resistance determinants (Otr) have been described and characterized 
(Chopra & Roberts, 2001). There is no inherent difference between a tetracycline and 
oxytetracycline resistance gene (Chopra & Roberts, 2001). The oxytetracycline genes 
were first identified in oxytetracycline-producing organisms and thus nomenclature 
reflects the organisms first shown to carry the particular gene 
(Chopra & Roberts, 2001). Of the 29 determinants, 14 are often associated with 
plasmids, while others are found on the chromosome (Table 1.3). The most 
widespread tetr determinant is tetB which has been identified in 20 Gram-negative 
genera. The tetB gene is found on conjugative plasmids of oral bacteria such as 
Actinobacillus, Pasteurella, Providencia, Treponema and most Haemophilus species 
(Table 1.4)(Roberts, 1998). TetM is the second most frequently described
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tetr determinant and has been identified in 28 different genera and in a large number 
of different species (Roberts, 1998). TetM determinants are associated with 
conjugative elements found in both Gram-positive peptostreptococci and streptococci 
and Gram-negative Fusobacterium and Veillonella (Roberts, 1998)(Tables 1.4 & 1.5). 
Many tetracycline-resistant bacteria contain two tet determinants and often the MIC 
of tetracycline towards these organisms is greater than those with only one 
tetr determinant (Rodriguez-Avial et al, 2003).
To date, three different mechanisms of tetracycline resistance have been studied:
1. Energy-dependent efflux of tetracycline by proteins inserted into the 
cytoplasmic membrane.
2. Protection of the bacterial ribosome from the action of tetracycline.
3. Enzymatic alteration and inactivation of tetracycline.
The tetr determinants associated with these mechanisms are summarised in Table 1.6.
Efflux proteins have been the best studied of the tetr determinants and all these genes 
code for energy-dependent membrane-associated proteins which export tetracycline 
out of the cell (Roberts, 1994). The protein is approximately 46kDa consisting of 
12 hydrophilic sequences. The efflux proteins exchange a protein for a 
tetracycline-cation complex and are antiporter systems (Roberts, 1994). The efflux 
proteins have amino acid and protein structure similarities with other efflux proteins
involved in multiple-drug resistance and resistance to quaternary ammounium 
compounds (QAC), chloramphenicol and quinolones.
The ribosomal protection mechanism of tetracycline resistance was first discovered in 
streptococci (Burdett, 1986). These are cytoplasmic proteins that protect the 
ribsosome from the action of tetracycline and confer resistance to doxycycline and 
minocycline. They confer a wider spectrum of resistance to tetracyclines than is seen 
with bacteria that carry tetracycline efflux proteins (Chopra & Roberts, 2001). 
Ribosomal protection proteins have been sequenced and have amino acid sequences 
similar to elongation factor G (EF-G) and elongation factor Tu (EF-Tu) 
(Taylor & Chau, 1986). The proteins show a ribosome-dependent GTPase 
(Chopra & Roberts, 2001).
To date, examples of enzymatically mediated resistance to tetracycline include TetX, 
Tet34 and Tet37 (Chopra & Roberts, 2001). The presence of TetX in Bacteroides is 
unusual because the protein is not operational in the absence of oxygen 
(Speer et al, 1991). Bacteroides are obligate anaerobes and therefore the clinical 
significance of TetX is questionable.
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1.13.3 Oral Flora and Tetracycline Resistance
Tetracycline antibiotics are frequently used as adjuncts to conventional periodontal 
therapy and thus many groups have studied the incidence of tet genes in periodontal 
pathogens. Mitsuokella multiacidus, Porphyromonas, Prevotella and 
Bacteroides species have been found to contain the tetQ gene (Leng et al, 1997, 
Chung et al, 2002). TetM has been found in Actinomyces, Bacteroides, 
Bifidobacterium, Clostridium, Eubacterium, Lactobacillus, Peptostreptococcus, 
Veillonella, Ureaplasma and Streptococcus (including ‘S. milleri\ S. gordonii,
S. mitis, S. oralis, S. parasanguinis and S. sanguinis), (Tables 1.4 & 1.5) 
(Lacroix & Walker, 1995, Roberts, 1996).
1.14 Metronidazole Resistance
1.14.1 The 5-nitroimidazoles
Metronidazole and other 5-nitroimidazole drugs are valuable agents in the treatment 
of several protozoal and anaerobic bacterial infections (Freeman et al, 1997, 
Piddock, 1998, Samuelson, 1999). However, compared to other classes of antibiotics, 
very little is known about the nitroimidazole compounds. Metronidazole enters the 
cell by diffusion and the nitro-group is reduced to a radical anion, while the released 
nitroso and hydroxylamine derivatives interfere with DNA synthesis and degrade
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existing DNA, resulting in cell death (Edwards, 1993). The process occurs at a low 
oxidation-reduction potential found in anaerobic conditions and the reduction is due 
to a ferredoxin-linked hydrogenase (Church et al, 1996). Metronidazole activity 
decreases in the presence of oxygen, often resulting in the isolation of apparently 
metronidazole-resistant anaerobes but when these organisms are further characterised, 
it is shown to be the consequence of an insufficiently anaerobic atmosphere 
(Piddock, 1998).
1.14.2 Metronidazole Resistance Mechanisms
Resistance to metronidazole is still rare, but is sometimes seen in clinical isolates 
especially Bacteroides species (Greenstein, 1993). Only a few metronidazole 
resistance genes have been cloned and characterised and these have been found to be 
located on both chromosomes and plasmids. They have been shown to be 
transferable by conjugation or by transformation, leading to the possibility of 
metronidazole resistance becoming more widespread in the future (Smith et al, 1998). 
The genes nimA, nimB, nimC and nimD have found to confer moderate to high-level 
metronidazole resistance in colonic Bacteroides species (Piddock, 1998). The 
nim genes are likely to code for a 5-nitroimidazole reductase which enzymatically 
reduces the 5-nitroimidazole to a 5-amino derivative (Roberts, 1998).
84
1.14.3 Oral Flora and Metronidazole Resistance
Metronidazole-resistant A. actinomycetenemcomitans, B. fragilis and 
Fusobacterium nucleatum have been isolated from subgingival plaque 
(Van Winckelhoff et al, 2000).
1.15 Aims of the study
There were several aims to the study. As very little information was available on 
mercury sensitivity testing, the first aim was to determine the most suitable agar and 
concentration of mercuric chloride to use in this project. The second aim was to 
determine whether children with fillings harboured a higher proportion of 
mercury-resistant bacteria in their oral flora than children without amalgam fillings. 
This was achieved through both a cross-sectional and longitudinal study. A further 
aim of the longitudinal study was to determine whether placement of mercury 
amalgam fillings in children’s teeth resulted in an increase in oral bacteria resistant to 
penicillin, ampicillin, erythromycin, vancomycin, tetracycline or metronidazole. The 
third aim was to identify the mercury-resistant bacteria and determine whether there 
were differences in the types of organism isolated from individuals with and without 
amalgam fillings. An additional objective was to investigate whether the 
mercury-resistant organisms were also resistant to 6  antibiotics and to determine 
whether there were differences between the non-amalgam and amalgam individuals. 
Finally, the mercury-resistant bacteria were screened using molecular techniques to
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determine whether they possessed the merA gene. A selection of the amplified genes 
were sequenced and compared to the B. cereus RC607 merA gene using the BLAST 
database.
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Mechanism Bacteriostatic Comments Examples
or Bacteriocidal
Damage cell membrane 
allowing contents to leak out
Bacteriocidal High toxicity to animals and humans. Topical use only Polymyxin
Inhibitors of bacterial cell wall 
synthesis
Bacteriocidal Animals and human do not have cell walls, so they are 
not affected
Penicllins 
Cephalosporins 
Bacitracin (topical) 
Glycopeptides
Inhibitors of folic acid synthesis 
which is needed for RNA and 
DNA synthesis
Bacteriostatic Animals and humans get folic acid from diet Sulphonamides
Trimethoprim
Cotrimoxazole
Inhibitors of protein synthesis Bacteriocidal/
Bacteriostatic
Eukaryotic and prokaryotic ribosomes are different. 
High doses of the drug can affect animals and humans
Tetracyclines
Aminoglycosides
Chloramphenicol
Macroliaes
Inhibitors of DNA function Bacteriocidal Drugs used affect bacterial cells more than animal or Quinolones
human cells Metronidazole
Rifampicin
Table 1.1 : Sites of antibiotic activity
Gram-positive, mycobacteria Gram-negative
Bacterium erm gene(s) Bacterium erm gene(s)
Actinomyces
Aerococcus
Arcanobacterium
Arthrobacter
Bacillus
Clostridium
Corynebacterium
Enterococcus
Gardnerella
Lactobacillus
Micrococcus
Micromonospora
Mobiluncus
Mycobacterium
Pediococcus
Peptostreptococcus
Propionibacterium
Rothia
Staphylococcus
Streptococcus
Streptomyces
C F 
B’
B, X 
R
B, D, C, G, 34
b’, ? , x
B ,C ,F
B, C, G5 T 
B. C, 3(>
W
F
37,38, 39 
B
A, B, C, F
X
B
A, B, C, F, 0 , Y, 33 
A, B, C. F, Q
E, H, I, N, 0 , S, U, V, Z, 30,31,32
Acinetobacter
Actinobacillus
Bacteroides
Enterobacter
Escherichia
Eubacterium
Fusobacterium
Haemophilus
Klebsiella
Neisseria
Pantoea
Porphyromonas
Prevote/la
Proteus
Pseudomonas
Selenomonas
Serratia
Treponema
Veulonella
Wolinella
B
A, B, C, F, O
A, B, C, F, G,
B
£ ’FB, F
i ’F
B ,C, F
B , R G
A, d, F, G 
B
B
F
B
F
B, C, F,Q
35
Table 1.2
Distribution of erm gGenes among Gram-positive Bacteria, Mycobacteria and Gram-negative Bacteria
Species in bold are part of the human oral flora 
(Modified from Roberts et al, 1999)
Plamid Chromosome
Tet A-E 
TetX  
Tet G, H 
Tet K 
TetL
Tet M (rare) 
TetO 
Tet P
TetS
Tet B (rare)
Tet K
Tet L (rare) 
Tet M 
TetO
Tet Q
Tet W 
Tet 32 
Otr A-C
Table 1.3
Location of the tetracycline resistance (Tet) determinants 
(Modified from Roberts, 1994, 1996 and Villedieu et al, 2003)
Efflux Ribosomal protection and/or efflux
Bacterium Tet determinant(s) Bacterium Tet determ inant(s)
Actino bacillus Te
Aeromonas Te
Agrobacterium Te
AJcaligenes Te
Alteromonas Te
Brevundimonas Te
Citrobacter Te
Edwardsiella Te
Enterobacter Te
Erwinia Te
Escherichia Te
Eubacterium Te
Francisella Te
Klebsiella Te
Mannheimia Te
Moraxella Te
Morganella Te
Pantoea Te
Pasteurella Te
Photobacterium Te
Plesiomonas Te
Proteus Te
Providencia Te
Pseudomonas Te
Ralstonia Te
Salmonella Te
Serratia Te
Shigella Te
Stenotrophomonas Te
Treponema Te
Yersinia Te
Vibrio Te
a :3d
E
D
B
f r
C
B’
!■
B
B’
I
vi
%
3$
B
B
A,
B, H, L, O 
B, D, E, 31
B, C, D 
D
C, D, M
B, C, D, E, G, M, I, Y
B, C, D, M 
G, H 
H
D, H
D, M, Y 
B, D, J
B, C, J
E, I
C, E, G, M, 34
B, C, D, G, L 
B, C, E, 34 
B, C, D
B, C, D, E, G
A cinetobacter T e
Bacteroides Te
Butyrivibrio Te
Camplyobacter Te
Capnocytophaga Te
Eikenella Te
Fusobacterium Te
Haemophilus Te
Kingella Te
Megasphaera Te
Mitsuokella Te
Neisseria Te
Pasteurella Te
Porphyromonas Te
Prevote/I a Te
Selenomonas Te
Veillonella Te
Vibrio Te
A, B. H, M, 39 
A, M, Q, X, 36
o, w 
o
&
L, M, W
A. B, K, M
M
o, w
M ,Q, W
B, M, Q, O, W 
B, D, IT, G, M
& W
w
q ;%
A, L, M, Q, S, W
A, B, C, D, E, G, M, 34, 35
Table 1.4
Distribution of tetracycline resistance (Tet) determinants among Gram-negative bacteria. 
Species in bold are part of the human oral flora
(Modified from Rooerts, 1994, 1996, Chopra & Roberts, 2001, Villedieu et al, 2003)
Efflux Ribosomal protection and/or efflux
Bacterium Tet determ inant(s) Bacterium Tet determ inant(s)
Nocardia Tet K Abiotrophia
Actinomyces
Aerococcus
Bacillus
Bacterionema
Bifidobacterium
Clostridium
Corvnebacterium
Eu bacterium
Gardnerella
Gemella
Lactobacillus
Listeria
Mobiluncus
Tet M
Tet L, M, W 
Tet M, 0  
Tet K, L, M, W 
Tet M 
Tet M, W
Tet K, L, M, P, Q, 32 
Tet M, Z, 33 
Tet K, M, Q 
Tet M, Q 
Tet M
Tet 0 , Q, S, W 
Tet K, L, M, S 
Tet O, Q
Mycobacterium
Mycoplasma
Tet K, L, M, V, Otr A, B, C
Tet M
Peptostreptococcus Tet K, L, M, O, Q
Staphylococcus Tet K, L, M, O, U, W, 38
Streptococcus Tet K, L, M, 0 , Q, T, W
Streptomyces Tet K, L, M, W, Otr A, B, C, tcr3
Ureaplasma Tet M
Table 1.5
Distribution of tetracycline resistance determinants among Gram-positive bacteria, mycobacteria, Mycoplasma, Nocardia,
Streptomyces and Ureaplasma 
Species in bold are part of the human oral flora 
(Modified from Roberts, 1994, 1996, Chopra & Roberts, 2001, Villedieu et al, 2003)
Efflux Ribosomal Enzymatic Unknown
Tet A-E Tet M TetX
Tet G-J TetO Tet 34
Tet K-L Tet P(B)a Tet 37
Tet P(A)a Tet Q
Tet U-V TetS
Tet Y-Z TetT
Tet W
Tet 30-3 lb Tetc
Tet 33 
Tet 35 
Tet 38-39
Otr B-C Tet 32
Ter 3C Tet 36
Otr A
Table 1.6
Classification of tetracycline resistance determinants according to their mechanism of resistance 
(Modified from Roberts, 1994, 1996, Chopra & Roberts, 2001, Villedieu et al, 2003)
Tet P(A) and Tet P(B) are counted as one gene 
First numbered genes
This gene has not been given a new designation
Chapter Two 
Materials and Methods
2.0 Materials and Methods
2.1 Microbiological Techniques
2.1.1 Bacteriological Agar
The bacteriological agar was purchased from Oxoid (Basingstoke, Hampshire, 
UK), with the exception o f Mitis Salivarius agar, which was supplied by 
Difco Ltd (Beckton Dickinson, Cowley, Oxfordshire, UK). All agars were made 
according to the manufacturer’s instructions and autoclaved in glass Duran bottles 
(Jencons, Leighton Buzzard, Bedfordshire, UK). Before pouring, the agar was 
allowed to cool to 50°C in a waterbath.
2.1.2 Bacteriological Broth
The Brain Heart Infusion and Tryptone Soya broths were purchased in powder 
form from Oxoid and made according to the manufacturers instructions.
2.1.3 Ringers Solution
Quarter-strength Ringers solution was obtained in tablet form from Oxoid and 
made according to the manufacturers instructions.
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2.1.4 Antibiotics
The antibiotics, with the exception of gentamicin, were obtained in powder form 
from Sigma-Aldrich (Poole, Dorset, UK). Gentamicin was obtained in ampoules 
from Sigma-Aldrich.
The gentamicin, erythromycin, tetracycline, and kanamycin used were not 
1 0 0 % pure and had been assayed by the manufacturer to determine the actual 
amount of biologically active drug present. The vancomycin used had a potency 
greater than 100%. This is because vancomycin powder is now produced in a 
purer form than the reference standard powder initially characterised many years 
ago. The formula below was used to determine the weight of powder required to 
prepare stock solutions of 10,000mg/litre (Equation 2.1).
P = Potency given by manufacturer in relation to base 
V = Desired volume (ml) stock solution 
C = Final concentration o f solution (multiples o f 1000) 
W = Weight (mg) o f antibiotic to be dissolved in V
Preparation of Antibiotic Stock Solutions 
The preparation and storage of the antibiotics are shown in Table 2.1.
x V x C
Equation 2.1:
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2.1.5 Phosphate Buffer
The phosphate buffer was prepared by mixing stock buffer A 
(KH2PO4, monobasic potassium phosphate)(Sigma-Aldrich) with stock buffer B 
(K2HPO4, dibasic potassium phosphate)(Sigma-Aldrich).
2.1.5.1 Stock Buffer A. KH9PO4 (0.2M)
27.22g monobasic potassium phosphate (anhydrous, KH2PO4)
200ml DD-H2O
This was brought up to 1000ml with distilled water and autoclaved at 121°C for 
15 minutes. This buffer was stored for 1 year at 2 - 8 °C.
2.1.5.2 Stock Buffer B. K?HPQ4 (0.2M)
45.64g dibasic potassium phosphate (K2HPO4.3 H2O)
200ml DD-H2O
Distilled water was added to bring the solution up to 1000ml and autoclaved at 
121°C for 15 minutes. This buffer was stored at 2 - 8°C for up to 1 year.
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2.1.5.3 Phosphate Buffer, pH8.0 (0.1M)
To prepare the 0.1M phosphate buffer (pH8.0), 2.65ml o f stock buffer A was 
mixed with 47.35ml stock buffer B and brought up to 100ml by adding distilled 
water. The pH was checked with a pH meter and adjusted as required with 
1M sodium hydroxide (NaOH) or 0.1M phosphoric acid (H3PO4). Autoclaving 
can alter the pH, so the buffer was sterilised by filtration. Finally, the buffer was 
stored at 25°C for up to 1 year.
2.1.6 Mercuric Chloride
The mercuric chloride used in this study was obtained from Sigma-Aldrich. 
A 0.1M stock solution was prepared by dissolving the mercuric chloride powder 
in sterile distilled water. The stock solution was stored in a plastic universal 
container (Sarstedt, Leicester, UK) wrapped in aluminium foil to protect from 
sunlight and was discarded if not used on the day on which it was prepared.
2.1.7 Control Organisms
The mercury-resistant organisms used in this study were Staph, aureus 
NCTC 50581, Ent. faecium  664 1H1, Enterococcus CE13 and Bacillus cereus 
RC607. The former was obtained from the Health Protection Agency 
(HPA)(formerly known as the Central Public Health Laboratory, Colindale, 
London, UK) and the enterococci and bacillus strains were obtained from 
Professor Anne Summers, University of Georgia, Athens, Georgia, USA. The
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enterococci were isolated from monkey gingiva, whereas the mercury-resistant 
B. cereus was isolated from Boston Harbour, Massachusetts, USA 
(Mahler et al, 1986, Summers et al, 1993). These mercury-resistant organisms 
were maintained by weekly subculturing on Mueller-Hinton (MH) agar containing 
20pM HgCU. Professor Summers also provided a mercury-sensitive S. mitis 
strain, 606 4T1. The mercury-sensitive Staph, aureus used in this study was 
Staph, aureus 8325-4, obtained from Dr Sean Nair (Department o f Oral Surgery, 
Eastman Dental Institute). This organism and NCTC 50581 are genetically 
identical, except that the mercury-sensitive strain lacks the plasmid pI258 that 
harbours the mercury operon. The mercury-sensitive organisms were subcultured 
every 7 days on Columbia agar containing 5% defibrinated horse blood 
(CBA)(E&0 Laboratories, Bonnybridge, Stirlingshire, UK).
The antibiotic-sensitive organisms, E. coli NCTC 10418 and Staph, aureus 
NCTC 6571 (Oxford Staphylococcus) were used to control the antibiotic 
breakpoint plates used in Chapters 4 and 5. These strains were obtained from the 
HPA and subcultured weekly onto CBA.
2.1.8 10% Glycerol-BHI Frozen Stocks
All the mercury- and antibiotic-resistant strains isolated from the study were 
frozen at -70°C in a 10% glycerol-BHI solution. The glycerol was bought from 
Sigma-Aldrich.
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2.2 Bacterial Identification
The chemicals in this section were purchased from Sigma-Aldrich.
Table 2.2 shows the tests used to identify the mercury-resistant bacteria to the 
genus level.
2.2.1 Oxidase Reagent (Cytochrome c Oxidase Activity)
A fresh solution of the reagent was prepared each time of use by adding a loopful 
of N,N,N’,N’-Tetramethyl-p-phenylenediamine dihydrochloride to 3ml sterile 
distilled water in a bijou container (Sarstedt). To test for oxidase activity a Q tip 
was immersed in the indicator solution and the excess solution removed by 
pressing the tip against the side o f the bijou. The test colony was touched with the 
Q tip and the appearance o f a dark purple colour on the Q tip within 30 seconds 
indicated a positive reaction.
2.2.2 Catalase Test
Catalase activity was detected using 3% hydrogen peroxide solution and a 
capillary tube. The presence o f gas bubbles (O2) indicated catalase activity.
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2.2.3 Streptococcal Identification
2.2.3.1 Biochemical Method 
TES Buffer
12.56g N-tris (hydroxymethyl) methyl-2-aminoethanesulphonic
acid (TES)
1000ml DD-H20
The pH was adjusted to pH7.5 with sodium hydroxide (NaOH) or hydrochloric 
acid (HC1) and the TES buffer was stored at 4°C.
Fermentation Tests
Carbohydrate Fermentation
The carbohydrate fermentation reactions were determined with a basal medium 
composed of Purple Broth Base and Thioglycollate medium (without dextrose or 
indicator)(Difco Ltd) with carbohydrates added at a concentration of 1% w/v:
16g Purple Broth Base, basal medium
24g Thioglycollate medium (without dextrose and indicator)
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Distilled water was added to make a solution of 1000 ml and this was divided into 
ten 100ml aliquots. The nine sugars tested were: Amygdalin, Arbutin, Lactose, 
Mannitol, Melibiose, N-acetylglucosamine, Raffmose, Glucose and Sorbitol. 
One gram of sugar was added to one o f the ten 100ml aliquot o f the basal 
medium. The remaining bottle containing basal medium without carbohydrate 
was used as a negative control to show that the streptococci tested were unable to 
ferment the basal medium in the absence of carbohydrate. The sugars were 
autoclaved at 115°C for 15 minutes and stored at 4°C.
Aesculin Hydrolysis Test
The tryptone and yeast extract were purchased from Oxoid.
lg  Tryptone
0.5g Yeast extract
lg  Sodium acetate (C2H3Na0 2 )
0.05g Ferric ammonium citrate (C6Hg0 7 )
0.5g Aesculin
0.1ml Tween 80 (Polyethylene glycol sorbitan monooleate)
0.5ml Salt A
0.5ml Salt B
100ml DD-H20
The solution was autoclaved at 115°C for 15 minutes and stored at 4°C.
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Arginine Hydrolysis Test
The peptone and yeast extract were purchased from Oxoid.
0.5g Peptone
0.3g Yeast extract
0.3g Glucose
lg  Sodium acetate (^HhNaC^)
0.3g L-Arginine
0.1ml Tween 80 (Polyethylene glycol sorbitan monooleate)
0.5ml Salt A
0.5ml Salt B
100ml DD-H20
The solution was autoclaved at 115°C for 15 minutes and stored at 4°C.
Salt A
0.16g Calcium carbonate (CaCOs)
0.16g Magnesium sulphate (MgS0 4 )
400ml DD-H2O
After autoclaving (121°C, 15 minutes), this solution was stored at 4°C for up to 
one year and used when required.
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Salt B
0.8g dibasic Potassium phosphate (K2HPO4)
8.0g Sodium bicarbonate (NaHCOs)
1.6 g Sodium chloride (NaCl)
0.8g monobasic Potassium phosphate (anhydrous, KH2PO4)
400ml DD-H2O
After autoclaving (121°C, 15 minutes), this solution was stored at 4°C for up to 
one year and used when required.
The carbohydrate fermentation and aesculin and arginine hydrolysis tests were 
performed in sterile flat-bottomed microtitre trays fitted with individual lids 
(Sterilin). A colour change from purple to yellow indicated carbohydrate 
fermentation. A colour change from light brown to black indicated aesculin 
hydrolysis, while a colour change from yellow to orange after the addition of 
45pl Nessler’s reagent indicated arginine hydrolysis.
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Enzyme Tests
The following 4-methylumbelliferyl-linked glycosides were used to test for the 
production of glycosidic enzymes: P-D-fucoside, P-N-acetylgalactosaminide,
a-neuraminate, a-L-fucoside, p-N-acetylglucosaminide, a-glucoside, 
p-glucoside, a-galactoside, a-arabinoside and P-galactoside.
0.00lg  4-methylumbelliferyl-linked glycoside
0.5ml DMSO (dimethylsulphoxide)
The glycoside and DMSO were dissolved in a universal container (Sarstedt) and 
9.5ml TES buffer was added to make a final volume of 10ml. The final working 
concentration of glycoside was lOOpg/ml. The glycoside solutions were stored at 
-20°C.
The enzyme hydrolysis tests were performed in non-sterile flat-bottomed 
microtitre trays (Sterilin) and incubated for 4 hours at 37°C. The results were 
read under a UV light.
Tables 2.3 and 2.4 show the scheme used to identify the streptococci to species 
level. The identification scheme used in this study is discussed further by 
Beighton (Beighton et al, 1991).
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2.2.4 16S rRNA Gene Sequence Identification
The oligonucleotide primers (Sigma-Genosys, Pampisford, Cambridgeshire, UK) 
used were:
27F 5 ’ - AG AGTTT G ATCMT GGCTC AG-3 ’
1492R 5 ’ -T ACGG YT ACCTT GTT ACG ACTT -3 ’
PCR was performed in 0.5ml eppendorf tubes (ABgene, Epsom, Surrey, UK) in a 
thermocycler (MWG Biotech (UK) Ltd, Milton Keynes, Bedfordshire, UK). 
Two microlitres of the DNA template was added to a reaction mixture (50pl final 
volume containing 10X PCR buffer, 1.5mM MgCE, 1.25U of Taq DNA 
polymerase (Promega, Southampton, Hampshire, UK), 20pmol o f each primer 
and 20pM of deoxynucleoside triphosphates (dNTPs) (Roche Diagnostics Ltd, 
Lewes, East Sussex, UK)). The PCR mixtures were denatured for 5 minutes at 
94°C and then subjected to 30 cycles of amplification (1 minute of annealing at 
94°C, 1 minute of elongation at 54°C and 2.5 minutes of elongation at 72°C). 
Finally, the samples were denatured at 72°C for 5 minutes. The samples were 
cleaned-up using the Qiagen QIAquick® kit (Qiagen Ltd, Crawley, West Sussex, 
UK) and the concentration o f the amplified products was determined by reading 
the OD at 260nm using a spectrophotometer (Pharmacia Biotech, Cambridge, 
UK). The PCR products were amplified using the polymerase chain reaction, but 
using only a single primer. Depending on the concentration o f the PCR product, 
the DNA was either used diluted or concentrated. Highly concentrated PCR 
products were diluted with DD-H2O to make a volume of
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4pl. Bigdye™ terminator cycle sequencing ready reaction solution 
(ABI PRISM Applied Biosystems, Warrington, Cheshire, UK) was diluted 1:4 
with 5X reaction buffer. Two pi o f the diluted ABI was added to lp l (5pmol) of 
either the forward or reverse primer and 4pl PCR product (neat or diluted) in a 
0.5ml eppendorf tube. The PCR mixtures were subjected to 99 cycles:
95°C Rapid thermal ramp
95°C for 10  seconds
50°C Rapid thermal ramp
50°C for 5 seconds
60°C Rapid thermal ramp
60°C for 4 minutes
4°C Rapid thermal ramp
4°C hold indefinitely
The temperature ramp was set to 1 °C s '1.
Before sequencing the PCR products, the DNA was cleaned up using cold 
centrifugation. In a 0.5ml eppendorf tube, 13pl of DD-H20  was added to 7pi of 
the PCR product and kept on ice. Two pi 3M sodium acetate and 50pl 95% ice 
cold ethanol was added to the mixture and incubated on ice for 10 minutes. After 
cold centrifugation (4°C) at 14k for 20 minutes, the supernatant was removed and 
ice cold 70% ethanol added. Cold centrifugation was repeated for 15 minutes and 
the ethanol removed. The DNA at the bottom of the tube was dried for a few 
seconds at 95°C, resuspended in 20pl Template Suppression Reagent (TSR)
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(ABI PRISM Applied Biosystems) and vortexed. The resuspended DNA was 
heated to 95°C for 2 minutes, vortexed and immediately placed on ice. The PCR 
products were sequenced using an ABB 10 Genetic Analyser (PE Biosystems, 
Warrington, Cheshire, UK) and analysed using the Ribosomal Database Project II 
(http://rdp.cme.msu.edu/html/) and BLAST at the National Centre for 
Biotechnological Information (NCBI) (http://www.ncbi.nlm.nih.gov/BLAST).
2.3 Molecular Biology Techniques
The chemicals in this section were purchased from Sigma-Aldrich.
2.3.1 Gel Loading Buffer (FBX)(6 X)
0.025 g Bromophenol Blue
0.025 g Xylene Cyanole
1.5 g Ficoll 400
Distilled water was added to make the solution to 10 ml. The loading dye was 
stored at room temperature indefinitely.
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2.3.2 0.5M EDTA (pH8.0)
186.1 g EDTA (disodium salt)
800 ml DD-H20
The solution was stirred vigorously and the pH adjusted with concentrated NaOH 
in order to dissolve the EDTA salt. Once a pH of 8 had been achieved by adding 
0.1M or 1M NaOH or HC1, the volume was adjusted to 1 litre by adding more 
distilled water and autoclaved to sterilise (121°C, 15 minutes). This solution was 
stored at room temperature.
2.3.3 25X TAE Running Buffer
1 2 1 .0 g Tris base
28.55ml glacial acetic acid
50ml 0.5 M EDTA (pH8.0)
600ml DD-H2O
The solution was made up to 1000 ml by adding distilled water. The Running 
buffer was not autoclaved because it contained acetic acid. This solution was 
stored at room temperature.
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2.3.4 IX TAE Running Buffer
40ml 25X TAE Running Buffer 
960ml DD-H20
This Running buffer was used as an electrophoresis buffer and to make agarose 
gels. The Running buffer was stored at room temperature.
2.3.5 Agarose Gels
All DNA samples (genomic and PCR products) were run on a 1% agarose gel 
made with IX TBAE.
2.3.6 5X Sequencing Reaction Buffer
0.203g Tris-HCl
4.85g Magnesium chloride (MgCh)
80ml DD-H2O
The pH was adjusted to pH9.0 with 10M NaOH and brought up to 100ml with 
distilled water. The 5X Sequencing Reaction Buffer was stored at room 
temperature.
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2.3.7 3M Sodium Acetate (pH5.5)
18.46 g Sodium acetate (C2H3Na0 2 )
The pH was adjusted to pH5.5 with glacial acetic acid and the volume made up to 
75 ml by adding water. The solution was sterilised by autoclaving and stored at 
room temperature.
2.3.8 Genomic DNA Isolation
Genomic DNA was extracted using Puregene™ DNA Isolation kit 
(Gentra Systems, Minneapolis, USA).
110
Antibiotic Solvent/Diluent Storage of solution Storage o f powder Notes
+4°C -20°C -70°C
Penicillin
(Benzyl)
(Potassium)
Water 1 month 1 month +4°C; protect 
from light and 
moisture
Ampicillin
(trihydrate)
Phosphate buffer, 
pH8.0, 0.1M
1 week Unstable 1 month +4°C; protect 
from light and 
moisture
Erythromycin 95% Ethanol 1 week +4°C stable 3 
years; protect 
from light and 
moisture
Vancomycin Water 1 week 3 months +4°C; protect 
from light and 
moisture
Tetracycline
(hydrochloride)
Water NRa NR4 Unopened vials: 
2 years at room 
temperature
Made fresh on the 
day o f use -  
tetracycline 
precipitates if  
frozen
Metronidazole Water 1 week +4-25°C; protect 
from light
Warming the 
solution in a 
waterbath (37°C) 
will help dissolve 
the metronidazole 
powder
Kanamycin Water +4°C; protect 
from light
Gentamicin Water +4-25°C; protect 
from light and 
moisture
a Not recommended
Table 2.1: Preparation and Storage of Antibiotic Solutions
Gram Stain Oxidase Catalase Growth in air Growth anaerobically
Rothia species GPR - + +
-
Staphylococcus species GPC + + +
Streptococcus species GPC - + +
Neisseria species GNC
+
+ +
■
Pseudomonas species GNR + - +
-
Table 2.2 Tests used to Identify the Genus of the Mercury-resistant Organisms isolated in the Cross-sectional and Longitudinal Studies
1 2 3 4 5 6 7 8 9 10
S. mu tans - - - - -  ^• 1 0 0 % 'X  71192% " - -
S. sobrinus - - - - - - -
S. sanguinis 73% - - - - - 3 3 %
S. parasanguinis 'joa* ~:V 100% - X a m x r / i iK ^  .
S. gordonii - - . 100% 100%** - 44%
Tufted fibril group - I x  100% - s '-7 « « %  * - - - 25%
S. oralis - 100% 100% - ■iB " m m h - - 64%
S. mitis - - - - w k - 40%
S. vestibularis - - - - - 100% : 100%
S. salivarius - - - - _ vT a. * ? \ x  i m  : ‘ 93% 86%
S. intermedius 100% 100% 100% - 100% - - -
S. anginosus - - - - - 100% - '  100% ■ - - 100%
S. constellatus - - - - - 1 ;* - -
Table 2.4: Scheme for Glycosidic Enzyme activities of Viridans Streptococci
% = Percentage of strains that give a positive reaction for each test
Enzyme: 1, p-D-fucosidase, 2 , p-N-acetylgalactosaminidase, 3, a-neuraminidase (sialidase), 4, a-L-fiicosidase,
5, P-N-acetylglucosaminidase, 6 , a-glucosidase, 7, p-glucosidase, 8 , a-galactosidase, 9, P-galactosidase, 10, p-galactosidase
(Beighton et al, 1991)
Amygdalin Arbutin Inulin Lactose Mannitol Melibiose N-Acetylglucosamine Raffmose Sorbitol Aesculin Arginine 1
S. mu tans 70% 100% 100% 100% , ,•.•100% ", 50-90% 100% 100% 100% -
S. sobrinus - - - to'  ^ . .. . 16% - - -
S. sanguinis 42% * n % 33% 100% - 75%- 100%/ •?': - , 42% - 75% 100%
S. parasanguinis 45% - JOOH t' - - J S o k ' : (i ^ s. ^ 8 8 ' : - ’-9% ^ ; ' ‘ 36% 100%
S. gordonii 100% 100% 100% 100% - ; . „"*>1 Ivy** ’ * rv-m- ■ - 100% 100%
Tufted fibril group - 100% - ■ 75% - - 1' : - - - 75%
S. oralis 9% 9%, - 100% - ; 55% ; ■ 'J 0 0 % '-"  : 55% - 18% -
S. mitis - - 10% 80% . 100% - - -
S. vestibularis 50% 53% - €6% - - - - 50% -
S. salivarius '*29%  ' : 93S 79% - —  ‘fit* '' 79% , - 93% -
S. intermedius - - * V . 3% ''x - 5% - -
S. anginosus - ' i M i :  '* - - 100% 100%
S. constellatus v? 29% - - 55% ' ' * 4% ?<*« - - 100% i 100%
Table 2.3 Scheme for Carbohydrate Fermentation o f Viridans Streptococci 
% = Percentage o f strains that give a positive reaction for each test
(Beighton et al, 1991)
Chapter Three 
Effect of Medium Composition on the Susceptibility 
of Oral Streptococci to Mercuric Chloride
3.0 Effect o f Medium Composition on the Susceptibility o f Oral
Streptococci to Mercuric Chloride
3.1 Introduction
The in vitro susceptibility breakpoint concentration of an antimicrobial is 
determined from knowing the in vivo pharmacodynamic (PD) and 
pharmacokinetic (PK) properties of the drug (MacGowen & Wise, 2001) 
(Equation 3.1)
. Cmax .Breakpoint concentration =  j  x s
et
Cmax = maximum serum concentration following a stated dose at steady
state (usually 1 hour post-dose)
e = factor by which the Cmax should exceed the MIC
/ =  factor to allow for protein binding
t = factor to allow for the serum elimination half-life
s = shift (or reproducibility) factor
Equation 3.1: Determination of the Breakpoint Concentration
Pharmacokinetic studies determine the absorption, distribution and elimination of 
drugs (Craig, 1998). These factors, combined with the dosage regimen, determine 
the time course of drug concentrations in serum, which in turn determine the time 
course of drug concentrations in tissue and body fluids. With respect to 
antimicrobials, the time course o f drug concentrations at the site of infection is of 
special interest. Pharmacodynamics is the relationship between serum 
concentration and the pharmacological and toxicological effects of drugs.
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As discussed in Chapter 1, before the discovery o f antibiotics, mercury was used 
as an antimicrobial to treat bacterial diseases caused by organisms such as 
Treponema pallidum  (Syphilis) and Mycobacterium leprae (Leprosy). 
However, since then it has been found that mercury is also toxic to human tissues 
and probably poisoned more people with the disease than it cured. For this 
reason, the PD and PK of mercury are not known and therefore its susceptibility 
breakpoint concentration has not been determined. Unlike antibiotic sensitivity 
testing, where the minimum inhibitory concentration (MIC) o f the antimicrobial 
against an organism can be determined using standardised methods described by 
quality assurance committees, mercury susceptibility testing cannot be carried out 
in this manner (Wheat, 2001). This has led to the use of a wide range of methods 
to determine whether organisms are ‘resistant’ to mercury. Many authors have 
employed agar dilution using various agars depending on the organisms tested. 
For example, studies determining mercury resistance in the faecal flora have used 
MacConkey agar (Summers et al, 1993), bile aesculin azide agar 
(Summers et al, 1993), Mueller-Hinton II agar (Osterblad et al, 1995), 
5% defibrinated horse blood and Antibiotic Sensitivity Medium II Agar 
(Edlund et al, 1996) and Luria agar (Wireman et al, 1997). Various other studies 
have employed nutrient agar (Khor & Jegathesan, 1983, 
Nakahara et al, 1977a, 1977b), modified Actinomyces defined medium (MADM) 
(Lyttle & Bowden, 1993b), Mitis Salivarius agar (Summers et al, 1993), 
tryptose-glucose-yeast (TGY) agar (Timoney, 1978) and cysteine-free agar 
(Rudrik et al, 1985). Depending on the agar used, these studies have also used 
various mercuric chloride (HgCfe) concentrations as the breakpoint value, ranging 
from 7.4pM -  125pM (2pg/ml - 34pg/ml) (Nakahara et al, 1977a,
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Khor and Jegathesan, 1983, Rudrik et al, 1985, Zscheck & Murray, 1990, 
Avila-Campos et al, 1991b, Summers et al, 1993, Osterblad et al, 1995, 
Edlund et al, 1996, Sadhukhan e/ al, 1997, Wireman e/ a/, 1997,
Huang et al, 1999, Nascimento e/ al, 1999, Kholodii e/ a/, 2000,
Pike e/ a/, 2002a, 2002b, Pike et al, 2003). Other studies have employed disc 
diffusion on a variety of agars (Dyke et al, 1970, Hall, 1970a, 1970b). In addition, 
the incubation conditions and times for which the plates were incubated varied 
according to the organisms tested.
3.2 Aims
As very little information was available on mercury sensitivity testing, the purpose 
of this study was to determine the most suitable agar and concentration of 
mercuric chloride to use in this project. This agar would be used to isolate the
mercury-resistant organisms from the patients’ samples and to determine the MIC
of mercuric chloride for each organism, as described in Chapters 4 and 5.
3.3 Materials and Methods
3.3.1 Bacterial Strains
A total of 99 oral streptococci were isolated from the plaque and saliva o f children 
attending a paediatric clinic at the Eastman Dental Hospital, London, UK. 
None of the children had received antibiotics during the three months prior to 
sampling. These organisms were isolated on Columbia agar (CBA) containing
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5% defibrinated horse blood (E&O Laboratories, Bonnybridge, Falkirk, UK). 
The plates were incubated anaerobically at 37°C for 48 hours. The organisms were 
identified to genus level on the basis of their atmospheric requirements, 
morphology, Gram staining reaction, oxidase and catalase tests (Table 2.2). 
Streptococci were speciated using a sugar and enzyme identification system 
described by Beighton (Tables 2.3 and 2.4)(Beighton et al, 1991). Some 
streptococci were unidentifiable using biochemical methods and were identified 
using 16S rRNA sequencing (Lane, 1996).
Mercury-resistant strains o f Staph aureus NCTC 50581, Ent. faecium  664 1H1, 
B. cereus RC607 and Enterococcus CE13, as described in Chapter 2.1.7, were 
used as positive controls. Mercury-sensitive Staph aureus 8325-4 and 
S. mitis 606 4T1 were used as negative controls.
3.3.2 Determination of the Minimum Inhibitory Concentration (MIC) of 
Mercuric Chloride
The MICs of HgCL were determined on different media by the agar dilution 
method in 9cm plastic petri-dishes (Sarstedt, Leicester, UK). The following 
media were used: Columbia agar (CA); Columbia agar with 5% defibrinated 
horse blood; Tryptone Soya agar (TSA); Tryptone Soya agar with 5% defibrinated 
horse blood; Iso-Sensitest agar (ISOA); Iso-Sensitest agar with 5% defibrinated 
horse blood; Mueller-Hinton agar (MHA); Mueller-Hinton agar with 
5% defibrinated horse blood; Brain Heart Infusion agar (BHIA); Brain Heart 
Infusion agar and 5% defibrinated horse blood; and Mitis Salivarius agar (MSA).
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The 0.1M HgCl2 stock solution was prepared by dissolving 0.272g mercuric 
chloride (HgC^) in 10ml sterile distilled water on the day of the test. This stock 
solution was stored in a plastic universal container (Sarstedt, Leicester, UK) 
wrapped in aluminium foil to protect from sunlight and was discarded if not used 
that day. The mercury agar plates were prepared on the same day that the MICs 
were determined. The agar was autoclaved in glass Duran bottles (Jencons) and 
allowed to cool to 50°C in a waterbath. The HgCL stock solution was added to the 
agar to make plates with final concentrations between 1 and 2048pM (serial 
two-fold dilutions). Control plates without mercuric chloride were used to 
determine whether the various agars could support the growth of the control and 
test organisms. Before use, the agar plates were dried in a laminar flow cabinet 
for 20 minutes and kept out o f direct light.
The test organisms were grown overnight on Columbia blood agar (CBA), 
harvested and emulsified in 3ml brain heart infusion (BHI) broth using a Q-tip. 
The broths were diluted with BHI to a 0.5 McFarland Standard (5xl06 CFU/ml). 
The agar dilution test plates were inoculated with a multipoint inoculator 
(Mast, Bootle, Merseyside, UK), resulting in a final inoculum of approximately 
104 CFU/spot (Steers et al, 1959). The plates were wrapped in aluminium foil and 
incubated in aerobic conditions at 37°C for 18 hours. The MIC was defined as the 
lowest concentration resulting in the absence of visible growth.
In order to assess the reproducibility of the MIC values obtained, the control 
organisms were tested up to 4 separate occasions.
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3.4 Results
The MICs of HgCh for the 99 oral streptococci and control strains are shown in 
Table 3.2, which highlights that the MICs vary depending on the agar used. 
For example, the MIC of HgCh for the mercury-resistant Staph, aureus 
NCTC 50581 ranged from 32pM (MHA and TSA) to 1024pM (BHIA & blood 
and ISOA & blood). The table shows that the MICs obtained from 
Mueller-Hinton agar without blood were generally lower than the values obtained 
from the other 5 agars tested and the MICs obtained from Brain Heart Infusion 
agar with blood and Mitis Salivarius agar were generally higher. All MICs 
increased considerably when 5% defibrinated horse blood was added to the 
medium.
Table 3.2 shows the cumulative percentage of oral streptococcal isolates 
(99 strains) sensitive to mercury chloride in different growth media. Each point 
on the graph represents the total number of bacteria sensitive to a given 
concentration of mercuric chloride, including those which are sensitive to lower 
concentrations.
The streptococci were classified as resistant to HgCE when the MIC value was 
equal to or greater than that of Staph, aureus NCTC 50581 when tested on the 
same agar. However, this organism was unable to grow on Mitis Salivarius agar, 
so the positive controls B. cereus RC607 and Ent. faecium  664 1H1 determine the 
breakpoint concentration on MSA. On Mueller-Hinton agar without blood only
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39 out o f the 99 streptococci (39.4%) tested were resistant to HgC^ (Table 3.4). 
However, when TSA without blood was used, 70.7% of the streptococci 
(70 out of 99) could be classified as being resistant.
Table 3.3 shows that the range of MIC values obtained varied according to the 
agar used. When Mitis Salivarius agar was used 9 different MICs were obtained, 
ranging from 2pM HgCh to 512pM HgCh. With Mueller-Hinton (without blood) 
there were only 6 different MICs (4pM HgCh to 64 pM HgCh). Tryptone Soy 
(with blood), Iso-Sensitest (without blood), Iso-Sensitest (with blood), Columbia 
(without blood) and Columbia (without blood) also gave 6 MIC values.
Table 3.3 shows that for some agars the values obtained for the mercury-sensitive 
and mercury-resistant control strains were often identical. With the exception of 
TSA (with and without blood) all o f the media tested were able to discriminate 
between the mercury-sensitive and mercury-resistant strains o f Staph, aureus. 
However, in most cases the difference in MIC amounted to only one doubling 
dilution, although Columbia agar with blood showed two doubling dilutions 
difference between the sensitive and resistant controls.
Table 3.4 shows the MIC determinations o f the mercury-sensitive and 
mercury-resistant control strains carried out on 4 separate occasions. 
Bacillus cereus strain RC607 was tested only on two separate occasions. The 
MHA (without blood) gave the most consistent MIC results. For 3 o f the control 
organisms {Staph, aureus 8325-4, S. mitis 606 4T1, Staph, aureus NCTC 50581), 
the MIC values obtained using this medium were identical on each o f the
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4 occasions they were determined. The MIC values obtained using Columbia agar 
(with blood) showed far greater variation and, for one of the organisms, ranged 
over 4 doubling dilutions on the different testing occasions. This suggests that 
using CBA gives non-reproducible results.
3.5 Discussion
The culture medium used in antibiotic sensitivity tests plays a very important role 
and can have a significant influence on the results. Not only must it provide a 
standard, reproducible nutritional environment for the optimal growth o f the 
organism(s) being tested, it must do so without affecting the activity of the 
antibiotics against the test organisms. In disc diffusion, it must also provide a 
suitable gel so that the antibiotics can diffuse freely in a uniform and reproducible 
manner. The cations Ca and Mg also strongly influence the MICs of 
antibiotics such as the aminoglycosides and tetracyclines 
(Garrod & Waterworth, 1971, Reller et ol, 1974, Post & Bridson, 1991, 
Andrews, 2001a). Adding supplements to agar can also result in interactions 
between the agar components and antibiotics. For example, 5% lysed horse blood 
is added to agar containing trimethoprim and sulphonamides to reduce the levels 
of thymidine which antagonises the action o f both antibiotics 
(Garrod & Waterworth, 1971, Andrews, 2001a). In addition, adding 
5% defibrinated blood to the agar can also extend the range of its growth 
supporting ability (Ericsson & Sherris, 1971). Adding sodium chloride to agar 
results in more effective detection of MRS A (French et al, 1987).
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A number of medium constituents are also known to bind to, or precipitate, 
mercury compounds resulting in a decrease in mercury’s antimicrobial activity. 
Such compounds include metal ions, glutathione, cysteine, proteins and lipids 
(Rudrik et al, 1985, Farrell et al, 1990, Delnomdedieu & Allis, 1993, 
Girault et al, 1996, Latinwo et al, 1998). Unfortunately, blood, one o f the most 
frequently used medium constituents in medical microbiology, contains many of 
these substances. Many o f these substances contain large amounts of the element 
sulphur and it is known that mercury binds to thiol groups (-SH) resulting in 
mercury chelation, leading to less ‘available’ mercury and significantly reducing 
its bactericidal activity. Studies of media supplemented with mercuric chloride in 
dialysis chambers showed that after 48 hours, blood agar still bound 96% of the 
available mercury, compared with 50% binding by modified Actinomyces Defined 
Medium (MADM). Table 3.1 shows that in this study, incorporating blood into 
the agar resulted in an increase in the MICs o f HgCh of all the oral streptococci 
and control strains tested. Avila-Campos observed an increase in the MIC of 
HgCh to 52 strains o f the B. fragilis group when tested on Brain Heart infusion 
agar (BHIA) and 5% blood in comparison to the values obtained from BHIA 
per se (Avila-Campos et al, 1991b). Studies by Rudrik have previously used a 
semi-synthetic anaerobic medium devoid of cysteine (Rudrik et al, 1985). This 
agar contains a minimal amount o f sulphur-containing amino acids resulting in 
less mercury chelation and thus greater bactericidal activity. The group found that 
by adding ImM cysteine hydrochloride increased the MIC of HgCh by up to 
17-fold. This made a previously sensitive organism appear resistant.
Table 3.3 shows that the MICs determined on Mueller-Hinton agar were usually 
lower than when determined on the other 5 agars tested. Mueller-Hinton is 
recommended by the National Committee for Clinical Laboratory Standards 
(NCCLS) in antibiotic susceptibility testing and is probably the most widely used 
medium internationally (Brown, 1994). However, various manufacturers produce 
Mueller-Hinton agar and variability in cations, thymine and thymidine from these 
manufacturers and batches are encountered (Reller et al, 1974). The agar contains 
starch to ensure that toxic factors produced during growth are absorbed and also 
contains peptides in the form of casein hydrosylate. This agar is relatively simple 
in comparison to the others tested, which may result in fewer interactions between 
the agar ingredients and mercuric chloride.
The MIC values obtained when using Tryptone Soya agar and Columbia agar were 
generally greater than those obtained from the Mueller-Hinton agar. Both agars 
contain peptones, which are necessary for optimum growth of 
chemo-organotrophic organisms. These agars also contain sodium chloride. 
Previous studies by Gupta have described how the presence o f sodium chloride in 
agar results in a decrease in the MIC of silver against E. coli strains by 
(Gupta et al, 1998). Chloride acts by increasing membrane permeability, resulting 
in an increase in the toxicity of Ag+ to bacteria. These studies found that low 
concentrations of chloride made the differences in MICs between sensitive and 
resistant strains larger, while high concentrations of chloride increased the 
sensitivity to silver ions (Ag+). This has also been demonstrated with mercury 
(Brown, 1994).
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The MICs obtained using Iso-Sensitest agar were greater than those found using 
Mueller-Hinton, Columbia and Tryptone Soya agar. Iso-Sensitest is 
recommended by the Working Party of the British Society for Antimicrobial 
Chemotherapy (BSAC) for antibiotic sensitivity testing in the UK and, unlike 
Mueller-Hinton, is produced by a single manufacturer (Oxoid). Iso-Sensitest is a 
closely defined medium with stabilised mineral content and allows growth of a 
wide range of organisms without supplementation. It contains a large number o f 
constituents such as peptones, sodium chloride and starch. In addition, it contains 
various sulphurous compounds such as colbalt sulphate, cupric sulphate, zinc 
sulphate and ferrous sulphate, which may result in a high degree of mercury 
chelation. Iso-Sensitest agar also contains L-cysteine hydrochloride 
(a sulphur-containing amino acid), biotin (a B vitamin containing sulphur) and 
menadione (non-sulphur containing vitamin K). Avila-Campos showed that 
adding menadione to BHIA resulted in a slight increase in the MIC o f HgCb 
towards isolates from the B.fragilis group (Avila-Campos et al, 1991b).
The MICs obtained from BHIA were the highest among all the 5 agars tested. 
Brain heart infusion is a highly nutritious agar, suitable for the culture of 
fastidious organisms such as pneumococci, streptococci, meningococci and dental 
pathogens. This highly proteinacious agar contains large quantities of beef heart 
and calf brain infusion solids and proteose peptones, which may result in the 
components interfering with mercury availability, possibly through chelation.
The MICs obtained with MS agar were greater than those obtained using 
Mueller-Hinton, Iso-Sensitest, Columbia and Tryptone Soya agar and, in some
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cases, greater than those found with BHIA. Mitis Salivarius agar is a selective 
agar that selects for the growth of viridans streptococci and enterococci. 
Mitis Salivarius agar contains compounds necessary for the growth o f these 
organisms, such as trypticase peptone, yeast extract, glucose and sucrose, and 
compounds that inhibit the growth of non-streptococcal organisms, such as trypan 
blue, crystal violet and potassium tellurite. One molecule of trypan blue contains 
four sulphur atoms (C34H24N 6 0 i4S4Na4) suggesting that mercury is chelating with 
these sulphur atoms, resulting in a decrease in bactericidal activity)(Figure 3.2).
Table 3.2 shows the results obtained from 99 oral streptococci that were able to 
grow on the MS agar. However, the table does not show the results o f 30 oral 
streptococci that were unable to grow on MS agar (mercury-free control plates), 
but were able to grow on the other agars tested. Despite MS agar being selective 
for the isolation of oral streptococci and enterococci, previous studies have shown 
that MS agar gives lower counts of mutans streptococci than many non-selective 
media such as Brain Heart Infusion agar (Gold et al, 1973, Schaeken et al, 1986, 
Leistevuo et al, 2000). In addition, the Staph, aureus control strains were unable 
to grow on this agar, although MS agar was able to support the growth of the 
B. cereus RC607 mercury-resistant strain. Using this agar in the study would only 
select for mercury-resistant streptococci and not other genera. Although
Na0 3 S S03Na NaO^S
Figure 3.2: Trypan blue
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streptococci account for a high proportion of organisms in the oral flora, 24% of 
the cultivable flora do not belong to this genus and belong to at least 30 other 
bacterial genera (Hardie, 1992, Chen et al, 1997).
In this study, the pH values of the agars used were very similar: BHIA, ISOA and 
MHA, were pH7.4, while TSA and CA were pH7.3 and MS was pH7.0. The pH 
of a medium also plays an important role in antibiotic sensitivity testing. For 
example, an acidic pH can result in an increase in the MIC of macrolides and 
therefore macrolide agar plates should be incubated in air and not carbon dioxide, 
unless the organism being tested is unable to grow in the absence of carbon 
dioxide. An acidic pH has been shown to increase the antimicrobial activity of 
mercury towards Pseudomonas jluorescens (Farrell et al, 1990). This group 
evaluated the toxicity of 3 different mercury salts; mercuric nitrate, mercuric 
chloride and mercuric acetate, in different pH conditions. They also studied the 
effect of chloride, citrate and cysteine on the toxicity of mercury. The work was 
carried out in liquid medium (M-IIY) and after incubation, growth was determined 
by measuring the optical density of the cultures. For each mercury salt, toxicity 
was greatest at pH6.0 and decreased significantly (P=0.05) at pH7.0. Increasing 
the pH to 8 had no effect on the toxicity of mercuric acetate or mercuric nitrate but 
significantly (P=0.05) reduced the toxicity of mercuric chloride. The toxicity of 
mercuric nitrate at pH8.0 was unaffected by the addition of citrate, enhanced by 
the addition of chloride and reduced by the addition o f cysteine 
(a sulphur-containing amino acid).
In this study, the MIC of HgC^ on various solid media was compared. Previous 
studies have compared the antibacterial activity of mercury in broth and agar. 
Avila-Campos has demonstrated that the MIC50 and MIC90 in broth media were 
markedly lower than those determined using the agar dilution method, possibly 
due to better diffusion of the agent in broth medium (Avila-Campos et al, 1991b). 
In addition, solid medium contains agar, a complex mixture o f polysaccharides 
extracted from red algae which contains sulphuric acid esters. The presence of 
these sulphuric compounds may also explain the increase in MICs o f HgCk on 
agar compared to broth.
It is essential that antimicrobial susceptibility tests provide reproducible results 
and the NCCLS suggest that with repeat testing, more than 95% of MICs should 
fall within an expected range, usually 3 log2 dilutions (Jorgensen, 1993). In this 
study, the 99 streptococci were not repeatedly tested, but both the positive and the 
negative control organisms were tested at least on 2 separate occasions. Some 
were tested on 4 separate occasions. Table 3.4 shows that when the 
mercury-sensitive and mercury-resistant controls were tested on 4 separate 
occasions, some of the results from some of the agars varied from test to test and 
were therefore not reproducible. While the majority of agars show values which 
range over only two doubling dilutions (BHIA, BHIA with blood, ISOA with 
blood, TSA with blood, MHA without blood, MHA with blood, CA without blood 
and MSA), ISO (without blood) and TSA (without blood) shows a range of 
3 two-fold dilutions. Columbia agar (with blood) showed greater variation and, 
for S. mitis 606 4T1, ranged over 4 two-fold dilutions on the different testing 
occasions. Some agars showed far less variation. For example, for 2 of the
organisms, BHIA (with blood) and CA (without blood), the MICs obtained were 
identical on each o f the 4 occasions they were determined. However, 
Mueller-Hinton agar (without blood) gave the most consistent results, where for 
3 of the controls tested, the MIC values were identical on all o f the testing 
occasions. For the other 2 organisms the MIC ranged over only 2 doubling 
dilutions.
In addition to giving reproducible MIC values, the medium must also be able to 
discriminate between mercury-sensitive and mercury-resistant control organisms 
and display a wide range of MIC values when used to test a group o f organisms 
with different susceptibilities to mercury. Mitis Salivarius agar gave the greatest 
range of MIC values for the organisms tested (9), TSA (with blood), MHA (with 
blood), ISO (without), ISO (with blood), CA (with blood), CA (without blood), all 
gave the least range o f MIC values for the organisms tested (6). All o f the agars, 
except TSA (with and without blood) were able to discriminate between 
mercury-sensitive and mercury-resistant strains of Staph, aureus 8325-4. 
However, Mitis Salivarius agar was unable to support the growth of this organism. 
In addition, in most cases, aside from Columbia (without blood), the difference in 
MIC amounted to only one doubling dilution.
In conclusion, it appears that significant interactions between mercuric chloride, 
chelating agents and test media occur and that adding blood to solid media 
strongly decreases the antibacterial activity of mercury. The study highlighted that 
before undertaking studies of mercury resistance it is important to choose the 
correct agar. Not only must the agar support the growth of the organisms tested
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but also its interaction with mercury must be determined, so that the correct 
concentration o f mercury is utilised when determining mercury resistance. 
Looking at the results obtained in Tables 3.2 and 3.3, all o f the agars tested have 
both advantages and disadvantages and it was difficult to easily choose a suitable 
agar. However, Mueller-Hinton appeared to be the most suitable as the MIC 
values of the control strains were very reproducible, it was able to discriminate 
between the mercury-sensitive and mercury-resistant control strains and displayed 
a wide range of MIC values for the randomly-picked group of oral streptococci 
tested. Furthermore, this agar was able to support the growth o f all the 
streptococci tested, plus the control strains belonging to other genera. This agar is 
fairly nutritious and will support the growth of most micro-organisms found in the 
oral flora. In this study it was found that mercury-resistant control organisms 
Staph, aureus NCTC 50581, Ent. faecium  664 1H1 and B. cereus RC607 grow on 
agars containing 16pM, 32pM and 128pM mercuric chloride respectively 
(MIC 32pM, 64pM and 256pM). Based on these results, Mueller-Hinton agar 
containing 40pM HgCL was used in the cross-sectional and longitudinal studies 
and the resistance to mercury o f any mercury-resistant strains isolated on this agar 
were confirmed by determining the MIC of HgCL for these organisms 
(Chapters 4 and 5). Osterblad chose to use Mueller-Hinton agar containing 
10pg/ml (37pM) HgCL in their study (Osterblad et al, 1995). In an environmental 
study, Henriette and co-workers used Mueller-Hinton agar containing 8pg/ml 
(29.6pM) HgCh to screen Gram-negative organisms from an aerobic fixed-bed 
reactor (Henriette et al, 1991).
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Figure 3.1: Cumulative percentage of Oral Streptococcal Isolates (99 strains) 
sensitive to Mercuric Chloride in different Growth Media
Strain Identification
BHIA & HgCi; 
Without 
blood
With
blood
TSA & HgCI;
Minimum Inhibitory Concentration (uM)
Without With
blood blood
64 1024
64 512
64 512
64 1024
64 1024
128 512
32 1024
128 1024
32 512
32 512
32 512
64 512
64 1024
64 1024
64 1024
32 512
64 512
128 1024
64 1024
32 512
512
■ ■ ■ I 1024
8 128
16 256
16 256
S 128
MHA & HgCI, ISOA & HitCI; CA & I
Without With
blood blood
32 512
32 512
512
32 1024
32 1024
32 512
32 512
32 1024
32 512
8 512
16 512
16 512
16 512
16 1024
32 1024
8 .M2
32 1024
64 1024
32 1024
8 1024
8 1024
■ ■ ■ 1024
16 64
16 256
16 64
16 64
Without
blood
With
blood
Without With
blood blood
61 1024
64 512
64 512
128 1024
128 1024
128 1024
64 512
128 1024
64 512
64 512
64 1024
64 512
128 1024
128 1024
128 1024
64 512
128 1024
128 1024
128 1024
64 512
64 1024
1024
8 64
16 64
16 128
1 64
152/2/0 
152/3/0 
152/2/A 
159/1/A 
159/2/A 
160/1/0 
160/3/0 
162/1/A 
166/2/A 
167/1/0 
167/2/0 
169/4/0 
170/1/0 
170/2/0 
170/4/0 
172/5/A 
173/1/0 
204/4/0 
256/1/0 
264/4/A 
266/1/A 
313/2/0 (3) 
321/3/170(1) 
321/1/T/A (1) 
321/2/T/A(l) 
321/3/T/A (I)
Streptococcus mitis 
Streptococcus mitis 
Streptococcus constellatus 
Streptococcus oralis 
Streptococcus oralis 
Streptococcus species 
Streptococcus salivarius 
Streptococcus oralis 
Streptococcus salivarius 
Streptococcus salivarius 
Streptococcus oralis 
Streptococcus gordonii 
Streptococcus species 
Streptococcus oralis 
Streptococcus mitis 
Streptococcus salivarius 
Streptococcus mitis 
Streptococcus oralis 
Streptococcus oralis 
Streptococcus salivarius 
Streptococcus salivarius 
Streptococcus oralis 
S. sanguis 
S. mitis 
S. oralis
315/4/0(2) Streptococcus oralis 128 512 64 1024 32 1024 128 1024 128 1024 128
3 15/VO (2) Streptococcus oralis 128 512 64 512 32 1024 128 1024 256 1024 64
316/2/A (2) Streptococcus mitis 1024 2048 256 1024 32 1024 128 1024 256 1024 256
318/3/A (1) Streptococcus mitis 512 2048 256 1024 64 1024 256 1024 256 1024 512
318/1/0(2) Streptococcus oralis 512 1024 256 1024 64 1024 256 1024 256 1024 512
318/3/0 (2) Streptococcus mitis 512 1024 256 1024 64 1024 256 1024 256 1024 512
318/1/0(3) Streptococcus oralis 128 1024 64 1024 32 1024 128 1024 128 1024 128
319/1/0(3) Streptococcus oralis 128 1024 64 1024 32 1024 128 1024 128 1024 128
319/4/0(3) Streptococcus salivarius 64 1024 32 512 16 1024 128 512 64 512 128
322/2/A (1) Streptococcus salivarius 128 1024 32 512 16 1024 128 512 64 1024 128
325/2/0(1) Streptococcus mitis 256 1024 128 1024 1024 128 ■ M M 128 1024 256
Table 3.2: Minimum Inhibitory Concentration of Mercuric Chloride for Streptococci when tested on a variety of Media
(Green shading indicates resistance)
BHIA & HgCI;
Strain Identification Without
blood
With
blood
325/3/0(1) Streptococcus mitis 256 1024
325/2/A (1) Streptococcus species 128 1024
328/2/0(1) Streptococcus species 64 128
328/3/0(1) Streptococcus species 64 128
329/2/0(1) Streptococcus species 32 128
329/3/0 (1) Streptococcus species 32 128
330/2/0(1) Streptococcus species 64 512
330/3/0(1) Streptococcus species 64 128
330/4/0(1) Streptococcus species 64 128
330/2/A (1) Streptococcus species 32 512
330/4/A (1) Streptococcus species 64 128
331/3/0(1) Streptococcus species 64 128
331/4/0(1) Streptococcus species 64 128
331/2/A (1) Streptococcus species 64 128
314/l/T /0(3) Streptococcus species 256 1024
3 1 7 /2 ^ /0 (2 ) Streptococcus sanguinis 16 32
317/1/T/A(2) Streptococcus mitis 32 64
320/2/T/A (1) S.sanguinis 16 32
321/2/T/OO) S. gordonii 16 16
321/2/T/O (2) Streptococcus species 32 256
321/3/T/O (2) Streptococcus species 32 256
317/2/T/A (2) S. parasanguis 32 512
317/3/T/A (2) Streptococcus species 16 64
317/1/T/O (3) Streptococcus oralis 64 ■ I H
317/2/T/0(3) S. salivarius 32 128
317/2/T/A (3) Streptococcus oralis 32 128
317/3/T/A (3) Streptococcus oralis ■ ■ ■ ■ ■ ■ ■
317/4/T/A (3) Streptococcus mitis 32 64
318/1/T/O (1) Streptococcus species 32 128
318/2/T/OO) Streptococcus species 32 128
3 1 8 /3 ^ /0 (1 ) Streptococcus species 64 64
318/1/T/A (1) Streptococcus species 32 64
318/3/T/0(2) Streptococcus species 32 128
318/1/T/A (2) Streptococcus mitis 32 128
318/2/T/A (2) Streptococcus mitis 32 128
318/3/T/A (2) Streptococcus mitis 32 64
318/4/T/A (2) S. parasanguis 64 64
319/1/T/O (1) Streptococcus species 64 64
TSA & HgCb
Minimum Inhibitory Concentration (pM)
MHA ISOA & HgCI; CA & H gC b
Without
blood
With
blood
Without
blood
With
blood
Without
blood
With
blood
Without
blood
With
blood
1024 64 | 128 1024
16 1024 512 128 ■ I B
16 256 64 256 32 256
16 128 32 256 16 128
8 64 32 128 16 128
16 256 32 256 16 256
16 I 512 64 256 16 256wmmm 512 64 256 32 256
8 128 64 128 32 64
16 256 32 512 16 256
■ ■ ■ 512 64 128 32 256
16 256 64 512 32 256
16 128 64 512 32 256
16 256 64 512 32 256
256 512 | 128 ■ ■ ■
4 64 32 64 8 64
8 64 32 64 16 64
4 32 16 64 8 32
16 32 16 32 16 64
16 64 32 128 16 128
16 64 32 128 16 128
16 256 32 256 16 256
8 64 32 64 8 256
16 | ■ ■ ■ 64 512 | .1 ' A jt '■ ■ ■ ■
8 256 32 256 16 256
8 256 32 256 16 256
16 | 64 512 | ■  IT ■
8 64 32 64 16 64
8 64 32 64 16 256
8 64 32 64 16 256
■ ■ ■ ■ 256 32 128 32 256
8 32 16 64 16 64
8 64 32 64 16 256
8 256 32 128 16 256
16 256 32 256 16 256
8 64 32 128 16 128
16 128 32 128 32 128
8 128 32 128 32 256
MSA
128
64
128
64
64
64
128
64
64
256
128
128
128
128
128
1024
256
256
256
256
256
256
256
256
256
256
256
256
256
128
128
128
32
256
256
256
256
Table 3.2 continued: Minimum Inhibitory Concentration of Mercuric Chloride for Streptococci when tested on a variety of Media
(Green shading indicates resistance)
Strain Identification
BHIA & HjjCI;
Minimum Inhibitory Concentration (uM)
Without With
blood blood
32 64
32 128
32 256
32 128
32 128
256
64 256
16 64
16 64
256
32 128
■ ■ ■ 128
64 256
32 128
32 256
16 64
32 64
16 64
32 64
32 64
32 256
32 512
32 64
32 64
64 512
32 64
128 1024
256 1024
512 2058
20S8 2058
31 27
31.3 27.3
ISOA & I CA & HgCl;
Without
blood
With
blood
Without
blood
With
blood
Without
blood
With
blood
Without
blood
With
blood
16 256 • 64 32 128 16 128
16 256 8 256 32 256 16 128
16 256 8 64 32 64 16 128
16 256 8 64 32 128 16 128
16 256 8 64 32 128 16 128
| 256 ■ ■ ■ 256 64 512 32 128
16 256 8 1■ 1 64 512 16 128
8 256 16 64 32 64 16 64
8 256 16 64 32 64 8 64
32 16 128 64 256
128 256 8 64 32 256 16 256
16 128 8 64 64 128 32 256
16 256 16 | 32 256 16 128
■ ■ ■ | 256 16 64 32 64 16 256
16 256 16 256 32 256 16 128
64 64 8 64 32 64 16 32
64 256 8 64 32 64 16 256
64 64 8 32 32 64 16 32
64 128 8 32 32 64 16 64
64 256 8 32 32 64 16 64
64 256 16 256 32 256 16 256
128 256 8 256 32 256 16 256
64 256 8 64 32 64 16 64
64 128 8 64 32 64 16 64
319/2/T/0(2) 
319/4/T/CH2) 
319/1/T/A(2) 
319/2/T/A (2) 
319/3/T/A (2) 
32Q/1/T/O0) 
320/I/T/A (I) 
321/1/T/A(2) 
321/2/T/A (2) 
321/3/TZO(3) 
321/ 1/T/A (3) 
321/3/T/A (3) 
322/1/T/A (1) 
322/3/T/A (3) 
323/2/T/O (1) 
325/1/T/O (2) 
325/2/T/O (2) 
32V1/T/A (2) 
325/2/T/O (3) 
325/3/T/A (3) 
327/1/T/O (3) 
327/3/T/O (3) 
327/1/T/A (3) 
327/2/T/A (3)
8325-4 
606 4T1
NCTC 50581 
664 1HI 
CEI3 
RC607
5. mitis 
S. mitis 
Streptococcus species 
Streptococcus species 
Streptococcus species 
5. sanguinis 
S. sanguinis 
S. mitis 
S. gordonii 
Streptococcus species 
Streptococcus species 
Streptococcus sanguis 
S. parasanguis 
S. parasanguis 
Streptococcus species 
Streptococcus gordonii 
Streptococcus species 
Streptococcus gordonii 
Streptococcus gordonii 
Streptococcus gordonii 
S. parasanguis 
Streptococcus mitis 
Streptococcus mitis 
S. parasanguis
Staphylococcus aureus 
Streptococcus mitis
Staphylococcus aureus 
Enterocuccus faecuim  
Enterococcus species 
Bacillus cereus
Number of resistant bacteria 
% resistant bacteria
256
32 512
128 512
128 1024
512 1024
70 38
70.7 38.4
256
64
32 512
32 512
128 1024
MJ24
512
64
28
28.3
42
42.4
30
30.3
21
21.2
40
40.4
256
256
1024
40
40.4
Table 3.2 continued: Minimum Inhibitory Concentration of Mercuric Chloride for Streptococci when tested on a variety of Media
(Green shading indicates resistance)
Agar MIC (pM) Number (%) of 
Hg-resistant 
strains
MIC of 
positive 
control (pM)
MIC of 
negative 
control (pM)
Susceptibility of 
Hg-sensitive strain 
of Staph, aureus
Range of MIC values 
(number o f doubling 
dilutions)
MIC50 MIC90
BHIA 16-2048 (8) 32 256 31 (31.3) 128 64 S
BHIA & blood 16-2048 (8) 256 1024 27 (27.3) 1024 512 S
TSA 8-512(7) 64 128 70 (70.7) 32 32 R
TSA & blood 32-1024 (6) 256 1024 38 (38.4) 512 512 R
MHA 4-256 (7) 16 32 28 (28.3) 32 16 S
MHA & blood 32-1024 (6) 256 1024 42 (42.4) 512 256 S
ISOA 16-512(6) 64 128 30 (30.3) 128 64 s
ISOA & blood 32-1024 (6) 256 1024 21 (21.2) 1024 512 s
CA 8-256 (6) 32 128 40 (40.4) 64 16 s
CA & blood 32-1024 (6) 256 1024 40 (40.4) 512 256 s
MSA 2-512(9) 64 128 53 (53.5) 64 NG NG
Table 3.3: Summary of MIC values for the Streptococcal Strains obtained using a range of Solid Media
NG = No Growth
Organism Sensitivity 
to HgCl2
MIC o f HgCl2 (*iM)
BHIA TSA MHA ISOA CA MSA
Without
blood
With
blood
Without
blood
With
blood
Without
blood
With
blood
Without
blood
With
blood
Without
blood
With
blood
Staph, aureus 8325-4 Sensitive 32 (3) 
64(1)
512(4) 16(2) 
128 (2)
256 (2) 
512(2)
16(4) 256 (3) 
512(1)
32 (2) 
64 (2)
256 (2) 
512(2)
16(4) 256 (4) NG
S. mitis 
606 4T1
Sensitive 16(1) 
32 (3)
64 (4) 8 (1)
16(2)
64(1)
128(1)
256(3)
8 (4) 32 (2) 
64 (2)
16(1) 
32 (3)
64 (3) 
128(1)
16(4) 32(1)
64(1)
128(1)
256(1)
16(2) 
32 (2)
Staph, aureus NCTC 
50581
Resistant 64(2) 
128 (2)
512(2) 
1024 (2)
32 (3) 
64(1)
256(1)
512(3)
32 (4) 256 (2) 
512(2)
64(1)  
128 (2) 
256(1)
512(2) 
1024 (2)
32 (2) 
64(2)
256 (2) 
512(2)
NG
Ent. faecium  664 1H 1 Resistant 128 (2) 
256 (2)
512(1) 
1024 (3)
128 (3) 
256(1)
1024(1)
512(3)
64(1) 
32 (3)
512(4) 128 (3) 
256(1)
512(2) 
1024 (2)
128 (4) 512(3)
256(1)
128(1) 
64 (3)
B. cereus RC607 Resistant 1024(1)
2058(1)
1024(1)
2058(1)
128(1)
512(1)
1024 (2) 128(1)
256(1)
1024 (2) 256(1)
512(1)
512(1)
1024(1)
128(1)
256(1)
1024 (2) 64 (2)
Table 3.4: Reproducibility of MIC of HgC^ for Mercury-sensitive and Mercury-resistant Control Strains 
The values in brackets indicate the number o f times this MIC value was obtained
NG = No Growth
Chapter Four  
A Cross-sectional Study -  
Resistance o f the Com m ensal Oral M icroflora to 
M ercury and Antibiotics in Subjects 
W ith and W ithout Dental Am algam  Fillings
4.0 A Cross-sectional Study -  Resistance o f the Commensal Oral
Microflora to Mercury and Antibiotics in Subjects With and Without 
Dental Amalgam Fillings
4.1 Introduction
As discussed in Chapter 1, few studies have looked at the possibility that the 
release of mercury from dental amalgam fillings can act as selective pressure for 
mercury and antibiotic resistance in bacteria, especially those found in close 
proximity to the filling, such as the oral flora found in dental plaque. However, 
from the limited number of studies carried out, the results have been inconclusive. 
Summers’ group found there to be a link between amalgam fillings and an 
increase in mercury and antibiotic resistance in the oral and faecal flora of 
primates (Summers et al, 1993). In contrast, Edlund found that, in human adults, 
there was no link between the presence of mercury amalgam fillings and the 
prevalence of mercury-resistant oral bacteria (Edlund et al, 1996).
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4.2 Aims
There were three aims to this study. These were:
1. To determine whether children with fillings harboured a higher
proportion o f mercury-resistant bacteria in their oral flora than 
children without amalgam fillings.
2. The second aim was to identify the mercury-resistant bacteria and 
determine whether there were differences in the types of organism 
isolated from individuals with and without amalgam fillings.
3. The final aim was to investigate whether the mercury-resistant 
organisms were also resistant to 6 antibiotics and to determine 
whether there were differences between the non-amalgam and 
amalgam individuals. The MIC of mercuric chloride for these 
organisms was also determined during this part of the study.
4.3 Materials and Methods
4.3.1 Patient Selection
Healthy children, aged between 5-16 years, attending a clinic at the Department of 
Paediatrics at the Eastman Dental Hospital were enrolled in the study. Children 
with chronic medical disorders or those that had known viral carriage were not
recruited into the study. Children that had been treated with antibiotics during the 
proceeding 3 months were also excluded. During the visit to the clinic the dentist 
clinically assessed the patient and the child’s guardian signed a consent form. The 
study was approved by the Ethics Committee of University College London.
The children were divided into two groups: Group 1 children had no amalgam 
fillings, while children in Group 2 had at least two tooth surfaces restored with 
amalgam.
4.3.2 Sample Collection
Plaque was collected from around the gingival margins and the surfaces o f all the 
teeth using an alginate swab (MW&E, Medical Wire Equipment Co. (Bath) Ltd, 
Corsham, Wiltshire, UK). The swab was placed into a sterile glass bijou 
containing 4ml lA strength Ringers solution (Oxoid) and five glass beads 
(Sigma-Aldrich). One ml saliva samples were collected in mercury-free sterile 
plastic universal containers (Sarstedt).
4.3.3 Sample Processing
The fresh saliva and plaque samples were cultured within 30 minutes of arrival at 
the laboratory, where the swab from each patient was vortexed for 30 seconds, 
added to the saliva sample from the same patient and vortexed for a further 
30 seconds. The sample mixtures were 10-fold serially diluted to 10’7 in Tryptone 
Soya broth (Oxoid).
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Duplicate lOOpl aliquots o f dilutions (1CT4, 10'5, 10‘6 and 10'7) of each sample 
were inoculated onto mercury-free Mueller-Hinton agar. Duplicate 100pi aliquots 
of the undiluted sample and 10'1, 10'2 and 10'3 dilutions were inoculated onto 
Mueller-Hinton agar containing 40 pM HgCb- These plates were prepared on the 
same day that the specimen was collected and kept out of direct light before use. 
Four plates were used for each dilution, two of which were incubated aerobically 
and two anaerobically for 48 hours. During incubation, all the 
mercury-containing plates were wrapped in aluminium foil to protect from light.
Following incubation, colonies growing on the mercury-containing and 
mercury-free media were enumerated. Colonies growing on the 
mercury-containing agar showed little morphological differences and therefore at 
least four colonies from each patient (aerobic and anaerobic) were subcultured 
onto mercury-containing and mercury-free Mueller-Hinton plates. After 
24-48 hours incubation (37°C, aerobic and anaerobic), the organisms were stored 
at -70°C, for identification and antibiotic-sensitivity testing at a later date.
4.3.4 Susceptibility Testing
Antimicrobial susceptibility was determined by an agar dilution technique, as
described by the British Society for Antimicrobial Chemotherapy
(BSAC)(Andrews, 2001b). Both the mercury and antibiotic plates were prepared
on the day that they were inoculated. Mueller-Hinton agar was used to determine
the MIC of HgCl2, while Iso-Sensitest agar supplemented with 5% defibrinated
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horse blood (E&O Laboratories) was used to determine the MICs of the 
antibiotics. The stock solutions used are described in chapter 2.1.4 and the range 
and breakpoints are shown in Table 4.1 below:
Antimicrobial Range (mg/1) Break]pointab
Gram-positive Pseudomonads
Mercury 1-1024 16 16
Penicillin 0.008-8 0.125 N/A
Ampicillin 0.008-8 1 8
Erythromycin 0.008-8 0.5 N/A
Vancomycin 0.0625-16 4 N/A
Tetracycline 0.016-128 1 1
Gentamicin 0.03125-128 l c
128d
8
Table 4.1: Concentration Ranges and Breakpoints used in the
Cross-sectional Study
a The mercuric chloride concentration was measured in pM. The antibiotic
concentrations were measured in mg/1 
b The breakpoint differs according to the organism tested. Penicillin is not
used to treat pseudomonal infections, while all Gram-negative bacteria are 
inherently resistant to vancomycin and low-levels of erythromycin 
c Breakpoint for all Gram-positive organisms except streptococci and
enterococci. Streptococci and enterococci exhibit inherent low-level 
resistance to gentamicin 
d Breakpoint for streptococci and enterococci
A Mueller-Hinton plate without mercuric chloride and an Iso-Sensitest plate 
without antibiotics were prepared to determine whether these agars could support 
the growth of the control and test organisms. Before use, the agar plates were 
dried in a laminar flow cabinet for 20 minutes and kept out of direct light.
The test organisms were grown overnight on Columbia blood agar (CBA), 
harvested and emulsified in 3ml brain heart infusion (BHI) broth using a Q-tip.
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The broths were diluted with BHI to a 0.5 McFarland Standard (5xl06 CFU/ml). 
The agar dilution test plates were inoculated with a multipoint inoculator (Mast) 
resulting in a final inoculum of approximately 104 CFU/spot. The plates were 
incubated in aerobic conditions at 37°C for 18 hours. The HgC^-containing 
plates were incubated in the same conditions, but wrapped in aluminium foil to 
prevent vapourisation o f mercury. Organisms that were unable to grow under 
aerobic conditions were incubated in 5% CO2 at 37°C for 18 hours. The MIC was 
defined as the lowest concentration resulting in the absence o f visible growth.
4.3.5 Identification of Isolates
Oral isolates able to grow on the Mueller-Hinton agar containing 16pM HgCL or 
greater were regarded as being mercury-resistant and were identified to the genus 
level using conventional microbiological techniques such as Gram stain, 
morphology, atmospheric requirements and standard biochemical tests 
(eg catalase and oxidase)(Table 2.2). The majority o f the organisms were 
members of the Streptococcus genus and were further identified using an in-house 
biochemical technique or 16S rRNA sequencing (Tables 2.3 and 2.4) 
(Beighton et al, 1991, Lane, 1996).
The 16S rRNA gene was amplified using global primers (27F and 1492R) 
(Genosys-Sigma) via the polymerase chain reaction (PCR) and is described 
further in Chapter 2.2.4. The PCR products were sequenced using an 
ABB 10 Genetic Analyser (PE Biosystems) and analysed using the Ribosomal
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Database Project II and BLAST at the National Centre for Biotechnological 
Information (NCBI).
4.3.6 Statistical Analysis
The percentages o f mercury-resistant bacteria from both the aerobic and anaerobic 
plates were analysed statistically. The mean, median and interquartile range (IQR) 
were determined to summarise the distribution pattern. The mean and IQR results 
from both incubation conditions and from both groups o f patients were greater 
than the correlating median, suggesting that the results did not show normal 
distribution and were severely positively skewed (Figures 4.1 & 4.2). Therefore, 
the results could not be subjected to parametric testing. Initially, the 
non-parametric test used was the Mann-Whitney test using SPSS software 
(SPSS, Chicago, Illinois, USA). The Kolmogorov-Smimov test was used to 
check that the overall shape and distribution of the data from each group did not 
differ significantly from each other.
145
A B
Figure 4.1: Dot chart represents normally (A) and non-normally (B) distributed 
data. The vertical line (|) represents the median and the asterisk (*) indicates the 
mean. The non-normally distributed data (non-parametric) is skewed to the right 
as the mean is greater than the median
A B
Figure 4.2: The bell-shaped curve shows normal (parametric) distribution (A), 
while the skewed curve shows non-normal (non-parametric) distribution (B)
Parametric tests are statistically more powerful than non-parametric tests,
increasing the likelihood of correctly identifying a significant result. This can be
achieved by transforming the data into a near-normal distribution by using a
variety of mathematical options. In this study, adding a small offset to the data
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and then transforming the results by the natural logarithm achieved this 
(Equation 4.1). The offset was added to allow zero values to be logged and also 
to maximise symmetry in both groups. The offset added to the aerobic data was 
0.0008 and the offset added to the anaerobic data was 0.0011.
z = ln(x+v) y  = offset value 
x  = original value
z = transformed value used in the parametric test
Equation 4.1: Data Transformation
The transformed data were analysed by multivariate multilevel regression using 
MLwiN software (Gilthorpe & Cunningham, 2000). All statistical tests were 
two-tailed, with the 5% level o f statistical significance adopted throughout.
The proportion of mercury-resistant bacteria (as a percentage o f both the aerobic 
and anaerobic viable counts) in the cultivable oral microflora o f each subject was 
assessed in relation to the number of surfaces restored with amalgam using the 
Pearson (parametric) and Spearman’s rho (non-parametric) correlation tests.
The Chi-square test was adopted to study whether there was a link between the 
presence of mercury and the identity of mercury-resistant organisms isolated from 
both groups.
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4.4 Results
The ‘amalgam’ group consisted o f 41 patients, mean age 10.7 years, SD 3.1; 
range, 6.3-16.8 years, with a mean of 4.7 amalgam surfaces (range 2-12). The 
control group (‘no amalgam’) consisted o f 42 patients, mean age 10.2 years, 
SD 2.9, range 5.9-16.3 years. The sex of the children was not recorded.
Bacteria able to grow on Mueller-Hinton agar containing 16pM HgCh and above 
were considered to be mercury-resistant, as the MIC of HgCh for the two control 
mercury-resistant organisms, Staph. aureus NCTC 50581 and 
Ent. faecium  664 1H1, were 32pM and 64 pM respectively. The
mercury-sensitive organisms, S. mitis 606 4T1 and Staph aureus 8325-4, were 
used as mercury-sensitive controls. These organisms were unable to grown on the 
agar containing 16pM HgC^.
In total, 139 mercury-resistant bacteria were isolated from 83 patients. Sixty four 
organisms were isolated from patients without amalgam and 75 bacteria were 
isolated from patients with amalgam.
Of those children who did not have amalgam fillings, 30 (71.4%) harboured 
mercury-resistant bacteria. A similar number (32) and proportion (78%) of 
children with amalgam fillings also harboured mercury-resistant bacteria.
Table 4.2 shows the proportions of mercury-resistant bacteria, expressed as
percentages of the total viable aerobic and anaerobic counts, present in the
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samples. The percentage range o f organisms isolated from both sets o f patients 
did not vary, either aerobically and anaerobically. The interquartile range (IQR) 
is a measure of the spread of the results. The mean and IQR for both incubation 
conditions and for both sets of patients were greater than the correlating median, 
suggesting that the results were not normally distributed and positively skewed 
(skewed to the right).
Under both aerobic and anaerobic conditions, it can be seen that the median 
numbers o f mercury-resistant bacteria were greater amongst subjects with fillings 
than those without fillings. However, these differences between the filling and 
no filling group were not significant at the 5% level (P>0.05) when using the 
non-parametric Mann-Whitney, whether analysing on the basis of the total viable 
aerobic count (P=0.101) or the total viable anaerobic count (P=0.218). The 
Kolmogorov-Smimov test results were not significant (P=0.225 and P=0.174, 
aerobic and anaerobic respectively), concluding that the overall shape and 
distribution of the data from each group did not differ significantly from each 
other.
Table 4.2 shows that the transformed data analysed using multivariate multilevel 
regression were not significant, whether analysing on the basis of the total viable 
aerobic count (P=0.107) or the total viable anaerobic count (P=0.256).
Using the Pearson correlation test, analysis of the aerobic data from the
amalgam-containing children revealed that the proportion of mercury-resistant
bacteria (expressed as a percentage o f the aerobic count) showed a significant
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linear association with the number o f surfaces present (r=0.45, P=0.004) 
(Table 4.3). However, the Pearson correlation coefficient test is sensitive to 
skewness and therefore this parametric test might not be reliable. Using 
Spearman’s rank-correlation coefficient test, a non-parametric test, and the raw 
(non-transformed) data, the correlation and level of significance were largely 
reduced (p=0.23, P=0.151). In contrast, when the proportion of mercury-resistant 
bacteria was expressed as a percentage o f the anaerobic count, only a borderline 
significant association with the number o f amalgam surfaces present was found 
using either the Pearson (parametric) or Spearman’s (non-parametric) correlation 
tests. The values calculated were r=0.31, P=0.053 and p=0.27, P=0.084, for the 
Pearson and Spearman’s tests respectively.
There was no significant difference between the two groups in terms of the
number of mercury-resistant species isolated, as shown in Table 4.4. O f the
mercury-resistant bacteria isolated, 88% of those isolated from children with
amalgam fillings were streptococci (Table 4.5). Similarly, 92% of the
mercury-resistant organisms isolated from the children without amalgam fillings
were identified as streptococci. O f those streptococci that could be identified, the
majority were S. oralis. This was found in both patient types. However,
mercury-resistant S. oralis was isolated more often from the amalgam group, and
found to be statistically significant using the Chi square test
(X2(i)—6-727, P=0.0095). In the non-amalgam group, the mercury-resistant
isolates showed a greater species diversity with no particular streptococcal species
being dominant in terms of frequency of isolation. Other mercury-resistant
organisms isolated included Staph, aureus and coagulase-negative staphylococci
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(CNS). A wider variety o f bacterial species were isolated from patients with 
amalgam fillings. The bacteria isolated included Rothia dentocariosa and one 
Gram-negative organism; Pseudomonas stutzeri. No mercury-resistant obligate 
anaerobes were isolated from either group.
Once identified, the mercury-resistant bacteria were tested for their level of 
resistance to mercury, by determining the MIC of HgCh. The majority of 
organisms had an MIC of 32pM, although some had an MIC o f 64jaM 
(Table 4.6). One S. mitis strain (with amalgam) had an MIC of 128pM, while the 
P. stutzeri (with amalgam) had an MIC o f 256pM.
Thirty-one (41%) and 21 (33%) of the mercury-resistant bacteria isolated from the 
groups with and without amalgam fillings respectively were also resistant to at 
least one of the antibiotics tested (Table 4.7). All o f the isolates were facultative 
anaerobes and therefore metronidazole resistance was not tested. None of the 
mercury-resistant bacteria exhibited resistance to ampicillin or gentamicin. The 
mercury-resistant organisms were most often resistant to tetracycline (22%) and to 
a lesser extent, erythromycin (17%). Penicillin resistance was occasionally 
encountered in these organisms (6%). Ten isolates, six from patients with 
amalgam and 4 from patients without amalgam, were resistant to two antibiotics 
(Table 4.7). These isolates were either resistant to both tetracycline and 
erythromycin or tetracycline and penicillin. Tetracycline and erythromycin 
resistance was more common in organisms isolated from patients with amalgam 
fillings (5 organisms) than those without (1 organism). Additionally, in the
amalgam group, four out of the five bacteria were identified as S. oralis.
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Tetracycline and penicillin resistance was more common in mercury-resistant 
bacteria isolated from patients without amalgam fillings (3 organisms) than those 
with (1 organism). The P. stutzeri isolated from a patient with amalgam was 
resistant to three antibiotics -  penicillin, vancomycin and erythromycin. 
However, members o f the Pseudomonas genus are inherently resistant to these 
antibiotics, so this high resistance pattern was not significant.
As previously reported in this chapter, mercury-resistant S. oralis were more 
commonly isolated in this study than any other streptococcal species. In addition, 
50% (18 out of 36) o f the S. oralis isolated from children with amalgam were also 
resistant to at least one antibiotic. In contrast, only 24% (4 out o f 17) o f the 
S. oralis from the non-amalgam patients were resistant to an antibiotic. 
Statistically, using the chi square test, these differences were marginally not 
significant (x2(i)=3.32, P=0.068). Focussing on specific antibiotic resistance in 
the mercury-resistant S. oralis isolated, 12 out o f 36 (33%) of the organisms 
isolated from patients with amalgam were resistant to tetracycline, while only 
1 out o f 17 (6%) S. oralis strains from the non-amalgam children were resistant to 
tetracycline. Statistically, using the chi square test, these results were significant 
(X2(i)=4.7, P=0.03). Similarly with erythromycin, 10 out of 36 (28%) S. oralis 
strains from the amalgam group were resistant, while only 2 out of 17 (12%) of 
the S. oralis isolates from patients without amalgam were resistant to 
erythromycin. However, these results were not significant using the chi square 
test (x2(i)=1-69, P=0.197).
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Tables 4.9 and 4.10 show the MIC range, MIC50 and MIC90 of the 6  antibiotics 
tested and percentage of resistance for all the streptococci isolated. All isolates 
from the amalgam and non-amalgam groups were sensitive to ampicillin 
(MIC90 = 0.25 and 0.5mg/l). All isolates displayed vancomycin sensitivity with 
MIC50 and MIC90 values of 0.5 and lmg /1 for both the non-amalgam and amalgam 
groups. In the non-amalgam group the rank order of susceptibility for the viridans 
streptococci was: vancomycin = gentamicin = ampicillin ( 1 0 0 %) > penicillin 
(94%) > erythromycin (85%) > tetracycline (82%). The same pattern was also 
observed with the amalgam group: vancomycin = gentamicin = ampicillin
(100%) > penicillin (97%) > erythromycin (79%) > tetracycline (72%). For both 
the non-amalgam and amalgam patients, more organisms were resistant to 
tetracycline than any of the other antibiotics tested, with the highest MIC90 values 
(16 and 64mg/l) and 18 and 28% resistance proportions.
Tables 4.11 and 4.12 show the MIC range, MIC50 and MIC90 o f the 6  antibiotics 
tested and percentage o f resistant strains for S. oralis, S. mitis and 
Streptococcus species (including the unspeciated streptococci, S. salivarius, 
S. parasanguinis, S. sanguinis, S. anginosus and S. vestibularis). The MIC range 
of vancomycin for the streptococci was narrow, with MIC90S of 0.5 and lmg/1. 
All of the organisms tested were sensitive to vancomycin. In contrast, the MIC 
ranges of the other antibiotics, especially erythromycin and tetracycline were 
much larger. Due to the large MIC range for these antibiotics, there were 
considerable differences between the MIC50 and MIC90 values. The results for the 
coagulase-negative staphylococci, Staph, aureus, R. dentocariosa and P. stutzeri
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are not listed in the table because of the limited number of these organisms 
isolated.
4.5 Discussion
The first aim of this study was to determine the number of children, with and 
without amalgam fillings, who harboured mercury-resistant bacteria in their oral 
flora and the prevalence o f these organisms. Similar numbers o f children without 
and with amalgam fillings harboured mercury-resistant bacteria in their oral flora 
(71.4% and 78% respectively). Summers reported that 63% of the human faecal 
samples tested in their study harboured mercury-resistant bacteria group 
(Summers et al, 1993). A similar study carried out by Ready and colleagues 
found similar proportions o f mercury-resistant bacteria in saliva 
(Ready et al, 2003). O f 76 amalgam-free children tested, 54 (71%) harboured oral 
bacteria resistant to mercuric chloride despite using a different medium to the 
current study to isolate the mercury-resistant bacteria. The group used 
Mueller-Hinton agar containing 5% defibrinated horse blood plus 
350pM mercuric chloride. As discussed in the previous chapter (Chapter 3.5), 
blood contains many constituents which can bind to mercury, resulting in less 
available mercury and significantly reducing its bactericidal activity.
In the current study, there were no statistically significant differences in terms of
the proportions o f mercury-resistant bacteria between the non-amalgam and
amalgam groups. However, analysing the aerobic amalgam data using the
Pearson correlation test revealed that the proportion of mercury-resistant bacteria
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showed a significant linear association with the number o f amalgam surfaces 
present. Several other investigators have shown that there are higher 
concentrations o f mercury in the saliva and faeces o f individuals with amalgam 
fillings than those without (Lyttle & Bowden, 1993b, Summers et al, 1993, 
Osterblad et al, 1995, Edlund et al, 1996, Leistevuo et al, 2002). However, only 
one of these studies has reported a statistically significant linear trend between the 
number of amalgam-filled surfaces and the logarithm of total mercury in saliva 
(Leistevuo et al, 2002). This group found the average level o f mercury in the 
(amalgam) group was 174nmol/l, 23 times higher than in the non-amalgam 
patients. Worryingly, 20.5% of the amalgam patients had more than 
250nml/l mercury in their saliva, which exceeds the European Economic 
Community (EEC) limit o f mercury in sewage. This study confirms that amalgam 
fillings are one o f the most important sources of mercury exposure in human 
saliva in developed countries. However, the link between the proportion of 
mercury-resistant bacteria and number of amalgam fillings has been disputed by 
other studies. A study carried out by Diaz-Mejia looked at mercury and antibiotic 
resistance in the oral flora of Mexican and Cuban subjects 
(Diaz-Mejia et al, 2002). The Cuban patients possessed more fillings than the 
Mexican patients, but showed no relationship between the number o f fillings and 
mercury and antibiotic resistance.
Unfortunately, there are few studies with which the results o f the present study
can be directly compared and, to complicate matters, there are many
methodological differences between published studies. One major problem is that
a standardised breakpoint concentration o f mercury has not been established,
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which has led to the use o f a variety o f concentrations, ranging from 
7.4pM -  350pM (2mg/l -  946mg/l)(Nakahara et al, 1977a,
Khor & Jegathesan, 1983, Rudrik et al, 1985, Zscheck & Murray, 1990, 
Avila-Campos et al, 1991b, Summers et al, 1993, Osterblad et al, 1995, 
Edlund et al, 1996, Sadhukhan et al, 1997, Wireman et al, 1997,
Huang et al, 1999, Nascimento et al, 1999, Kholodii et al, 2000,
Pike et al, 2002a, 2002b, Pike et al, 2003, Ready et al, 2003). The agar used often
depends on the type o f bacteria tested. For example, MacConkey and bile 
aesculin azide agar has been used to determine mercury resistance in the faecal 
flora, while mitis salivarius agar has been used to isolate mercury-resistant oral 
streptococci (Summers et al, 1993). Other studies have used 5% defibrinated 
horse blood and Antibiotic Sensitivity Medium II Agar (Edlund et al, 1996), 
5% defibrinated horse blood and Mueller-Hinton agar (Ready et al, 2003), 
Luria agar (Wireman et al, 1997), nutrient agar (Khor & Jegathesan, 1983, 
Nakahara et al, 1977a), modified Actinomyces defined medium (MADM) 
(Lyttle & Bowden, 1993b), tryptose-glucose-yeast (TGY) agar
(Timoney et al, 1978) and cysteine-free agar (Rudrik et al, 1985). In addition, the 
conditions and times for which the plates were incubated varied according to the 
organisms tested.
To date, only four other studies have looked at the likelihood that mercury
released from amalgam fillings could select for antibiotic- and mercury-resistant
bacteria (Summers et al, 1993, Osterblad et al, 1995, Edlund et al, 1996,
Leistevuo et al, 2000). O f these, Summers studied antibiotic and mercury
resistance in the faecal and oral flora of monkeys and Osterblad looked at
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resistance in the faecal flora o f humans (Summers et al, 1993,
Osterblad et al, 1995). Edlund studied antibiotic and mercury resistance in the 
oral flora (and faecal flora) o f humans, whereas Leistevuo looked at resistance in 
S. mutans isolated from human saliva (Edlund et al, 1996, Leistevuo et al, 2000). 
Summers’ research differed to the others in that it was a longitudinal survey and 
will be discussed in Chapter 5 (Summers et al, 1993). The others were 
cross-sectional, investigating the flora isolated from patients without and with 
amalgam and, in two o f the studies, from a group of patients that had their 
amalgam fillings removed and replaced with glass ionomers 
(Osterblad et al, 1995, Edlund et al, 1996, Leistevuo et al, 2000).
Edlund found that mercury exposure from amalgam fillings was not a major factor 
in the selection o f mercury and antimicrobial resistance in the oral and faecal flora 
(Edlund et al, 1996). Nevertheless, Edlund found a significant increase in the 
proportion of mercury-resistant Bacteroides species in the intestinal flora o f adults 
with amalgam fillings compared to subjects without amalgam. However, they did 
not find significant differences in the proportion of mercury-resistant E. coli or 
enterococci from the two sets o f patients. Unfortunately, several criticisms can be 
made regarding the experimental design of Edlund’s study. Firstly, the group 
isolated mercury- and antibiotic-resistant organisms from only 20 adults 
(10 without and 10 with amalgam fillings), while the current survey studied 
resistance in organisms isolated from 83 children. Increasing the number of 
subjects in each group increases the reliability of the data analysis. Secondly, 
Edlund’s study isolated mercury-resistant bacteria from only saliva samples and 
not saliva and plaque. The latter gives a more representative sample o f the oral
microflora. Drucker and Jolly found that the percentage o f patients with 
streptococci resistant to penicillin and erythromycin appeared to be greater when 
samples were obtained from the gingival margin than when saliva per se was 
sampled (Drucker & Jolly, 1971). Furthermore, an increase in the number o f sites 
sampled would increase the likelihood o f detecting antibiotic-resistant strains. 
Thirdly, Edlund’s group included blood in the Antibiotic Sensitivity Medium II 
agar used to isolate the mercury-resistant bacteria, which as discussed in 
Chapter 3 binds to mercury (Avilo-Campos et al, 1991b,
Lyttle & Bowden, 1993b, Leistevuo et al, 2000). The group incorporated 
50pM HgCb into their agar, which is a low concentration given that they also 
added 5% defibrinated horse blood. The authors do not report why they chose to 
use this concentration. All the patients in the study harboured mercury-resistant 
bacteria in their saliva, while the proportion (median) o f mercury-resistant 
bacteria was around 50% in both sets o f patients. This is in marked contrast with 
the present study where the proportions of mercury-resistant bacteria were less 
than 1% of the total viable count. However, Edlund’s, group checked that these 
mercury-resistant organisms were not false positives by determining the MICs of 
HgCh and using E. coli ATCC 25922, a mercury-sensitive organism (MIC 25pM) 
as a control. The group should have used a mercury-resistant control and any 
isolates with a MIC of HgCh equal to or greater than that o f the control, could be 
classified as mercury-resistant. These final points may suggest that many o f the 
organisms classified as mercury-resistant in Edlund’s study were not truly 
resistant.
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In a study of the susceptibility o f S. mutans to mercury and to 3 antibiotics, 
Leistevuo found that the MICs o f the 4 antimicrobials did not differ for isolates 
from patients with amalgam, without amalgam and those who had amalgam 
removed (Leistevuo et al, 2000). The group determined the MICs o f HgCh on 
Mitis Salivarius agar using a series o f concentrations ranging from 
2-128mg/l (7.4-473.6pM). They found that the MICs of HgCL for the 
455 S. mutans tested were between 4-32mg/l (14.8-118.4pM). However, they did 
not state at which concentration the organisms were considered mercury-resistant 
or which, if any, organisms were used as mercury-resistant controls. In addition, 
Leistevuo did not mention the percentage of organisms from each group resistant 
to mercury, but report only the concentration range, MIC50 and MIC90 results. 
From these results one can only conclude that more organisms from the group 
who had had amalgam removed were less susceptible to mercury than the 
organisms from the other two groups, as the former had a higher MIC90. 
Additionally, the group did not mention the breakpoint concentration for the 
3 antibiotics tested or the percentage o f organisms resistant to these antibiotics. 
Again, the concentration range, MIC50 and MIC90 were reported, which were very 
similar for each group, which may suggest that very few differences in antibiotic 
resistance were observed between the three groups.
Osterblad grouped subjects on the basis o f whether they had amalgam fillings, had
recently had them removed or had never had amalgam fillings
(Osterblad et al, 1995). No significant differences in either mercury or antibiotic
resistance in the aerobic Gram-negative faecal flora of these subjects were seen.
However, the group reported that both ampicillin and nalidixic acid resistance
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were higher in the flora isolated from the amalgam group than the other two 
groups. They also showed a strong correlation between multiple antibiotic 
resistance with mercury resistance; 36% of all mercury-resistant strains were also 
resistant to two or more antibiotics. Like the present study, this group used 
Mueller-Hinton agar and both studies used a similar concentration o f HgCh to 
isolate mercury-resistant bacteria. Osterblad incorporated 10mg/l (37pM) HgCh, 
while the present study used 40pM HgCfj. However, Osterblad plated the diluted 
faecal samples directly onto MacConkey agar and after incubation, replica plated 
onto the mercury- and antibiotic-containing agar, whereas the present study 
inoculated diluted samples directly onto mercury-containing agar. In both studies, 
mercury resistance was confirmed by determining the MIC of HgCh using agar 
dilution. Osterblad only reported the percentage o f subjects harbouring 
>1% mercury-resistant bacteria and found that 21%, 21% and 15% subjects 
without amalgam, removed amalgam and with amalgam respectively harboured 
mercury-resistant bacteria. In contrast, the present study reported the number of 
subjects who harboured >0.00014% mercury-resistant bacteria. If the present 
study, like Osterblad, had reported the number o f patients harbouring 
>1% mercury-resistant bacteria in their oral flora, 21.4% patients without 
amalgam and 22% patients with amalgam harboured mercury-resistant bacteria. 
Unfortunately, Osterblad’s group did not report how many fillings the subjects 
had or had removed. Previous studies have shown that the number o f amalgam 
fillings is a significant variable in predicting amalgam mercury exposure in 
humans (Leistevuo et al, 2002). Additionally, the number, gender and ages o f the 
subjects in the 3 groups were not well-matched. Osterblad collected faecal 
samples from 92 subjects with amalgam fillings, but only enrolled 56 and 43
subjects in the removed amalgam and non-amalgam groups respectively. Three 
times more female subjects than male were in the non-amalgam and removed 
amalgam groups, while the mean age of the subjects in the non-amalgam group 
was 22, compared to 48 years o f age in the amalgam group and 50 years o f age in 
the removed amalgam group. Ideally, the groups studied should be well-matched 
with respect to age and gender, but in practice this is usually impossible.
The second aim of the current study was to identify the mercury-resistant bacteria 
and determine whether there was a difference in the type o f organisms isolated 
from the two groups. The majority o f mercury-resistant bacteria isolated from 
both groups were streptococci. Previous studies have shown that streptococci are 
the predominant cultivable oral flora in children between the ages o f 2 and 10 
years (Chen et al, 1997, Kamma et al, 2000). Furthermore, in the case o f the 
amalgam group, a large proportion were »S. oralis. Streptococcus oralis is a 
common member o f the microflora of several oral habitats including 
supragingival plaque, saliva and mucosal surfaces. A study by Lucas found the 
predominant oral streptococci in children aged between 5 and 16 years to be 
S. salivarius (Lucas et al, 2000). Two other major species were S. oralis and 
S. mitis. In the present study S. mitis and S. salivarius were the second and third 
most commonly isolated streptococcal species. Similar work carried out by 
Ready et al (2003) also found that streptococci were the most commonly isolated 
mercury-resistant genera found within the oral flora. However, the group found 
that S. mitis were more predominant than S. salivarius, S. sanguinis and S. oralis, 
which were the second, third and fourth most commonly isolated 
streptococcal species.
The MIC of HgCb was determined against all the mercury-resistant organisms 
isolated. The MICs ranged from 32-256pM, with MIC50 and MIC90 values of 
32 and 64 respectively. The majority o f streptococci had an MIC o f 32 or 64pM, 
while only one S. mitis had a MIC o f 128pM (with amalgam). Ready isolated 
many more streptococcal species with higher MICs than the present study 
(Ready et al, 2003). This group used the same methods to determine the MIC as 
the present study and isolated S. sanguinis, S. mitis and S. oralis with MICs of 
128, 256 and 512pM respectively.
Few researchers have studied the susceptibility o f oral bacteria to mercury and 
even fewer have studied mercury resistance in oral streptococci. Lyttle and 
Bowden tested the ability o f oral streptococci and Actinomyces to grow in the 
presence of mercury (Lyttle & Bowden, 1993b). They found that streptococci 
were more resistant to mercury than Actinomyces and all o f the streptococcal 
strains tested were able to grow on solid media containing 5mg/l (18.5pM) HgCh. 
They also found that S. oralis, S. mitis and S. sanguinis were able to adapt to 
growth in levels o f mercury that would inhibit them on initial isolation.
The final aim of this study was to investigate whether the mercury-resistant 
organisms were also resistant to any o f 6 antibiotics and to determine whether 
there were differences between the two groups.
For several decades the increase in antibiotic resistance of pathogenic organisms
has been well documented, while the antibiotic resistance patterns of commensal
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organisms have been investigated to a lesser extent. However, several in vitro 
susceptibility studies have recently reported antibiotic resistance in oral 
streptococci (Doem et al, 1996, Traub & Leonhard, 1997, Teng et al, 1998). 
These organisms are regarded as opportunistic pathogens and commonly the 
causative agent o f infective endocarditis (Johnson et al, 2001). However, during 
the last 20 years, viridans streptococci bacteraemia in neutropaenic cancer patients 
has become more common (Oppenheim, 1998, Tunkel & Sepkowitz, 2002). 
Therefore, the majority o f antibiotic resistance surveillance studies on viridans 
streptococci have investigated the susceptibilities of bacteria isolated from blood 
cultures from endocarditis patients and, more recently, from neutropaenic cancer 
patients (Carratala et al, 1995, Endtz et al, 1997, Johnson et al, 2001). At present, 
very few epidemiological studies have been published which look at the antibiotic 
susceptibility patterns of the oral flora isolated directly from saliva and plaque 
samples from healthy human subjects. For this reason, the majority o f the studies 
referred to in this discussion have looked at the antimicrobial susceptibility 
patterns of viridans streptococci isolated from the blood cultures o f patients with 
bacteraemia. However, care must be taken when comparing results from clinical 
isolates (pathogens) and commensal organisms isolated from healthy patients. 
Ideally, blood cultures should be taken before antibiotic treatment, although in 
many circumstances antibiotics are administered before the blood culture is taken. 
This is especially true with immunocompromised patients, such as neutropaenic 
cancer patients who are often on prophylactic treatment against Gram-negative 
infections and Pneumocystis carinii and take antibiotics long-term, such as the 
fluoroquinolones and trimethoprim-sulfamethoxazole (co-trimoxazole) 
(Carratala et al, 1995, Kennedy et al, 2001, Tunkel & Sepkowitz, 2002,
Westling et al, 2002). Traub and Leonhard found that viridans and p-haemolytic 
streptococci isolated from hospitalised patients were, in general, more resistant to 
24 antibiotics than the streptococci isolated from pharyngeal swabs o f healthy 
medical students (Traub and Leonhard, 1997). However, surprisingly, they also 
found that the isolates from the healthy students were more resistant to the 
macrolide antibiotics. In another study, Westling and colleagues investigated 
resistance to penicillin in viridans streptococci isolated from non-neutropaenic 
and neutropaenic patients (Westling et al, 2002). Sixty four out of 74 of the 
neutropaenic patients had been treated prophylactically with antibiotics and nine 
o f the streptococci isolated from these patients were resistant to penicillin. None 
o f the organisms isolated from the non-neutropaenic patients, who had not been 
treated prophylactically with antibiotics, were resistant to penicillin. Diekema 
also found that viridans streptococci isolated from the blood cultures o f patients 
with cancer were more resistant to antibiotics than those organisms isolated from 
the blood cultures o f patients without cancer (Diekema et al, 2001). Therefore, 
organisms isolated from septicaemic patients may be more resistant due to the 
prophylactic antibiotic treatment, resulting in selective pressure.
Another difficulty, when trying to compare this study with others, is that most
other studies have used the NCCLS guidelines to test the susceptibility patterns of
viridans streptococci (Bantar et al, 1996, Wisplinghoff et al, 1999,
Poutanen et al, 1999). However, the present study used the British Society for
Antimicrobial Chemotherapy (BSAC) guidelines. The NCCLS recommends
Mueller-Hinton agar, while the BSAC advise the use o f Iso-Sensitest agar.
Different breakpoints have been endorsed by the two committees and in general,
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the breakpoints recommended by the BSAC are lower than those recommended 
by the NCCLS (Brown, 1994). For example, the BSAC breakpoint for 
tetracycline is lmg/1, while the NCCLS breakpoint is 4mg/l. In addition, the 
NCCLS describe organisms as either sensitive, intermediate resistant 
(low-level resistance) or resistant (high-level resistance), especially with regard to 
penicillin, whereas the BSAC describe organisms as either sensitive or resistant. 
In many studies discussed in this chapter, organisms showing low-level resistance 
are described as ‘non-susceptible’ and only organisms displaying high-level 
resistance are described as resistant.
Another complication when trying to compare the results from the present study 
with others is that many o f the viridans streptococci, especially those belonging to 
the ‘S. m illerf group (S. anginosus, S. constellatus and S. intermedius), require 
carbon dioxide for growth. In general, previous studies have incubated plates in 
CO2. This can decrease the pH of the medium, often resulting in a two-fold 
increase in the MIC o f macrolide antibiotics (Carratala et al, 1995, 
Endtz et al, 1997, Tuohy & Washington, 1997). In the present study, when 
determining the MIC, all organisms were initially tested in air and only those that 
were unable to grow in these conditions were re-tested in 5% carbon dioxide.
A further problem encountered when comparing the results of this study with 
others is that many other studies have not identified the streptococci to the species 
level. This is probably due to time constraints and more conceivably to the 
difficulty in identifying these organisms using biochemical methods. This is 
especially true with the mitis group (Kawamura et al, 1999).
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The viridans streptococci were once believed to be uniformly susceptible to 
p-lactam antibiotics, macrolides and tetracyclines (Pfaller and Jones, 1997). 
However, many studies have recently shown that the susceptibility patterns can 
vary according to the species o f the organism. In a US study, it was found that 
58% of S. mitis strains were resistant to penicillin, while only 26% of S. sanguinis 
were resistant to the same antibiotic (Tuohy & Washington, 1997). In contrast, 
100% of the ‘S. millerV strains tested were susceptible to penicillin. In the UK, 
the Public Health Laboratory found that 13% o f S. oralis, 14% of S. sanguinis and 
5.5% of S. gordonii isolated from the blood cultures of patients with endocarditis 
were resistant to penicillin (Johnson et al, 2001). In contrast, all o f the 
S intermedius, S. constellatus, S. bovis type I and S. mutans strains tested were 
susceptible to penicillin. These differences in resistance are also seen with the 
macrolide antibiotics and the tetracyclines. Wisplinghoff and colleagues found 
that 26% of S. oralis and 46% of S. mitis strains in their study were resistant to 
tetracycline (Wisplinghoff et al, 1999). In Taiwan, Teng found 50% of S. mitis 
were resistant to erythromycin, while 100% of S. mutans were susceptible to this 
antibiotic (Teng et al, 1998). Generally, antibiotic resistance in any member of 
the ‘S. milleri ’ group is rare (Jacobs and Stobberingh, 1996, Bantar et al, 1996). 
These findings are in keeping with those of other investigators who found higher 
rates of resistance in S. mitis than in other Streptococcus species 
(Renneberg et al, 1997, Gershon et al, 2002). This suggests that S. mitis should 
be considered an indicator organism of increasing antimicrobial resistance in oral 
streptococci as well as pneumococci (Renneberg et al, 1997). This is highlighted
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in the present study where, alarmingly, 44% of the S. mitis isolated from the 
non-amalgam patients were resistant to tetracycline.
Penicillin is the preferred drug o f choice for the treatment o f infections caused by 
a-streptococci (viridans) and p-streptococci, especially in the treatment of 
endocarditis, where it is used in combination with gentamicin to create a 
synergistic effect (Johnson et al, 2001). However, unlike p-haemolytic 
streptococci, where resistance to P-lactams is uncommon, viridans group 
streptococci have demonstrated resistance to penicillin and other p-lactams 
(Pfaller and Jones, 1997, Ieven et al, 2000, Johnson et al, 2001). 
Penicillin-resistant strains o f viridans group streptococci were first reported in 
1963 in the oropharynx of children receiving continuous penicillin prophylaxis 
against rheumatic fever (Naiman and Barrow, 1963). Generally, viridans 
streptococci exhibit low-level resistance to penicillin (MIC 0.25-4mg/l), as 
observed in this study and many others (Endtz et al, 1997, 
Wisplinghoff et al, 1999, Seppala et al, 2003). In this study, high-level penicillin 
resistance (MIC>8mg/l) was not encountered. Nevertheless, some authors have 
reported a trend toward high-level penicillin resistance in S. mitis 
(Venditti, et al, 1989, Endtz et al, 1997, Poutanen et al, 1999,
Ioannidou et al, 2001). However, as in this study, other groups have failed to 
show this trend (Watanakunakom & Pantelakis, 1993).
Many of the streptococci in this study exhibited low-level resistance to gentamicin
(51% from the non-amalgam group, 75% from the amalgam group), which is
inherent resistance and not significantly important. The MIC values for
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gentamicin in the present study are in line with those found in previous studies 
(Carratala et al, 1995, Jacobs & Stobberingh, 1996, Tuohy & Washington, 1997, 
Johnson et al, 2001). To date, high-level resistance to aminoglycosides been 
demonstrated in S. mitis, Streptococcus uberis, Aeromonas viridans and 
Gemella morbillorum (Potgieter et al, 1992, Kaufhold & Potgieter, 1993, 
Kobayashi et al, 2003). Most o f these organisms also demonstrated high-level 
penicillin resistance (MIC 16-32mg/l).
Vancomycin resistance was not observed in any o f the streptococci isolated. 
Resistance to vancomycin is rarely encountered in viridans streptococci 
(Venditti et al, 1989, Carratala et al, 1995, Teng et al, 1998, 
Wisplinghoff et al, 1999, Luh et al, 2000, Diekema et al, 2001, 
Ioannidou et al, 2001, Kennedy et al, 2001, Gordon et al, 2002). Low-level 
resistance to vancomycin (MIC 16-32mg/l) was first reported in a S. mitis in 
Slovakia in 1996 (Krdmery et al, 1996a).
Many of the mercury-resistant isolates (6% non-amalgam, 9% amalgam) were
also resistant to two or more antibiotics. In the present study, 3% of the
mercury-resistant bacteria were resistant to penicillin and tetracycline, while
4% of the isolates were resistant to erythromycin and tetracycline. This
association was also observed by Ready who found that 8% of mercury-resistant
isolates were resistant to penicillin and tetracycline, while tetracycline and
erythromycin resistance was more common and present in 11% of the isolates
(Ready et al, 2003). In both studies, organisms resistant to both penicillin and
erythromycin were not observed. However, organisms resistant to penicillin and
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erythromycin and another antibiotic such as either tetracycline and/or vancomycin 
were isolated. In the present study, resistance to penicillin, erythromycin and 
vancomycin was observed in a Gram-negative species, while Ready isolated 
3 strains of viridans streptococci resistant to penicillin, erythromycin and 
tetracycline (Ready et al, 2003).
As discussed, in the current study, mercury-resistant S. oralis was the most 
commonly isolated streptococcal species. Streptococcus oralis is very closely 
related to S. pneumoniae and both organisms share 99% sequence homology 
(Whatmore et al, 2002). Streptococcus pneumoniae is also closely related to 
S. mitis and there is evidence o f the exchange o f genetic material between the 
3 species (Kawamura et al, 1995). Uptake of DNA from S. mitis, S. oralis or 
S. gordonii by S. pneumoniae followed by recombination into the chromosome 
can result in the creation o f ‘new genes’. This results in susceptible genes being 
replaced by mosaic penicillin binding proteins leading to penicillin resistance 
(Dowson et al, 1993). In addition, erythromycin resistance genes have been 
shown to transfer, via conjugation, from viridans group streptococci to 
S. pneumoniae, and vice versa (Luna et al, 1999).
As previously discussed, seven mercury-resistant staphylococci were isolated in
this study. The organisms were identified using 16S rRNA sequencing. O f the
organisms isolated, two were Staph, aureus, one Staph, hominis,
one Staph, warneri and one Staph, epidermidis. Two of the organisms were
unidentifiable using 16S rRNA and are therefore referred to as coagulase-negative
staphylococci. Mercury resistance in Staph, aureus has been studied quite
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extensively. The merA gene can be found chromosomally, but is often on plasmid 
pI258 (Witte et al, 1986, Laddaga et al, 1987). In this study, the staphylococci 
isolated were fairly susceptible to the antibiotics tested. Only Staph, hominis 
showed resistance to penicillin, while the Staph, aureus from an amalgam patient 
showed resistance to tetracycline. Ampicillin- and erythromycin resistance was 
not observed in any o f the staphylococci. In addition, gentamicin resistance was 
not encountered in any o f the mercury-resistant staphylococci isolated. However, 
other studies have shown that gentamicin resistance is commonly encountered in 
all Staphylococcus species, although it is more common in CNS than in 
Staph, aureus (de Neeling et al, 1998, Schmitz et al, 1999, Henwood et al, 2000). 
Vancomycin resistance was not observed in any o f the staphylococci isolated in 
this study. Generally, vancomycin resistance is uncommon in staphylococci and 
was first reported in a coagulase-negative Staphylococcus in 1981, 7 years before 
the first vancomycin-resistant enterococci (VRE) was isolated 
(Cherubin et al, 1981, Srinivasan et al, 2002). Since then several reports have 
described low-level resistance (MIC 8-16mg/l) in Staph, epidermidis and 
Staph, haemolyticus (Schwalbe et al, 1987, Krcmery et al, 1996b). These strains 
were also resistant to methicillin. The first vancomycin-resistant Staph, aureus 
was isolated in 1996 in Japan (Hiramatsu et al, 1998).
In this study, six mercury-resistant Rothia dentocariosa strains were isolated.
Five were isolated from patients with amalgam, while only one was isolated from
a patient without amalgam. This organism, a member o f the family
Micrococcacae, is a normal inhabitant of the oral cavity (Salamon & Prag, 2001).
It is present in human saliva and is most frequently isolated from supragingival
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plaque. Though it appears to be an organism of low virulence, the recent increase 
in the number o f reported cases o f R. dentocariosa bacteraemia has established 
the pathogenic potential o f this organism. The most frequent clinical 
presentations include septicaemia, endocarditis and pneumonia 
(Kong et al, 1998). However, very few authors have looked at the antimicrobial 
susceptibility patterns of this organism and the ones that have are ones in which 
the organism caused an infection (Kong et al, 1998, Salamon & Prag, 2001). In 
3 cases of bacteraemia, the organisms were found to be susceptible to penicillin, 
ampicillin, erythromycin, vancomycin and gentamicin (Salamon & Prag, 2001). 
In a case of endocarditis, the organism was found to be susceptible to penicillin, 
amoxycillin and erythromycin, but resistant to gentamicin (Kong et al, 1998). 
Susceptibility to vancomycin was not tested. In the present study, one o f the 
isolates from a patient with amalgam was found to show low-level resistance to 
penicillin (0.5mg/l).
Only one Gram-negative mercury-resistant organism was isolated during this 
study and this organism was more resistant to mercuric chloride than any o f the 
other mercury-resistant organisms isolated from the cross-sectional study. The 
MIC of HgCh was 256pM and the organism was identified as P. stutzeri using 
16S rRNA sequencing. It was isolated from a patient with amalgam fillings. The 
organism was found to be resistant to penicillin, erythromycin and vancomycin. 
However, all Pseudomonads are inherently resistant to these antibiotics. 
Pseudomonas stutzeri is a saprophyte, usually found in the environment and rarely 
causes human disease (Yan et al, 2001). It is often found as a contaminant in 
bottled water, contact lens solutions and water cooling systems and many studies
have looked at biocide resistance in this organism rather than antibiotic resistance 
(Papapetropoulou et al, 1994, Tattawasart et al, 1999). This organism has been 
shown to develop resistance to non-oxidising water treatment bactericides and 
acquire resistance after exposure to gradually increasing concentrations of 
biocides (Brozel et al, 1993, Russell et al, 1998). Pseudomonas stutzeri has been 
shown to be more sensitive to biocides, including mercury, and antibiotics than 
P. aeruginosa (Tattawasart et al, 1999). However, other groups have found that 
strains of P. stutzeri contain plasmids that harbour mercury and silver resistance 
genes (Haefeli et al, 1984, Barbieri et al, 1989). Pseduomonas stutzeri is not 
regarded as a member o f the normal oral flora of man. However, Ready also 
isolated a mercury-resistant P. stutzeri. Unfortunately, the MIC of HgCU was not 
reported (Ready et al, 2003).
In conclusion, this study has shown that mercury and antibiotic resistance is 
widely distributed among the oral microflora of healthy children, although dental 
amalgam alone is not a key factor in promoting its spread. Many other factors and 
agents detrimental to bacteria may act as confounding variables in this study, 
selecting for resistance and masking the possible effect o f mercury in amalgam 
fillings. These could be components o f food or drugs. Traces of antibiotics in 
food, such as meat, milk, vegetables and fruit, might have some effect 
(Corpet, 1993). Traces of mercury are often found in fish and some studies have 
exclusively employed volunteers that had not eaten fish for one month prior to 
and during the study (Edlund et al, 1996).
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One of the main findings o f the study is that mercury-resistant strains of S. oralis 
were isolated significantly more frequently from children with amalgam fillings 
than from those without. In addition, 50% of the S. oralis isolated from children 
with amalgam were also resistant to at least one antibiotic, while only 24% of 
S. oralis from non-amalgam patients were resistant to an antibiotic. Despite this, 
these differences were narrowly not statistically significant. However, it was 
statistically significant that 33% S. oralis isolated from patients with amalgam 
were resistant to tetracycline, while only 6 % S. oralis strains from the 
non-amalgam children were resistant to this antibiotic.
An additional important outcome o f this study was the finding that the proportion 
o f mercury-resistant oral bacteria showed a significant correlation with the 
number o f amalgam surfaces in the children’s mouth (Table 4.3).
The most important outcome o f this study was that mercury- and 
antibiotic-resistant organisms are common in the oral flora of children with and 
without amalgam fillings. Resistance to these commonly used antimicrobial 
agents suggests the need for comprehensive surveillance programmes to monitor 
resistance in these and other commensal organisms (Bax et al, 2000).
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Proportion of aerobic count (%) 
without amalgam with amalgam
Proportion of anaerobic count (%) 
without amalgam with amalgam
Range
Mean
Median
Inter-quartile range 
Mann-Whitney P value 
(Kolmogorov-Smirnov P value) 
Multivariate regression P  value3
0-15.00
0.593
0.0083
0.2848
0.101
(0.225)
0.107
0-14.88
1.263
0.085
0.7978
0-17.32
0.825
0.014
0.3261
0.218
(0.174)
0.256
0-9.28
0.97
0.055
0.7948
Table 4.2: Proportions o f Mercury-resistant Microbes in the Oral Microflora o f Children with and without Amalgam Fillings
Multivariate regression in this instance uses multilevel modelling to analyse the two outcomes (with respect to the amalgam groups) 
simultaneously in order to optimise the statistical power
Number of amalgam fillings Proportion o f aerobic count (%)
2 0.024
2 0.56
2 0.037
2 0.23
2 3.02
2 1.48
2 0 .0 0 1 2
2 0.046
2 0.962
2 0.0845
2 0.0081
2 0.062
2 0 .6 6
3 0.26
3 0.25
3 0.24
3 0.777
4 0.0047
4 0.05
4 0.046
4 1.93
5 0.5
5 0.94
5 0.0066
5 0.501
5 5
5 4.44
6 0.0015
6 0.00033
6 0.149
6 0.18
6 0.82
7 0 .8 8
7 0.44
7 14.881
8 0.0025
8 0.016
8 0.364
11 5
12 0.0013
12 13,11
Table 4.3 : Proportion of Mercury-resistant Microbes in the Oral Microflora of 
Children with Given numbers of Fillings
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Number of mercury-resistant 
organisms
Number (% ) of patients
Without Amalgam With Amalgam
0 12 (28.6) 9 (22.0)
1 10 (23.8) 11 (26.8)
2 11 (26.2) 9 (22.0)
3 5(11.9) 5 (12.2)
4 3 (7.1) 5 (12.2)
5 1 (2.4) 1 (2.4)
6 0  (0.0) 1 (2.4)
Table 4.4: Number o f Patients with a given number of Mercury-resistant Species
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Organism
No. (% ) o f isolates from children
without amalgam fillings with amalgam fillings
Streptococcus oralis 17(27) 36 (48)
Streptococcus mitis 9(14) 7(9)
Streptococcus salivarius 8(13) 5(7)
Streptococcus sanguis 1 (2 ) 3 (4)
Streptococcus parasanguis 6(9) 2 (3 )
Streptococcus vestibularis 1 (2 ) 0 (0 )
Streptococcus anginosus 2(3) 0 (0 )
Unidentified streptococci 15(23) 13(17)
Staphylococcus aureus 1 (2 ) 1(1)
Coagulase-negative staphylococci 3(5) 2(3 )
Rothia dentocariosa 1 (2 ) 5(7)
Pseudomonas stutzeri 0 (0 ) 1(1)
Total 64 75
Table 4.5: Identity of Mercury-resistant Bacteria from the Patient Groups
No. isolates
without amalgam___________________ with amalgam
Organism
Mercury concentration (pM)
32 64 128 256 32 64 128 256
Streptococcus oralis 14 3 0 0 34 2 0 0
Streptococcus mitis 8 1 0 0 3 3 1 0
Streptococcus salivarius 8 0 0 0 5 0 0 0
Streptococcus sanguis 1 0 0 0 3 0 0 0
Streptococcus parasanguis 6 0 0 0 2 0 0 0
Streptococcus vestibularis 1 0 0 0 - - - -
Streptococcus anginosus 2 0 0 0 - - - -
Unidentified streptococci 13 2 0 0 11 2 0 0
Staphylococcus aureus 1 0 0 0 1 0 0 0
Coagulase-negative staphylococci 3 0 0 0 2 0 0 0
Rothia dentocariosa 1 0 0 0 5 0 0 0
Pseudomonas stutzeri - - - - 0 0 0 1
Total 58 6 0 0 6 6 7 1 1
Table 4.6: Identity and Minimum Inhibitory Concentration (HgCh) of Mercury-resistant Isolates
No. (% ) of Hg-resistant isolates exhibiting resistance
Antibiotic without amalgam fillings with amalgam fillings
Penicillin 5(8) 4 (5 )
Ampicillin 0 (0 ) 0 (0 )
Erythromycin 9(14) 15(20)
Vancomycin 0 (0 ) 1(1)
Tetracycline 11(17) 19(25)
Gentamicin3 0 (0 ) 0 (0 )
At least one antibiotic 21 (33) 31 (41)
One antibiotic only 17(27) 24 (32)
Two antibiotics 4(6) 6 (8 )
Three antibiotics 0 (0 ) K D
Table 4.7: Resistance to antibiotics o f Mercury-resistant Bacterial Isolates from Children
Streptococci have inherent resistance to aminoglycosides and low-level resistance to gentamicin is not significant 
(MIC > 2- 128mg/l)
A MIC >128mg/l gentamicin is high-level resistance
Number o f isolates displaying resistance8
Tetracycline Erythromycin Penicillin Vancomycin One antibiotic Two antibiotics Three antibiotics
Mercury-resistant
isolate
-Am +Am -Am +Am -Am +Am -Am +Am -Am +Am -Am +Am -Am +Am
S. oralis 1 12 2 10 1 0 0 0 4 14 0 4 0 0
S. mitis 4 2 0 1 0 1 0 0 4 2 0 1 0 0
S. salivarius 0 0 2 0 0 0 0 0 2 0 0 0 0 0
S. sanguis 0 0 0 1 0 0 0 0 0 1 0 0 0 0
S. parasanguis 3 0 2 0 2 0 0 0 1 1 3 0 0 0
Unidentified 3 4 3 2 1 1 0 0 5 5 1 1 0 0
streptococci 
S. aureus 0 1 0 0 0 0 0 0 0 1 0 0 0 0
CNS 0 0 0 0 1 0 0 0 1 0 0 0 0 0
Rothia dentocariosa c 0 - 0 - 1 - 0 - 1 - 0 - 0
Pseudomonas spb - 0 - 1 - 1 - 1 - 0 - 0 - 1
Table 4.8: Antibiotic Resistance Profiles o f Mercury-resistant Bacteria from Children without (-Am) and
with (+Am) Amalgam Fillings
No ampicillin- and high-level gentamicin-resistant bacteria were found
Penicillin is not used to treat pseudomonal infections, while all Gram-negative bacteria are inherently resistant to erythromycin and 
vancomycin
A dash indicates that this organism was not isolated from this patient group
Antimicrobial
agent
Viridans streptococci (n=59)
Range MICjo
(mg/1)
MIC*)
(mg/1)
%R
Mercury 32-64 32 64 100
Penicillin <0.008-0.5 0.03125 0.125 6
Ampicillin <0.008-1 0.0625 0.5 0
Erythromycin <0.008-4 0.03125 2 15
Vancomycin 0.125-1 0.5 1 0
Tetracycline 0.0625-32 0.25 16 18
Gentamicin* 0.0625-4 2 4 0
Table 4.9: In vitro activities o f 6  Antimicrobial Agents against Mercury-resistant 
Oral Streptococci isolated from non-amalgam Patients
Antimicrobial _________Viridans streptococci (n=66)
agent Range MICjo
(mg/1)
MIC*,
(mg/1)
%R
Mercury 32-128 32 64 100
Penicillin <0.008-0.5 0.03125 0.125 3
Ampicillin <0.008-1 0.03125 0.25 0
Erythromycin <0.008-8 0.03125 2 21
Vancomycin 0.25-1 0.5 1 0
Tetracycline 0.03125-64 0.5 64 28
Gentamicin* 0.0625-8 2 8 0
Table 4.10: In vitro activities o f 6  Antimicrobial Agents against Mercury- 
resistant Oral Streptococci isolated from amalgam Patients
“ Streptococci have inherent resistance to aminoglycosides and low-level resistance to 
gentamicin is not significant (MIC >2-128mg/l). A MIC >128mg/l gentamicin is high- 
level resistance.
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Antimicrobial S. oralis (n:= 17) 5. mitis (n=9) Other streptococci (n=33)
agent Range
(pg/ml)
MICjo
(pg/ml)
MIC*,
(pg/ml)
%R Range
(pg/ml)
MICjo
(pg/ml)
MIC*,
(pg/ml)
%R Range
(pg/ml)
MIC50
(pg/ml)
MIC*,
(pg/ml)
%R
Mercury 32-64 32 64 100 32-64 32 64 100 32-64 32 32 100
Penicillin <0.008-0.5 0.03125 0.125 6 <0.008-0.125 0.03125 0.125 0.0 <0.008-0.25 0.0625 0.125 6
Ampicillin <0.008-1 0.03125 0.125 0.0 0.016-0.5 0.03125 0.5 0.0 <0.008-1 0.0625 0.25 0.0
Erythromycin <0.008-2 0.03125 1 12 0.016-0.0625 0.03125 0.0625 0.0 <0.008-4 0.03125 2 21
Vancomycin 0.25-1 0.5 0.5 0.0 0.125-1 0.5 1 0.0 0.125-1 0.5 1 0.0
Tetracycline 0.0625-16 0.25 0.5 6* 0.0625-32 0.5 32 44 0.0625-4 0.25 4 18
Gentamicin8 1-4 2 4 0.0 1-2 2 2 0.0 0.0625-4 1 4 0.0
Table 4.11: In vitro activities of 6  Antimicrobial agents against Mercury-resistant Oral Streptococci isolated from
non-amalgam Patients
Antimicrobial S. oralis (n==36) S. mitis (n=7) Other streptococci (n=23)
agent Range MIC50 MIC*, %R Range M IC50 MIC*, %R Range MIC50 MIC*) %R
(pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml)
Mercury 32-64 32 32 100 32-128 64 128 100 32-64 32 32 100
Penicillin <0.008-0.125 0.03125 0.125 0.0 0.016-0.5 0.03125 0.5 14 <0.008-0.25 0.03125 0.0625 4
Ampicillin <0.008-0.25 0.03125 0.125 0.0 0.016-1 0.0625 1 0.0 <0.008-0.25 0.03125 0.25 0.0
Erythromycin <0.008-8 0.03125 2 28 <0.008-1 0.03125 1 14 <0.008-4 0.03125 1 13
Vancomycin 0.25-1 0.5 1 0.0 0.5-1 1 1 0.0 0.5-1 0.5 1 0.0
Tetracycline 0.125-64 0.5 64 33* 0.0625-64 0.5 64 29 0.03125-64 0.25 32 17
Gentamicin8 0.5-8 2 8 0.0 0.5-8 2 8 0.0 0.0625-8 2 8 0.0
Table 4.12: In vitro activities o f 6  Antimicrobial Agents against Mercury-resistant Oral Streptococci isolated from amalgam Patients
8 Streptococci have inherent resistance to aminoglycosides and low-level resistance to gentamicin is not significant (MIC >2-128). A MIC >128pg/ml gentamicin 
high-level resistance 
* Significant difference using the Chi squared test at the 5% level (P>0.05)
Chapter Five 
A  Longitudinal Study -  
Resistance o f the Com m ensal Oral M icroflora  
to M ercury and Antibiotics in Subjects 
before and after the placem ent o f Am algam  Fillings
5.0 A Longitudinal Study -  Resistance of the Commensal Oral Microflora
to Mercury and Antibiotics in Subjects before and after the placement 
of Amalgam Fillings
5.1 Introduction
As previously discussed, only a few studies have investigated whether the 
presence o f mercury in dental amalgam fillings can act as selective pressure for 
mercury and antibiotic resistance in commensal bacteria found in the oral and 
gastrointestinal tract (Summers et al, 1993, Osterblad et al, 1995,
Edlund et al, 1996). In the few studies that have been undertaken, the majority 
are cross-sectional studies, where results obtained from subjects with amalgam 
fillings are compared with results from subjects without amalgam fillings 
(Osterblad et al, 1995, Edlund et al, 1996). The only reported longitudinal study 
was carried out by Summers’ group in the USA, who found that in cynomolgus 
monkeys there was a significant increase in mercury resistance in the faecal and 
oral flora post-amalgam placement (Summers et al, 1993).
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5.2 Aims
There were three aims to this study. These were:
1. To determine whether placement o f mercury amalgam fillings in
children’s teeth results in an increase in oral bacteria resistant to
mercury, penicillin, ampicillin, erythromycin, vancomycin,
tetracycline or metronidazole.
2. The second aim was to identify any mercury-resistant bacteria isolated
and determine whether there was a difference in the types of
organisms isolated from the pre- and post-amalgam saliva and plaque 
samples.
3. The final aim was to investigate whether the mercury-resistant
organisms were also resistant to any o f 5 antibiotics and to determine 
whether there were differences pre- and post-amalgam placement.
5.3 Materials and Methods
5.3.1 Patient Selection and Sampling
Plaque and saliva samples were collected from children (aged 5-18 years) during 
3 consecutive visits to the Paediatric department o f the Eastman Dental Hospital. 
These children were healthy and had not taken antibiotics during the preceding
months. They needed conservative dental treatment and had never had amalgam 
restorations in the past. During the first visit to the clinic the patient was 
clinically assessed and the child’s guardian signed a consent form. One sample of 
supragingival plaque and one sample o f saliva was collected. The sampling 
technique is described in further detail in Chapter 4.3.1. Further samples were 
collected one month later, when the patient returned to have the carious lesion 
restored with amalgam. These samples were taken prior to treatment. The final 
samples were collected one month after the restoration.
5.3.2 Sample Processing
The fresh saliva and plaque samples were cultured within 30 minutes of arrival at 
the laboratory, where they were vortexed together and 1 in 10  serially diluted in 
tryptone soy broth (Chapter 2.3.2). Duplicate lOOpl aliquots o f dilutions o f each 
sample ( 10-4, 1 0 '5 1 0 '6 and 1 0 '7) were inoculated onto mercury-free
Mueller-Hinton agar. Duplicate lOOpl aliquots of the undiluted sample and 
10"1, 10*2 and 10' 3 dilutions were inoculated onto Mueller-Hinton agar containing 
40pM HgCb- These plates were prepared on the same day that the specimen was 
collected and kept out of direct light before use. Four plates were used for each 
dilution, two of which were incubated aerobically and two anaerobically for 
48 hours. The samples were also screened for the presence of bacteria resistant to 
penicillin, ampicillin, erythromycin, tetracycline, vancomycin and metronidazole 
and each antibiotic was incorporated into Iso-Sensitest agar supplemented with 
5% defibrinated horse blood (E&O Laboratories). The concentrations used are 
shown in the Table 5.1 below:
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Antimicrobial Concentration (mg/1)
Penicillin 4
Ampicillin 8
Erythromycin 1
Vancomycin 8
Tetracycline 8
Metronidazole 32
Kanamycin 50
Table 5.1: Antibiotic Concentration used in the Screening Plates
The dilutions (10'2, 10*3, 10*4 and 10’5) were plated in duplicate as lOOpl volumes 
onto the antibiotic plates. Duplicate lOOpl aliquots of dilutions of each sample 
(10*4, 10‘5 10*6 and 10‘7) were inoculated onto antibiotic-free Iso-Sensitest agar. 
Four plates were used for each dilution -  two were incubated at 37°C 
anaerobically for 48 hours and two aerobically for 48 hours.
Following incubation, colonies growing on the mercury-containing and 
mercury-free media were enumerated. Colonies growing on the 
mercury-containing agar showed little morphological differences and therefore at 
least four colonies from each patient (aerobic and anaerobic) were sub-cultured 
onto Mueller-Hinton agar containing 40pM HgCl2. After 24-48 hours incubation 
(aerobic and anaerobic), the organisms were stored at -70°C, for identification and 
antibiotic-sensitivity testing at a later date. Due to the presence o f blood, the 
organisms growing on the antibiotic-free and antibiotic-containing Iso-Sensitest 
agar exhibited morphological differences and each colony morphotype was 
enumerated and a representative colony was sub-cultured to obtain a pure culture.
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After 24-48 hours incubation (aerobic and anaerobic), the organisms were stored 
at -70°C.
5.3.3 Susceptibility Testing
The MIC of mercury and 5 antibiotics were determined for all the 
mercury-resistant organisms by an agar dilution technique, as described by the 
British Society for Antimicrobial Chemotherapy (BSAC)(Andrews, 2001b). Both 
the mercury and antibiotic plates were prepared on the day that they were 
inoculated. Mueller-Hinton agar was used to determine the mercury MIC, while 
Iso-Sensitest agar supplemented with 5% defibrinated horse blood was used to 
determine the MICs of the antibiotics. The stock solutions used are described in 
Chapter 2.1.4 and the range and breakpoints are shown Table 5.2.
Antimicrobial Range3 Breakpoint3^  
Gram-positive and Neisseria species
Mercury 1-1024 16
Penicillin 0.008-8 0.125
Ampicillin 0.008-8 1
Erythromycin 0.008-8 0.5
Vancomycin 0.0625-16 4
Tetracycline 0.016-128 1
Table 5.2: Range and Breakpoint Concentrations o f Antibiotics
3 The mercuric chloride concentration was measured in pM. The antibiotic 
concentrations were measured in mg/1
The breakpoint differs according to the organism tested. All Neisseria 
(Gram-negative) are inherently resistant to vancomycin
A Mueller-Hinton plate without mercuric chloride and a 5% defibrinated horse
blood Iso-Sensitest plate without antibiotics were prepared to determine whether
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these agars could support the growth of the control and test organisms. Before 
use, the agar plates were dried in a laminar flow cabinet for 2 0  minutes and kept 
out o f direct light.
The method is described in further detail in Chapter 4.3.4.
5.3.4 Statistical Analysis
The mean, median and interquartile range (IQR) were determined to summarise 
the distribution pattern o f the results obtained. In most cases, the mean and IQR 
were greater than the median, signifying that the results did not exhibit normal 
distribution, but were severely positively skewed and therefore could not be 
subjected to parametric testing (Figures 4.1 & 4.2). The non-parametric Wilcoxon 
signed-rank test was used to compare the results obtained during visits 1 and 2  
(pre-amalgam). This test is based on ranking results in order and allows two 
groups of the same size ( k ) to be compared. The non-parametric Friedman 
two-way ANOVA (analysis of variance) test was used to analyse the results 
obtained from the 3 visits. Again, this test is based on ranking results in order, but 
allows three or more groups of the same size ( k ) to be compared. The 5% level of 
statistical significance was adopted throughout (P<0.05).
5.4 Results
The group consisted of 16 patients, mean age 8  years, SD 3.3; range 5-18.4 years. 
Eleven of the patients were male (69%), while 5 were female (31%).
189
Prior to looking for potential differences in the proportion o f resistant bacteria 
pre- and post-amalgam, it was important to determine whether there were any 
differences in the proportion o f resistant bacteria during visits 1 and 2  
(pre-amalgam). If the proportions o f mercury- and antibiotic-resistant bacteria 
varied considerably between visits 1 and 2  for each patient, it would have been 
pointless to continue with the longitudinal study and obtain results from 
post-amalgam patients. Statistically, using the non-parametric Wilcoxon test, the 
differences between visits 1 and 2 were found not to be significant, with P values 
ranging from 0.1928-1.
On each visit (visits 1 and 2, pre-amalgam, and visit 3, post-amalgam), 13 o f the 
16 children (81%) had mercury-resistant bacteria in their oral flora. Ten o f the 
children had mercury-resistant bacteria isolated from their oral flora on all 
3 visits. Four children did not have mercury-resistant bacteria during one o f the 
visits, while two children did not possess mercury-resistant bacteria during two 
visits. All o f the children had mercury-resistant bacteria during at least one visit. 
Table 5.3 shows the proportions o f mercury-resistant bacteria, expressed as 
percentages of the total viable aerobic and anaerobic counts, present in the 
samples. Under aerobic conditions o f cultivation, the median proportions of 
mercury-resistant bacteria were greater amongst subjects post-amalgam (visit 3) 
than pre-amalgam (visits 1 and 2). However, using anaerobic cultivation, the 
median proportion o f mercury-resistant bacteria was far greater with visits 2 
(pre-amalgam) and 3 (post-amalgam) than visit 1 (pre-amalgam). The mean and 
IQR for both incubation conditions and for all 3 visits were greater than the
correlating median, suggesting that the results were not normally distributed and 
positively skewed (skewed to the right). However, unlike the cross-sectional 
study results (Chapter 4.4), which were transformed logarithmically to allow 
parametric testing, these results could not be transformed, since transformation is 
not suitable for small data sets (only 16 patients were sampled in this study). 
Therefore, a non-parametric test was conducted in which the results from the 
3 visits were all compared. The Friedman two-way ANOVA test fits the criteria. 
Only the anaerobic results were analysed because most o f the bacteria o f interest 
were either obligate anaerobes or facultative anaerobes. These differences 
between the 3 groups were not significant at the 5% level (P<0.05) as P=0.802.
Bacteria resistant to penicillin were isolated from 94%, 100% and 100% of the 
16 children on visits 1, 2 and 3 respectively. When expressed as a proportion of 
the total aerobic count, the median proportions o f mercury-resistant bacteria were 
greater amongst subjects during visit 1 (pre-amalgam) than visits 2  (pre-amalgam) 
and 3 (post-amalgam)(Table 5.4). However, when expressed as a proportion of 
the total anaerobic count, the median proportions of mercury-resistant bacteria 
were very similar during the 3 visits. As with the mercury-resistant proportions, 
the mean and IQR for both incubation conditions and for all 3 visits were greater 
than the correlating median, suggesting that the results were not normally 
distributed and positively skewed. Again, the results based on the total anaerobic 
count were analysed using the two-way Friedman test and the results were found 
to be not significant (P=0.549).
191
Ampicillin-resistant bacteria were isolated from 94%, 8 8 % and 100% of the 
16 children on visits 1, 2 and 3 respectively. Table 5.5 shows that the mean and 
IQR were greater than the correlating median, signifying non-normal distribution. 
Therefore, the results based on the total anaerobic count were analysed using the 
Friedman test and found to be not significant (P=0.936).
Erythromycin-resistant bacteria were isolated from all o f the children on each of 
the 3 visits. The mean, median and IQR were calculated on the basis o f the total 
aerobic and anaerobic counts (Table 5.6). For some visits the mean, median and 
IQR were found to be very similar, indicating that these results were normally 
distributed and should be analysed using a parametric test. However, for some 
visits, the mean and IQR were greater than the median, indicating that these 
results were positively skewed and could be analysed using a non-parametric test. 
As a result, the non-parametric Friedman test was used as previous results in this 
study had been analysed using this test. There was no significant difference in the 
proportions of erythromycin-resistant bacteria isolated on the 3 visits (P=0.819).
Bacteria resistant to tetracycline were isolated from all 16 of the children on each 
of the 3 visits. The mean and IQR for both incubation conditions and for all 
3 visits were greater than the correlating median, suggesting that the results were 
not normally distributed and positively skewed (Table 5.7). Using the Friedman 
test, the results obtained on each visit were found to be not significantly different 
(P=0.766).
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Vancomycin-resistant bacteria were isolated from all o f the children on each of 
the 3 visits (Table 5.8). However, all Gram-negative bacteria are inherently 
resistant to vancomycin and it is probable that these vancomycin-resistant 
organisms were Gram-negative organisms. It would be necessary to Gram stain 
these organisms to determine whether resistance is inherent or acquired. 
However, due to time constraints, this was not possible. Using the Friedman test, 
there was no significant difference in the proportions of vancomycin-resistant 
bacteria isolated on the 3 visits (P=0.344).
No metronidazole-resistant organisms were isolated from any of the 16 children. 
Although initially organisms were isolated on the metronidazole-containing agar, 
after retesting by growing the bacteria under aerobic and anaerobic conditions, 
none of the isolates were found to be obligate anaerobes.
All the mercury-resistant organisms were identified to the genus level, and, if 
possible, to the species level, and the MIC of HgCh was determined for each. 
Table 5.9 shows the number of mercury-resistant species isolated during each 
visit. There were no obvious differences between the three visits in terms o f the 
number of mercury-resistant species isolated. Four patients (25%) from
visit 1 and three patients (20%) from visits 2 and 3 did not have any 
mercury-resistant bacteria. Fewer mercury-resistant species were isolated from 
patients during visit 1 (pre-amalgam). During visit 1, o f the patients that 
harboured mercury-resistant bacteria, only 1 to 3 different species were isolated 
from each patient. During visit 3 (post-amalgam), of the patients that harboured 
mercury-resistant bacteria, between 1 and 4 different mercury-resistant species
were isolated. However, during visit 2 (pre-amalgam) between 1 and 5 different 
mercury-resistant organisms were isolated from patients that harboured 
mercury-resistant organisms.
A total of 8 8  different mercury-resistant organisms were isolated from the study. 
Twenty one, 34 and 33 mercury-resistant organisms were isolated on 
visits 1, 2 and 3 respectively (Table 5.10). Eighty o f the 8 8  (91%) 
mercury-resistant bacteria were streptococci. O f the mercury-resistant bacteria 
isolated from the children pre-amalgam, 91% (50 out o f 55) were streptococci. 
Indeed, all o f the mercury-resistant organisms isolated during the first visit were 
identified as streptococci. Similarly, 91% (30 out of 33) of the mercury-resistant 
organisms isolated from the children post-amalgam were identified as 
streptococci. O f those streptococci that could be easily identified biochemically 
and by 16S rRNA sequencing, the majority were S. oralis (32%). In the 
pre-amalgam group, 24% (13 out o f 55) of the organisms were S. oralis, while in 
the post-amalgam group, 45% (15 out of 33) of the organisms were S. oralis. 
However, using the Chi square test, this difference was narrowly not significant
•j
(X (i>=3.576, P=0.0586). Streptococcus mitis was the second most commonly 
isolated mercury-resistant streptococcal species (25%). Twenty nine percent 
(16 out of 55) of the mercury-resistant organisms isolated from visits 1 and 2 were 
identified as S. mitis, while during visit 3, 18% (6  out o f 33) o f the bacteria were 
S. mitis. However, using the Chi square test, these differences were not 
significant (x2(i)=0.792, P=0.373).
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As discussed, all o f the mercury-resistant organisms isolated during visit 1 were 
identified as streptococci. However, the mercury-resistant bacteria isolated from 
visits 2 and 3 showed a greater diversity with a variety of genera exhibiting 
mercury resistance. The other mercury-resistant organisms isolated included the 
Gram-positive bacteria coagulase-negative staphylococci {Staph, hominis, 
Staph, epidermidis and unidentified CNS) and R. dentocariosa and a 
Neisseria species. These organisms will be discussed later in this chapter. No 
mercury-resistant obligate anaerobes were isolated from either pre-amalgam or 
post-amalgam patients.
Once identified, the mercury-resistant bacteria were tested for their level of 
resistance to mercury, by determining the MIC of HgCh. The majority of 
organisms had an MIC of 32pM, although some had an MIC o f 64 pM 
(Table 5.11). Only one organism, a Staph, hominis from a patient post-amalgam, 
displayed an MIC of 128pM.
All o f the mercury-resistant bacteria isolated were tested for their susceptibility to
5 commonly used antibiotics by determining the MIC of the antibiotic.
Fifteen (27%) and 13 (40%) o f the mercury-resistant bacteria isolated from the
pre- and post-amalgam patients were also resistant to at least one of the antibiotics
tested (Table 5.12). Resistance to metronidazole was not tested as all o f the
mercury-resistant organisms were identified as facultative anaerobes. None o f the
mercury-resistant bacteria exhibited resistance to ampicillin. The
mercury-resistant organisms were most often resistant to erythromycin (25%) and
to a lesser extent, tetracycline (10%). Penicillin resistance was occasionally
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encountered in these organisms (7%). Four isolates, three from patients 
pre-amalgam and one from a post-amalgam patient, were resistant to two 
antibiotics. These isolates were either resistant to both penicillin and 
erythromycin, penicillin and tetracycline or tetracycline and erythromycin 
(Table 5.13). A Neisseria species isolated from a patient pre- and post-amalgam 
was resistant to four antibiotics -  penicillin, vancomycin and erythromycin and 
tetracycline (Table 5.14). However, Neisseria are Gram-negative and therefore 
inherently resistant to vancomycin, so it is only the penicillin, erythromycin and 
tetracycline resistances that are o f significance.
Tables 5.15, 5.16 and 5.17 show the MIC range, MIC50 and MIC90 o f the 
5 antibiotics tested and the percentage o f resistance for all the streptococci 
isolated. All isolates from the pre- and post-amalgam patients were sensitive to 
ampicillin (MIC90 = 0.125mg/l). All isolates displayed vancomycin sensitivity 
with MIC50 and MIC90 values o f 0.5 and lmg /1 for both pre- and post-amalgam. 
Pre-amalgam, the rank order o f susceptibility for the viridans streptococci was: 
vancomycin = ampicillin (100%) > penicillin (97%) > tetracycline (93%) > 
erythromycin (81%). The same pattern was also observed post-amalgam: 
vancomycin = ampicillin = penicillin (100%) > tetracycline (93%) > erythromycin 
(73%). For both the pre- and post-amalgam patients, erythromycin seemed to be 
the least active, with 21 and 27% resistance rates.
Tables 5.18, 5.19 and 5.20 show the MIC range, MIC50 and MIC90 o f the
5 antibiotics tested and the percentage of resistant strains for S. oralis, S. mitis and
Streptococcus species (including the unspeciated streptococci, S. salivarius,
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S. parasanguinis, S. sanguinis, S. dysgalactiae, S. infantis, S. peroris and 
S. vestibularis). The MIC range o f vancomycin for the streptococci was narrow, 
with MIC90S o f 0.5 and lmg/1 and all o f the organisms tested were sensitive to 
vancomycin. In contrast, the MIC ranges of the other antibiotics, especially for 
erythromycin and tetracycline were much larger. Due to the large MIC range for 
these antibiotics, the MIC50 and MIC90 values also varied quite considerably. The 
results for the coagulase-negative staphylococci, Staph. hominis, 
Staph, epidermidis, R. dentocariosa and the Neisseria species are not listed in the 
table because o f the limited number of these organisms isolated.
Four mercury-resistant staphylococci were isolated in this study and identified to 
species level using 16S rRNA sequencing. O f the organisms isolated, one was a 
Staph, hominis, one was a Staph, epidermidis and 2 were unidentifiable using 
16S rRNA and therefore referred to as coagulase-negative staphylococci. The 
MIC of HgCh for the coagulase-negative staphylococci and the 
Staph, epidermidis was 32pM to mercury, while that for the Staph, hominis was 
128pM, indicating a high resistance to HgCh (Table 5.11). This organism was 
isolated from a patient post-amalgam. All the staphylococci isolated were 
moderately resistant to the antibiotics tested. The Staph, hominis showed 
resistance to penicillin (MIC=0.5mg/l) and tetracycline (MIC=64mg/l), while one 
o f the coagulase-negative staphylococci (post-amalgam) was resistant to 
erythromycin (MIC=lmg/l)(Table 5.14). Ampicillin and vancomycin resistance 
was not observed in any o f the staphylococci.
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In this study, two mercury-resistant R. dentocariosa strains were isolated from 
patients without amalgam fillings. These organisms were identified using 
16S rRNA sequencing. The MIC of mercury for both organisms was 32pM 
(Table 5.11). Both isolates were fully susceptible to the 5 antibiotics tested 
(Tables 5.13 and 5.14).
The only mercury-resistant Gram-negative organism isolated in this study was a 
Neisseria species which was isolated from a patient during visits 2 and 3 
(pre- and post-amalgam). This organism was tentatively identified as 
Neisseria sicca by 16S rRNA gene sequencing. The MIC of HgCb was 32pM for 
this organism (Table 5.11). It was also resistant to penicillin (MIC=2mg/l), 
erythromycin (MIC=4mg/l), tetracycline (MIC=2mg/l) and vancomycin 
(MIC>16mg/l).
5.5 Discussion
Since the normal flora o f individuals can vary considerably from individual to
individual, this study, like all longitudinal studies, allows each subject to act as
their own longitudinal control. Few studies have looked at the prevalence or
persistence of mercury- and antibiotic-resistant organisms in the oral cavity, so
before investigating whether the presence o f amalgam results in an increase in the
proportion o f mercury- or antibiotic-resistant bacteria, it was important to
determine whether the number o f mercury- and antibiotic-resistant bacteria
remained constant during the pre-amalgam two month period. If the proportion of
mercury- and antibiotic-resistant organisms varied considerably for each patient
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between visits 1 and 2 , it would have been pointless to have continued the study 
and collect post-amalgam samples. Fortunately, using the Wilcoxon Signed rank 
test, any potential differences observed during visits 1 and 2  were found not to be 
significant, with all the P values greater than 0.05.
The first aim o f this study was to explore whether the placement o f amalgam 
fillings resulted in an increase in mercury-resistant bacteria in the oral flora of 
children. Similar numbers of children, pre- and post-amalgam, harboured 
mercury-resistant bacteria in their oral flora (81%). These results were similar to 
those found in the cross-sectional study (Chapter 4) in which 71% of children 
without amalgam fillings and 78% of children with amalgam fillings were found 
to harbour mercury-resistant bacteria in their oral flora.
Previous studies have shown that newly-placed amalgam releases greater levels of 
mercury vapour than older amalgam that has tarnished (Brune, 1981). Therefore, 
if the theory that amalgam results in an increase in mercury and antibiotic 
resistance is valid, one would expect to see a change in the proportion of resistant 
bacteria shortly after the amalgam restoration. However, in this study, the 
proportion of mercury-resistant bacteria had not significantly changed one month 
after placement of the mercury amalgam fillings.
There was also a failure to detect any change in the proportion o f oral bacteria
resistant to penicillin, ampicillin, erythromycin, vancomycin or tetracycline. All
the children in the study harboured erythromycin-, vancomycin- and
tetracycline-resistant bacteria in their oral flora and a large proportion of the
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children also harboured penicillin- and ampicillin-resistant bacteria. Statistically, 
the prevalence o f antibiotic-resistant bacteria pre- and post-amalgam was not a 
significant difference.
Various studies have incorporated antibiotics into agar to select for, and to 
determine the proportion o f antibiotic-resistant commensal bacteria in the oral and 
faecal flora. It is particularly common in longitudinal studies that look at the 
effect on resistance o f taking a course o f antibiotics, where the proportion of 
resistant bacteria is determined prior to and after the administration of the 
antibiotic. Most of these studies have found that most individuals carry 
antibiotic-resistant oral streptococci in their mouths prior to taking antibiotics 
(Maskell et al, 1990, Sefton et al, 1999). An investigation by Maskell found that, 
in a preliminary study o f 45 subjects, 44 harboured oral streptococci resistant to 
lmg/1 erythromycin and 30 yielded organisms resistant to 64mg/l o f the antibiotic 
(Maskell et al, 1990). However, in general, this constituted only 0.01% 
(0.00001-0.18%) o f the total streptococci isolated. In the second part o f the study, 
prior to antibiotic administration, it was found that of the 16 subjects tested, all 
harboured bacteria resistant to lmg/1 erythromycin. However, the proportion of 
resistant oral streptococci constituted less than 1.5% of the total streptococci. 
Finally, it was found that 87% of the subjects harboured bacteria resistant to 
4mg/l erythromycin and 50% yielded bacteria resistant to 64mg/l of the antibiotic. 
In addition 81% of the subjects harboured bacteria resistant to lmg/1 amoxycillin. 
Twenty five percent of subjects had streptococci resistant to 4mg/l amoxycillin. 
Finally, after the administration of erythromycin, the proportion of 
erythromycin-resistant organisms increased substantially.
An investigation by Sefton also showed that o f 16 subjects investigated, all 
harboured streptococci resistant to lmg/1 erythromycin (Sefton, 1999). Similarly 
to Maskell’s results, the proportion o f streptococci resistant to lmg/1 was less than 
1.5% of the total cultivable streptococcal population (Maskell et al, 1990). 
Eighty eight percent and 38% of individuals yielded streptococci resistant to 
4mg/l and 64mg/l erythromycin respectively. As with Maskells’ study, two days 
after the administration o f a macrolide antibiotic the proportion of 
erythromycin-resistant streptococci increased.
In the present study, prior to amalgam placement, 94% of patients during 
visit 1 and 88% of patients during visit 2 harboured bacteria resistant to 
8mg/l ampicillin. The proportion o f bacteria resistant to ampicillin ranged from 
0-100% of the total cultivable flora. The sample that contained 100% 
ampicillin-resistant organisms was taken pre-amalgam and seems to be erroneous, 
as the median from the sampling group was 6.6. However, such high levels of 
resistance have also been observed in a study by Koh where a patient with a 
history of rheumatic fever had 95% of oral streptococci resistant to 
lmg/1 amoxycillin (Koh et al, 1986). In the present study, one month after the 
placement of amalgam, 100% of patients yielded bacteria resistant to 
8mg/l ampicillin. Similar to Maskell’s and Sefton’s work, all 16 patients in the 
present study harboured bacteria resistant to lmg/1 erythromycin. However, the 
present study found that the proportion of erythromycin-resistant bacteria ranged 
from 0.42-100% (median 19.6%) o f the total bacterial count, while the earlier 
studies found that less than 1.5% of the total streptococci were resistant to the
same concentration of erythromycin (lmg/1). These differences may be accounted 
for by the fact that in the present study the erythromycin-resistant bacteria were 
isolated on non-selective media while Maskell and Sefton isolated their resistant 
bacteria on erythromycin-containing Mitis Salivarius Agar, which is selective for 
viridans streptococci. The majority o f erythromycin-resistant bacteria isolated in 
the present study may be species other than streptococci. These 
erythromycin-resistant bacteria were not identified due to time limitations.
Two other mercury resistance studies have looked at the incidence of antibiotic 
resistance directly by incorporating antibiotics into the agar. Edlund carried out a 
cross-sectional study, while Summers’ study was longitudinal 
(Summers et al, 1993, Edlund et al, 1996). Edlund incorporated 16mg/l 
ampicillin and 4mg/l erythromycin into various types o f agar. In both the 
non-amalgam and amalgam groups, the proportion o f organisms resistant to 
ampicillin was very low and the median values for both groups were zero. The 
erythromycin results were not well reported, but it can be concluded that the 
group found that erythromycin resistance did not vary significantly between the 
2 groups. When analysing the groups together, the median percentage (range) of 
the oral microflora resistant to erythromycin was 1.4% (0-52%). However, the 
paper does not report on the number or percentage of individuals harbouring 
erythromycin-resistant bacteria.
The longitudinal study carried out by Summers and co-workers found that even
prior to amalgam installation, oral streptococci resistant to 15mg/l tetracycline
were present. While tetracycline resistance persisted, it did not fluctuate with the
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placement or removal of the amalgam fillings. The percentage of streptococci 
resistant to 15mg/l tetracycline ranged from 0-20%. In the present study all 
16 patients harboured bacteria resistant to 8mg/l tetracycline, with a median value 
o f 29.9% of the total cultivable microflora. However, unlike in the present study 
where the majority o f pre-amalgam patients harboured ampicillin-resistant 
organisms, Summers’ group did not isolate any ampicillin-resistant streptococci 
on initial screening. Summers’ reported that ampicillin-resistant streptococci 
were ia te r’ isolated at a low incidence in a few gingival scrapings, but did not 
state whether this was pre-amalgam, post-amalgam or post amalgam replacement. 
The differences between the two groups may be explained in that Summers’ group 
incorporated 25mg/l ampicillin into Mitis Salivarius agar, while the present study 
incorporated only 8mg/l into Iso-Sensitest agar.
The second aim o f the study was to identify the mercury-resistant bacteria and to
determine whether there were differences in the genera and species isolated from
the pre- and post-amalgam samples. Table 5.9 shows the number o f different
species isolated at each visit. In general, the number of different species isolated
did not differ greatly pre- and post-amalgam. Table 5.10 shows that the majority
of mercury-resistant organisms were streptococci. Both pre- and post-amalgam,
91% of the mercury-resistant organisms were streptococci. Streptococcus mitis
was more commonly isolated from patients pre-amalgam, while post-amalgam,
S. oralis was the most common Streptococcus species. This pattern was also
observed in the cross-sectional study (Chapter 4). In children, these species of
streptococci, plus S. salivarius, are the most predominant streptococci found in the
oral flora (Lucas et al, 2000). Lyttle and Bowden have shown that strains o f
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S. oralis and S. mitis can adapt to a high concentration o f mercury by enrichment 
culture (Lyttle & Bowden, 1993b).
The other species o f mercury-resistant organisms {Staphylococcus, Neisseria and 
Rothia) isolated in this study will be discussed later in this chapter.
The final aim o f this study was to investigate whether the mercury-resistant 
organisms were also resistant to any o f 5 antibiotics and to determine whether 
there were differences pre- and post-amalgam. These antibiotics were penicillin, 
ampicillin, erythromycin, tetracycline and vancomycin. Metronidazole was not 
tested as all o f the mercury-resistant organisms were facultative anaerobes. None 
of the streptococci were resistant to vancomycin or ampicillin. Three percent o f 
the pre-amalgam isolates were resistant to penicillin, while none o f the 
post-amalgam streptococci were resistant to penicillin. The rank order of 
susceptibility for the mercury-resistant viridans streptococci isolated both from 
pre- and post-amalgam samples was: vancomycin = ampicillin > penicillin > 
tetracycline > erythromycin. However, in the cross-sectional study, the rank order 
of susceptibility for the mercury-resistant viridans streptococci isolated samples 
taken from patients’ with and without amalgam was: vancomycin = ampicillin > 
penicillin > erythromycin > tetracycline. In the longitudinal study, more isolates 
were resistant to erythromycin than to tetracycline, while in the 
cross-sectional study, more isolates were resistant to tetracycline than to 
erythromycin. In the cross-sectional study, eighteen percent o f the isolates from 
the non-amalgam group and 28% of the isolates from the amalgam group were 
resistant to tetracycline. However, in the longitudinal only 7% of the isolates
from both the pre- and post-amalgam samples were resistant to tetracycline. In 
the cross-sectional study, fifteen percent o f the isolates from the non-amalgam 
group and 21% of the isolates from the amalgam group were resistant to 
erythromycin. Nineteen percent o f pre-amalgam and 27% of post-amalgam 
streptococci were resistant to erythromycin. Similar to the longitudinal study, all 
the mercury-resistant viridans streptococci isolated in the cross-sectional study 
(Chapter 4) were found to be sensitive to vancomycin and ampicillin. In addition, 
a similar proportion o f organisms were resistant to penicillin (6% non-amalgam 
and 3% amalgam).
As discussed, this study and many others have shown that antibiotic and mercury 
resistance is commonly encountered in viridans streptococci 
(Summers et al, 1993, Jones and Pfaller, 2000, Johnson et al, 2001). There is 
substantial evidence to suggest that viridans streptococci can act as genetic 
reservoirs and transfer genetic information to transient bacteria as they make their 
way through the mouth, a principal entry point for a wide variety o f bacteria 
(Cvitkovitch, 2001, Bryskier, 2002,). O f particular concern is transfer of 
antibiotic resistance from viridans streptococci to S. pneumonias, which are 
naturally transformable (Dowson et al, 1993). Many viridans streptococci such as 
S. mutans, S. mitis, S. oralis, S. sanguinis and S. infantis are also naturally 
competent (Gaustad, 1985, Ronda et al, 1988, Whatmore et al, 2000, 
Cvitkovitch, 2001, Ween et al, 2002). These organisms possess the com operon 
which contains the three genes, comC, comD and comE, which encode proteins 
involved in regulating competence (Whatmore et al, 2000).
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Only one other longitudinal study has investigated whether the placement of 
amalgam fillings results in an increase in mercury and antibiotic resistance in the 
commensal flora. This study, by Summers, found an increase in the numbers of 
mercury-resistant oral and faecal bacteria following amalgam placement in 
Cynomolgus monkeys (Summers et al, 1993). After 8 weeks, the amalgam 
fillings were replaced with glass ionomer fillings, resulting in a sudden increase in 
the number o f mercury-resistant Enterobacteriaceae and oral streptococci. 
However, a peak in mercury resistance in enterococci was not seen until 5 weeks 
after the amalgam was removed. The study found that removal of amalgam
^  I
fillings resulted in an increase o f Hg in the faeces of the monkeys. In one
monkey, the level of Hg rose to 288pg/g. In contrast, the average Hg in faeces
while the amalgam fillings were in place was 2-5pg/g. In this study, the monkeys
received a massive number o f amalgam fillings. Each monkey was given
16 small, occlusal (biting) surface amalgam fillings containing between 93 and
lOOmg of mercury. In the present study, the mean number o f fillings per child
post-amalgam was only six. In Summers’ study, the fillings were placed on the
biting surface of the tooth, an area where abrasion, common through eating and
bruxism (grinding), occurs. This is likely to have resulted in a greater release of
mercury than would be observed with “randomly” placed fillings. The group
found that 2-5pg/g mercury was excreted (in faeces) daily. In contrast, the study
by Osterblad found that only 1 pg/g mercury was excreted daily from adults with
fillings and O.lpg/g mercury was found in the faeces of adults that had their
amalgam removed (Osterblad et al, 1995). However, there is no reference to the
number of fillings present or removed during the study. Edlund found that
subjects with amalgam fillings (mean 19 surfaces) excreted only 0.7pg/g mercury
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in their faeces per day (Edlund et al, 1996). Another shortcoming with Summers’ 
study is that the group worked with only 6 monkeys, which is a very small sample 
number. Although longitudinal studies require fewer subjects than cross-sectional 
studies, small sample groups can result in sampling errors and bias and the study 
findings can be assumed to be less reliable.
Four mercury-resistant staphylococci were isolated in this study and identified as 
Staph, hominis, Staph, epidermidis and 2 unidentifiable coagulase-negative 
staphylococci. The Staph, hominis was very resistant to mercury with an MIC of 
128pM and was isolated from a patient post-amalgam. This organism also 
showed high-level resistance to tetracycline (MIC=64mg/l). The breakpoint for 
tetracycline is lmg/1. Many studies have looked at mercury resistance in 
Staph, aureus, although few have considered other species of staphylococci 
(Dyke et al, 1970, Hall, 1970a, 1970b, Groves et al, 1975, Porter et al, 1982, 
Witte et al, 1986). Groves compared antibiotic- and heavy metal resistance in 
Staph, aureus and coagulase-negative staphylococci isolated from the 
nasopharynx and skin o f rural and urban populations exposed to either antibiotics 
or heavy metals (Groves et al, 1975). In a rural population that had been exposed 
to a methylmercury fungicide, a significant increase in mercury resistance in 
staphylococci was not detected. However, the study found that Staph, aureus was 
less susceptible to mercury than coagulase-negative organisms. O f the 
mercury-resistant coagulase-negative staphylococci isolated, very few were also 
resistant to the two antibiotics tested - penicillin and tetracycline. Interestingly, 
Groves’ study also found that, in Staph, aureus, exposure to antibiotics led to an
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increase in mercury-, copper- and cadmium resistance. This was not seen in the 
coagulase-negative strains.
In this study, two mercury-resistant Rothia dentocariosa strains were isolated 
from patients without amalgam fillings. This organism is a normal inhabitant of 
the oral cavity and is present in human saliva and supragingival plaque 
(Salamon and Prag, 2001). Up to now, few authors have looked at mercury 
resistance in this organism although studies have found the merA gene in 
micrococci, also a member o f the Micrococcaceae (Silver and Misra, 1988, 
Bogdanova and Mindlin, 1991). The only reports of antimicrobial susceptibility 
patterns of Rothia dentocariosa are cases in which the organism has caused an 
infection in predisposed individuals (Kong et al, 1998, Salamon and Prag, 2001). 
Authors have reported susceptibility to penicillin, ampicillin, erythromycin and 
vancomycin (Kong et al, 1998, Salamon and Prag, 2001). In the present study, all 
isolates were fully sensitive to these antibiotics.
Only one Gram-negative Hg-resistant organism was isolated in this study and was
tentatively identified as Neisseria sicca. Neisseria sicca is part of the commensal
bacterial flora of the human upper respiratory tract and shares this ecological
niche with Neisseria meningitidis. Like other Neisseria species, N. sicca is
naturally transformable and can acquire resistance genes from other organisms in
the environment. It is possible that antibiotic resistance genes can transfer from
N. sicca to N. meningitidis. The transfer of penicillin resistance genes, from
N. sicca to N. meningitidis is o f concern as penicillin is the drug o f choice for the
treatment and prophylaxis o f meningococcal mengitidis. However, there are few
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studies on the susceptibility patterns of N. sicca to the antimicrobial drugs 
frequently used in the treatment and prophylaxis o f meningococcal disease. This 
is because, to date, commensal Neisseria species are regarded as non-pathogenic 
saprophytes. However, cases have been reported in which these commensals have 
been isolated from blood cultures o f patients with septicaemia and endocarditis 
(Feder & Garibaldi, 1984, Szabo et al, 1990, Heiddel et al, 1993). The majority 
of these patients had a predisposing factor such as rheumatic heart disease or a 
history of intravenous drug abuse. Neisseria sicca has also been reported as a 
cause of mengitidis, pneumonia, inflammatory spondylitis, osteomyelitis and 
urethritis (Heiddel et al, 1993). To date, few authors have reported on mercury 
resistance in Neisseriaceae. One study by Riley and Taylor looked at the 
susceptibility o f 56 Moraxella (Branhamella) catarrhalis strains and 
10 Neisseria species to l l  heavy metals, including mercury 
(Riley & Taylor, 1989). None o f the Neisseria species were identified as N. sicca. 
The group determined susceptibility by agar dilution, using GC agar 
supplemented with 0.5% yeast extract and found that, with all the metals, the 
M. catarrhalis strains were less susceptible than the Neisseria species. Organisms 
able to grow on agar containing 100pM (370mg/l) HgCb were regarded as 
mercury-resistant and the group found that 94.6% of the M. catarrhalis tested 
were resistant. The authors concluded that these organisms were probably 
intrinsically resistant to the metals or contained plasmids that harboured heavy 
metal resistance genes. In the present study, the
mercury-resistant N. sicca was also resistant to penicillin, erythromycin, 
tetracycline and vancomycin. However, all members o f the Neisseriaceae are 
intrinsically resistant to vancomycin. Therefore this organism was sensitive to
ampicillin and resistant to penicillin, erythromycin and tetracycline. As 
discussed, there are very few reports on antimicrobial susceptibility patterns of 
infections caused by N. sicca, however, in one case o f N. sicca endocarditis, the 
organism was found to be sensitive to penicillin, plus ampicillin, erythromycin 
and tetracycline (Heiddel et al, 1993).
In this study and the cross-sectional study (Chapter 4), mercury-resistant obligate 
anaerobes were not isolated from any o f the patients. However, this does not 
mean that mercury-resistant anaerobes do not exist. Several groups have reported 
mercury-resistant Bacteroides species isolated from human and primate faecal 
samples (Avila-Campos et al, 1991a, Edlund et al, 1996). Avila-Campos showed 
that mercury resistance was stable after 10 successive subcultures. However, the 
study was unable to show whether resistance was plasmid-mediated. 
Mercury-resistant Bacteroides ruminicola and Clostridium perfringens have also 
been isolated from clinical and sewage samples (Rudrik et al, 1985). Rudrik 
isolated the organisms on cysteine-free agar, since it is known that mercury 
chelates to the sulphur found in this amino acid, which could result in the isolation 
o f false-positives. However, another study led by Summers and Sugarman, found 
that sulfhydryl groups in this amino acid are necessary for mediating mercury 
resistance by maximising the activity of mercury reductase, the enzyme that 
reduces Hg2+ to Hg° (Summers and Sugarman 1974). It is possible that the agar 
used in the present study contained insufficient sulfhydryl groups for the mercury 
reductase in anaerobic organisms to work and therefore the organisms were 
unable to grow on the mercury-containing agar.
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In conclusion, this study shows that mercury and antibiotic resistance in the oral 
flora is widely distributed among healthy children and that dental amalgam alone 
does not appear to be a key factor in promoting spread. This was also observed in 
the cross-sectional study (Chapter 4). However, in the cross-sectional study, it 
was difficult to control other factors and variables that may select for resistance. 
These include traces o f antibiotics and mercury in food, such as meat, fish, milk, 
vegetables and fruit (Corpet, 1993). Although these variables were also present in 
longitudinal studies, they did not pose such a problem as each subject acts as their 
own longitudinal control.
The longitudinal study showed that mercury resistance was present in a variety o f 
different organisms found in the oral flora such as Streptococcus, Staphylococcus, 
Rothia and Neisseria. Akin to the cross-sectional study, S. oralis was the most 
commonly isolated mercury-resistant Streptococcus species. Twenty four percent 
of the mercury-resistant organisms isolated during the pre-amalgam visits were 
S. oralis, while in the post-amalgam group 45% of the organisms were S. oralis. 
However, unlike the cross-sectional study, these results were narrowly not 
significant.
Other differences between the cross-sectional and longitudinal study were also 
observed. An important difference between the longitudinal and cross-sectional 
studies was that in the longitudinal study more mercury-resistant organisms were 
resistant to erythromycin (25.0%) than tetracycline (10.2%). In the 
cross-sectional study, more of the mercury-resistant organisms were resistant to 
tetracycline (21.6%) than erythromycin (17.3%).
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This study highlights that, like the cross-sectional study, viridans streptococci are 
the group that exhibits most resistant types to commonly used antimicrobial 
agents, suggesting the need for comprehensive surveillance programmes to 
investigate and monitor resistance in commensal organisms (Bax et al, 2000).
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Proportion o f aerobic count (%) Proportion o f anaerobic count (%)
without amalgam with amalgam without amalgam with amalgam
Visit 1 Visit 2 Visit 3 Visit 1 Visit 2 Visit 3
Range 0-9.57 0-2.66 0-1.585 0-4.44 0-2.33 0-4.56
Mean 0.8569 0.2299 0.14448 0.8192 0.2999 0.4111
Median 0.0038 0.004 0.0095 0.0006 0.025 0.029
Inter-quartile range 0.2725 0.125 0.0258 1.1638 0.185 0.1586
Friedman test P value P=0.802
Table 5.3: Proportions o f Mercury-resistant Microbes in the oral Microflora o f Children with and without Amalgam Fillings
Proportion of aerobic count (%)_________   Proportion of anaerobic count (%)
without amalgam with amalgam without amalgam with amalgam
Visit 1 Visit 2 Visit 3 Visit 1 Visit 2 Visit 3
Range 0-2.58 0-4.76 0-1.82 0-18.15 0.054-17.65 0.003-27.02
Mean 0.6465 0.6245 0.3487 3.1491 4.3883 4.2446
Median 0.2 0.04 0.0575 1.775 1.48 1.415
Inter-quartile range 0.5465 0.719 0.2314 3.125 7.07 5.34
Friedman test P value P=0.549
Table 5.4: Proportions of Penicillin-resistant Microbes in the Oral Microflora of Children with and without Amalgam Fillings
Proportion o f aerobic count (%) Proportion o f anaerobic count (%)
without amalgam_________ with amalgam__________ without amalgam_________ with amalgam
Visit 1 Visit 2 Visit 3 Visit 1 Visit 2 Visit 3
Range 0-100 0-21.24 0-5.17 0-6.86 0-4.43 0-2.19
Mean 6.6577 1.7654 0.434 1.7011 0.905 5.813
Median 0.03 0.01 0.0199 0.15 0.21 0.455
Inter-quartile range 0.6825 0.42 0.225 2.4125 0.882 0.6125
Friedman test P value P=0.936
Table 5.5: Proportions of Ampicillin-resistant Microbes in the Oral Microflora of Children with and without Amalgam Fillings
Proportion o f aerobic count (%)__________________ Proportion of anaerobic count (%)
without amalgam with amalgam without amalgam with amalgam
Visit 1 Visit 2 Visit 3 Visit 1 Visit 2 Visit 3
Range 0.42-56.38 4.47-100 5.61-38.84 5-64 2.79-100 6.95-46.83
Mean 22.3956 22.58 16.4169 28.1944 28.922 25.1138
Median 22.705 14.42 14.265 20.76 22.54 24.435
Inter-quartile range 21.0825 15.355 10.6125 28.225 27.935 14.6275
Friedman test P value P=0.819
Table 5.6: Proportions of Erythromycin-resistant Microbes in the Oral Microflora of Children with and without Amalgam Fillings
Proportion of aerobic count (%)__________________ Proportion of anaerobic count (%)
without amalgam with amalgam without amalgam with amalgam
Visit 1 Visit 2 Visit 3 Visit 1 Visit 2 Visit 3
Range 0.015-18.51 0.011-17.34 0.2-14.10 0.02-17.56 0.13-23.94 0.27-14.54
Mean 4.2066 4.2167 4.8963 4.1938 7.218 4.43
Median 2.05 2.39 2.345 3.36 3.81 2.235
Inter-quartile range 3.27 4.77 6.7425 6.2975 10.72 3.045
Friedman test P value P=0.766
Table 5.7: Proportions of Tetracycline-resistant Microbes in the Oral Microflora of Children with and without Amalgam Fillings
Proportion o f aerobic count (%)___________________Proportion o f anaerobic count (%)
without amalgam with amalgam without amalgam with amalgam
Visit 1 Visit 2 Visit 3 Visit 1 Visit 2 Visit 3
Range 4.6-34.27 2.04-26.61 4.12-31.83 2.66-84.44 2.8-58.89 4.97-100
Mean 18.0163 12.1187 11.3056 17.7066 16.1547 26.4856
Median 16.38 9.78 10.195 9.64 11.11 18.035
Inter-quartile range 11.1275 9.08 4.79 13.895 17.34 14.895
Friedman test P value P=0.344
Table 5.8: Proportions o f Vancomycin-resistant Microbes in the Oral Microflora of Children with and without Amalgam Fillings
Number of mercury-resistant organisms
Number of patients
Pre-amalgam Post-Amalgam
Visit 1 Visit 2 Visit 3
0 4 (25.0) 3 (33.0) 3 (18.8)
1 5 (31.3) 1 (6.3) 2 (12.5)
2 5 (31.3) 4 (25.0) 5 (31.3)
3 2 (12.5) 4 (25.0) 3 (18.8)
4 0 (0.0) 2 (12.5) 3 (18.8)
5 0 (0.0) 1 (6.3) 0 (0.0)
Table 5.9: Number (% ) of Patients with a given number of Mercury-resistant Species
No. (%) isolates from children
Pre Amalgam _____________  Post Amalgam
Organism Visit 1 Visit 2 Visit 3
Streptococcus oralis 6(29) 7(21) 15 (45)
Streptococcus mitis 7(33) 9(27) 6(18)
Streptococcus salivarius 0(0) 3(9) 1(3)
Streptococcus sanguis 2(10) 3(9) 1(3)
Streptococcus parasanguis 0(0) 1(3) 0(0)
Streptococcus dysgalactiae 1(5) 0(0) 0(0)
Streptococcus infantis 0(0) 1(3) 0(0)
Streptococcus peroris 1(5) 0(0) 0(0)
Streptococcus vestibularis 1(5) 0(0) 1(3)
Unidentified streptococci 3(14) 5(15) 6(18)
Coagulase-negative staphylococci 0(0) 2(6) 2 (6 )
Rothia dentocariosa 0(0) 2(6) 0(0)
Neisseria species 0(0) 1(3) 1(3)
Total streptococci 21 (100) 29 (85) 30(91)
Total 21 34 33
Table 5.10: Identity of Mercury-resistant Bacteria from the pre- and post-amalgam Patients
No. isolates
Organism
_______ Pre Amalgam_____________  _
Visit 1______________ Visit 2_________
Mercury concentration (pM)
Post Amalgam 
Visit 3
32 64 128 32 64 128 32 64 128
Streptococcus oralis 5 1 0 7 0 0 10 5 0
Streptococcus mitis 4 3 0 8 1 0 6 0 0
Streptococcus salivarius - - - 3 0 0 1 0 0
Streptococcus sanguis 2 0 0 3 0 0 1 0 0
Streptococcus parasanguis - - - 1 0 0 - - -
Streptococcus dysgalactiae 1 0 0 - - - - - -
Streptococcus infantis - - - 1 0 0 - - -
Streptococcus peroris 1 0 0 - - - - - -
Streptococcus vestibularis 1 0 0 - - - 1 0 0
Unidentified streptococci 2 1 0 5 0 0 4 2 0
Coagulase-negative staphylococci - - - 2 0 0 1 0 1
Rothia dentocariosa - - - 2 0 0 - - -
Neisseria species - - - 1 0 0 1 0 0
Total 16 5 0 33 1 0 25 7 1
Table 5.11: Identity and Minimum Inhibitory Concentration (HgCh) of the Mercury-resistant Isolates
No. (%) of Hg-resistant isolates exhibiting resistance
______________ Pre-amalgam__________________________________   Post-amalgam
Visit 1 Visit 2 Visit 3
Penicillin
Ampicillin
Erythromycin
Vancomycin
Tetracycline
1(5)
0(0)
6(29)
0(0)
1(5)
2 (6)
0 (0)
6(18)
1(3)
4(12)
2 (6 ) 
0 (0 ) 
10(30) 
1 (3) 
4(12)
At least one antibiotic 8(38) 7(21) 13(40)
One antibiotic only 8(38) 3(9) 11 (33)
Two antibiotics 0(0) 3(9) 1 (3)
Three antibiotics 0 (0 ) 0(0) 0(0 )
Four antibiotics 0(0) 1(3) 1(3)
Table 5.12: Resistance to Antibiotics of Mercury-resistant Bacterial Isolates from Children pre- and post-amalgam
Number o f isolates displaying resistance
One antibiotic Two antibiotics Three antibiotics Four antibiotics
Mercury-resistant isolate
Am +Am -Am +Am Am +Am Am +Am
Visit 1 Visit 2 Visit 3 Visit 1 Visit2 Visit 3 Visit 1 Visit 2 Visit 3 Visit 1 Visit 2 Visit 3
S. oralis 2 1 4 0 0 0 0 0 0 0 0 0
S. mitis 2 0 2 0 0 0 0 0 0 0 0 0
S. salivarius - 1 1 - 2 0 - 0 0 - 0 0
S. sanguis 1 0 0 0 0 0 0 0 0 0 0 0
S. parasanguis - 1 - - 0 - - 0 - - 0 -
S. dysgalactiae 0 - - 0 - - 0 - - 0 - -
S. infantis - 0 - - 0 - - 0 - - 0 -
S. peroris 0 - - 0 - - 0 - - 0 - -
S. vestibularis 1 - 1 0 - 0 0 - 0 0 - 0
Unidentified streptococci 2 0 2 0 1 0 0 0 0 0 0 0
CNS - 0 1 - 0 1 - 0 0 - 0 0
Rothia dentocariosa - 0 - - 0 - - 0 - - 0 -
Neisseria species - 0 0 - 0 0 - 0 0 - 1 1
Table 5.13: Antibiotic Resistance Profiles of Mercury-resistant Bacteria from Children pre- (-Am) and post-amalgam (+Am) Fillings
Number o f isolates displaying resistance8
Penicillin Erythromycin Tetracycline Vancomycin
-Am +Am -Am +Am -Am +Am -Am +Am
Mercury-resistant isolate Visitl Visit2 Visit3 Visitl Visit2 Visit 3 Visitl Visit2 Visit3 Visit 1 Visit 2 Visit 3
S. oralis 0 0 0 2 1 3 0 0 1 0 0 0
S. mitis 0 0 0 1 0 2 1 0 0 0 0 0
S. salivarius - 1 0 - 2 1 - 0 0 - 0 0
S. sanguis 1 0 0 0 0 0 0 0 0 0 0 0
S. parasanguis - 0 - - 0 - - 1 - - 0 -
S. dysgalactiae 0 - - 0 - - 0 - - 0 - -
S. infantis - 0 - - 0 - - 0 - - 0 -
S. peroris 0 - - 0 - - 0 - - 0 - -
S. vestibularis 0 - 0 1 - 1 0 - 0 0 - 0
Unidentified streptococci 0 0 0 2 1 1 0 1 1 0 0 0
CNS - 0 1 - 0 1 - 0 1 - 0 0
Rothia dentocariosa - 0 - - 0 - - 0 - - 0 -
Neisseria species - 1 1 - 1 1 - 1 1 - 1 1
Table 5.14: Antibiotic Resistance Profiles o f Mercury-resistant Bacteria from Children pre- (-Am) and post-amalgam (+Am) Fillings 
No ampicillin-resistant bacteria were found.
Antimicrobial
agent
All streptococci (n=21)
Range MIC50
(pg/ml)
MIC*,
(pg/ml)
%R
Mercury 32-64 32 64 100
Penicillin <0.008-0.5 0.03125 0.125 5
Ampicillin <0.008-0.5 0.0625 0.125 0
Erythromycin 0.016-4 0.03125 2 29
Vancomycin 0.25-1 0.5 1 0
Tetracycline 0.125-2 0.25 0.5 5
Table 5.15: In vitro activities of 5 Antimicrobial Agents against 
Mercury-resistant Oral Streptococci isolated from pre-amalgam Patients (Visit 1)
Antimicrobial _______________All streptococci (n=29)
agent Range MICso
(pg/ml)
MIC*)
(pg/ml)
%R
Mercury 32-64 32 32 100
Penicillin <0.008-1 0.03125 0.125 3
Ampicillin <0.008-0.25 0.0625 0.125 0
Erythromycin 0.016-8 0.03125 2 21
Vancomycin 0.125-2 0.5 1 0
Tetracycline 0.03125-16 0.25 4 10
Table 5.16: In vitro activities o f 5 Antimicrobial Agents against 
Mercury-resistant Oral Streptococci isolated from pre-amalgam Patients (Visit 2)
Antimicrobial ______________ All streptococci (n=30)
agent Range MIC50
(pg/ml)
MIC*,
(pg/ml)
%R
Mercury 32-64 32 64 100
Penicillin <0.008-0.125 0.0625 0.0625 0
Ampicillin <0.008-0.25 0.0625 0.125 0
Erythromycin 0.016-2 0.03125 2 27
Vancomycin 0.25-1 0.5 1 0
Tetracycline 0.125-64 0.25 0.5 7
Table 5.17: In vitro activities of 5 Antimicrobial Agents against 
Mercury-resistant Oral Streptococci isolated from post-amalgam Patients (Visit 3)
222
Antimicrobial S. oralis (n=6) S. mitis (n=7) Other Streptococcus species (n=8)
agent
Range M1C50
(pg/ml)
MIC90
(pg/ml)
%R Range MIC50
(pg/ml)
MIC90
(pg/ml)
%R Range MIC50
(Pg/ml)
MIC*,
(pg/ml)
%R
Mercury 32-64 32 64 100 32-64 32 64 100 32-64 32 64 100
Penicillin <0.008-0.0625 0.03125 0.0625 0 0.016-0.125 0.0625 0.125 0 0.016-0.5 0.03125 1 12.5
Ampicillin <0.008-0.125 0.0625 0.125 0 0.016-0.5 0.125 0.5 0 <0.008-0.5 0.0625 1 0
Erythromycin 0.016-1 0.03125 1 33 0.016-1 0.03125 1 14 0.016-4 0.25 4 38
Vancomycin 0.25-0.5 0.5 0.5 0 0.5 0.5 0.5 0 0.5-1 1 1 0
Tetracycline 0.125-0.5 0.25 0.5 0 0.25-2 0.25 2 14 0.125-0.5 0.25 0.5 0
Table 5.18: In vitro activities of 5 Antimicrobial Agents against Mercury-resistant Oral Streptococci isolated from pre-amalgam Patients
(Visit 1)
Antimicrobial S. oralis (n=7) S. mitis (n=9) Other Streptococcus species (n=13)
agent
Range MIC50
(pg/ml)
MIC90
(pg/ml)
%R Range MIC50
(pg/ml)
m ic 90
(pg/ml)
%R Range MIC50
(pg/ml)
MIC90
(pg/ml)
%R
Mercury 32 32 32 100 32-64 32 64 100 32 32 32 100
Penicillin <0.008-0.0625 0.03125 0.0625 0 0.03125-0.125 0.0625 0.125 0 <0.008-1 0.03125 0.125 8
Ampicillin <0.008-0.125 0.0625 0.125 0 <0.008-0.125 0.0625 0.125 0 <0.008-0.25 0.0625 0.25 0
Erythromycin 0.016-0.25 0.03125 1 14 0.016-0.5 0.3125 1 11 0.016->8 0.03125 2 23
Vancomycin 0.25-1 0.5 1 0 0.25-1 0.5 1 0 0.5-2 1 1 0
Tetracycline 0.125-0.5 0.25 0.5 0 0.125-0.5 0.25 0.5 0 0.0625-16 0.5 8 23
Table 5.19: In vitro activities o f 5 Antimicrobial Agents against Mercury-resistant Oral Streptococci isolated from pre-amalgam Patients
(Visit 2)
Antimicrobial S. oralis {n=15) S. mitis (n=6) Other Streptococcus species (n=9)
agent
Range MIC50
(pg/ml)
MICck)
(pg/ml)
%R Range M1C50
(pg/ml)
MIC*)
(pg/ml)
%R Range MIC5o
(pg/ml)
MICoo
(pg/ml)
%R
Mercury 32-64 32 64 100 32 32 32 100 32-64 32 64 100
Penicillin <0.008-0.125 0.03125 0.125 0 <0.008-0.125 0.0625 0.125 0 <0.008-
0.0625
0.0625 0.0625 0
Ampicillin <0.008-0.25 0.0625 0.125 0 <0.008-0.125 0.125 0.125 0 <0.008-0.25 0.0625 0.25 0
Erythromycin 0.016-2 0.03125 1 20 0.03125-1 0.0625 1 33 0.016-2 0.03125 2 33
Vancomycin 0.25-1 0.5 0.5 0 0.25-1 0.5 1 0 0.5-1 0.5 1 0
Tetracycline 0.125-64 0.25 0.5 7 0.25-0.5 0.25 0.5 0 0.25-32 0.5 32 11
Table 5.20: In vitro activities o f 5 Antimicrobial Agents against Mercury-resistant Oral Streptococci isolated from post-amalgam Patients
(Visit 3)
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6.0 Mercury Reductase (merA) Genes in the Oral Flora
6.1 Introduction
Mercury resistance is ubiquitous and has been observed in a wide variety of 
bacterial genera isolated from human, animal and environmental samples 
(Moore, 1960, Nakahara et al, 1977a, Porter et al, 1982,
Khor and Jegathesan, 1983, Rudrik et al, 1985, Avila-Campos et al, 1989,
Lyttle and Bowden, 1993a). The most widely reported and studied mechanism of
2 +
mercury resistance is the enzymatic reduction o f divalent mercuric ions (Hg ) to
the metallic form (Hg°) by the cytoplasmic flavoenzyme mercuric reductase
(MerA) (Hart et al, 1998). The gene for this enzyme is found on the mer operon,
among other genes required for regulation and transport and the vast majority of
information has been obtained from studies of Gram-negative bacteria
(Silver and Phung, 1996, Osborn et al, 1997). The mer determinants from these
bacteria are often located on plasmids and/or transposons, indicating the potential
for high mobility of these elements (Hobman and Brown, 1997). In comparison,
less research has been undertaken on Gram-positive bacteria. The first
Gram-positive mercury-resistant determinants to have been sequenced were the
plasmidal mer operon of Staph, aureus pI258 and the chromosomal operons of
B. cereus RC607 and Streptomyces lividans 1326 (Laddaga et al, 1987,
Wang et al, 1989, Sedlmeier and Altenbuchner, 1992). Although all 3 mer
operons contained merA genes homologous to Gram-negative merA genes, the
mercuric ion transport genes showed little similarity to Gram-negative transport
genes. In recent years, the mer operon also has been found on transposons found
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in Bacillus megaterium, B. cereus and an Exiguobacterium species 
(Huang et al, 1999, Bogdanova et al, 2001).
The merA gene is long with 631 codons (1896bp). The MerA protein 
(69 kilodaltons) is composed o f two monomers, producing a rough globular dimer 
(Silver and Phung, 1996). The structure of the MerA protein o f B. cereus RC607 
was established though X-ray crystallography and it is used as the model for all 
mercury reductases from both Gram-positive and Gram-negative bacteria 
(Schiering et al, 1991). This structure is also seen in the other members o f the 
pyridine nucleotide-disulphide oxidoreducatase family such as glutathione 
reductase, lipoamide dehydrogenase and thioredoxin (Petsko, 1991). These 
enzymes are FAD-containing, NAD(P)H-dependent oxidoreductases that contain 
a redox-active disulphide in the active site. The three-dimensional structure of 
MerA from B. cereus RC607 can be divided into 3 parts (Figure 6.1). These 
include two N-terminal regions (residues 1-166), the core (residues 167-616) and 
the C-terminal extension (residues 617-631). Mercury reductase is the only 
member of the oxidoreductase family to possess the N-terminal region. The 
N-terminal domain is also absent or shorter in mercury reductases from 
Gram-positive bacteria with a high genomic G+C content such as Arthrobacter, 
Citreobacterium, Micrococcus, Mycobacterium, Rhodococcus and Streptomyces 
(Silver and Misra, 1988, Bogdanova and Mindlin, 1991). The N-terminal domain 
is easily removed by proteolysis and contains four cysteines. It was once believed
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to play a role in acquiring Hg from the MerP transport protein as approximately 
70 amino acids of the N-terminal domain are homologous in sequence to this 
protein. However, further work has concluded that the terminal acts as an
intracellular buffer, preventing inhibitory binding of other proteins in the cell to 
Hg2+ and to act as the specific delivery agent o f Hg2+ to the catalytic core 
(Barkay et al, 2003). The presence and number o f repeats o f the N-terminal 
domain may be correlated with the type and quantity o f thiol synthesised by the 
species. Bacteria that lack glutathione and have low intracellular concentrations 
o f other thiols, such as members o f the Bacillus and Clostridium genera 
(low G+C content) have double repeats in the N-terminal domain. Cells that 
synthesise glutathione or have high intracellular concentrations o f thiols such as 
cysteine and coenzyme A have a single repeat in the N-terminal domain. 
Streptomycetes completely lack the N-terminal domain. However, there are some 
exceptions. Some Bacillus strains, which have a low genomic G+C content only 
have a single N-terminal repeat (Bogdanova et al, 1998, Narita et al, 2003).
The C-terminal and core region o f the MerA protein are more conserved than the 
N-terminal domain. The C-terminal contains two cysteines, which assist in 
Hg2+ binding at the active site. Mutagenesis studies have shown that they are 
essential for enzyme activity (Barkay et al, 2003). Wang showed that in 
RC607, pI258, Tn501 {P. aeruginosa) and Tn21 (S. flexneri), 22 o f 28 amino 
acids are completely conserved (Wang et al, 1989). The C-terminal of RC607 
and pI258 are 100% identical (Wang et al, 1989). Specific areas of the core are 
conserved, such as the FAD domain, NADPH binding site and a redox-active 
disulphide site. In Tn21, Tn501 and pI258 these sites have been shown to be 90% 
identical (Laddaga et al, 1987).
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Figure 6.1: Model of MerA from Crystal Structure of Bacillus Enzyme 
The conserved cysteine and tyrosine residues are shaded in 
yellow and red respectively (Barkay et al, 2003)
6.2 Aims
Despite many research groups having isolated mercury-resistant bacteria from 
plaque and saliva samples, to date none have published information as to whether 
these bacteria possess the merA gene. The aim of this part of the study was to 
determine whether the mercury-resistant bacteria isolated from the cross-sectional 
and longitudinal studies (Chapters 4 and 5) possessed the merA gene. The
presence o f the merA gene was determined by the polymerase chain reaction. 
A selection o f the amplified genes were sequenced and compared to the 
B. cereus RC607 merA gene using the BLAST database.
6.3 Materials and Methods
6.3.1 Bacterial strains
The mercury-resistant strains were isolated from the cross-sectional and 
longitudinal studies (Chapters 4 and 5). Table 6.1 shows the mercury-resistant 
organisms isolated from the cross-sectional study screened for the presence o f the 
merA gene. The only organism tested for the presence o f the merA gene from the 
longitudinal study was the Neisseria species isolated from patient 332 during visit 
2 (pre-amalgam) and visit 3 (post-amalgam).
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Organism
No. o f isolates
without amalgam fillings with amalgam fillings
Streptococcus oralis 17 35
Streptococcus mitis 8 7
Streptococcus salivarius 8 5
Streptococcus sanguis 1 3
Streptococcus parasanguis 6 2
Streptococcus anginosus 2 0
Streptococcus vestibularis 1 0
Unidentified streptococci 13 10
Staphylococcus aureus 1 0
Coagulase-negative staphylococci 3 1
Rothia dentocariosa 1 5
Pseudomonas stutzeri 0 1
Total 61 69
Table 6.1: Mercury-resistant bacteria isolated from the cross-sectional study
tested for the merA gene
The bacteria were grown overnight aerobically at 37°C in 10ml Brain Heart 
Infusion broth (Oxoid) in the presence o f 15pM HgC^ (Sigma-Aldrich).
6.3.2 Isolation o f Genomic DNA
The overnight cultures were centrifuged in a MSE Centaur 2 
(MSE Scientific Instruments, Crawley, Sussex, UK) at lOOOg for 3 minutes and 
the supernatants removed using a Pasteur pipette. The genomic DNA was 
isolated using Puregene™ DNA Isolation Kit (Gentra Systems, Minneapolis, 
USA).
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6.3.3 Oligonucleotide Primers
Two sets o f primers were designed using the Sigma-Genosys DNA calculator 
found on the company’s website (www.sigma-genosvs.com/order DNAcalc.asp).
6.3.3.1 BAMERA Primers
The BAMERA primers were capable o f amplifying the merA gene from 
B. cereus RC607 (GenBank accession AB036431)(Wang et al, 1989):
BAMERA-F 5 ’ -CAT C ATCGGTT CT GGT GG AG-3 ’
BAMERA-R 5’-AGTTGTCCTAATTCCATGCC-3’
The BAMERA primers produced an amplicon 532 base pairs in length when used 
on the positive control B. cereus RC607. These primers were designed to amplify 
the core region o f the merA gene (Figure 6.2).
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63.3.2 MerAl Primers
The second primers were designed to amplify the N-terminal domain and core 
region o f the merA gene (Figure 6.2). The primer is able to amplify most known 
merA genes found in Gram-positive organisms as determined by the known 
merA sequences on the BLAST database.
MerAl-F 3 ’ -CT GGTT GT G AAG A AC AT-5 ’
MerAl-R 3’-TCCTTCTGCCATTGTT -5’
The MerAl primer produced an amplicon 1246 base pairs in length when used on 
B. cereus RC607, which acted as a positive control.
6.3.4 PCR Amplification
The PCR was performed in 0.5ml eppendorf tubes (ABgene, Epsom, Surrey, UK) 
in a thermocycler (MWG Biotech (UK) Ltd, Milton Keynes, Bedfordshire, UK).
6.3.4.1 BAMERA Amplification
The PCR reaction mixtures were composed o f 2 pi DNA, 5pi 10X ThermoPol 
Reaction Buffer, 1U o f VentR® DNA Polymerase (New England Biolabs (UK) 
Ltd, Hitchin, Hertfordshire), 25pmol of each primer and lOpM of 
deoxynucleoside triphosphates (dNTPs) (Roche Diagnostics Ltd, Lewes,
East Sussex, UK). DD-H2O was added to make a total volume of 50pl. The PCR
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mixtures were denatured for 4 minutes at 94°C and then subjected to 35 cycles of 
amplification (30 seconds o f annealing at 94°C, 30 seconds o f elongation at 55°C 
and 1 minute o f elongation at 72°C). Finally, the samples were denatured at 72°C 
for 5 minutes and held indefinitely at 4°C.
6.3.4.2 MerAl Amplification
Two microlitres o f the DNA template was added to a reaction mixture (50pl final 
volume containing 10X PCR buffer, 1.5mM MgCL, 1.25U o f Taq DNA 
polymerase (Promega, Southampton, Hampshire, UK), 20pmol o f each primer 
and 20pM of deoxynucleoside triphosphates (dNTPs) (Roche Diagnostics Ltd, 
Lewes, East Sussex, UK). The reactions were made up to a total volume o f 50pl 
with sterile DD-H2O. The PCR mixtures were denatured for 3 minutes at 94°C 
and then subjected to 30 cycles o f amplification (1 minute o f annealing at 94°C, 
1 minute of elongation at 50°C and 1 minute o f elongation at 72°C). Finally, the 
samples were denatured at 72°C for 3 minutes and held indefinitely at 4°C.
6.3.5 Sequencing the Amplified Products
The PCR products were cleaned-up using the Qiagen QIAquick® kit (Qiagen Ltd,
Crawley, West Sussex, UK) and the concentration determined by reading the
OD at 260nm using a spectrophotometer (Pharmacia Biotech). PCR products in
low concentrations were used neat, while highly concentrated PCR products were
diluted with DD-H2O. Products produced using the BAMERA and MerAl
primers were sequenced overnight using a single BAMERA and MerAl primer
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respectively. This is described in further detail in Chapter 2.2.4. The method 
used to clean-up the products for sequencing and the sequencing technique is 
described further in Chapter 2.2.4.
6.4 Results
A total o f 130 organisms isolated from the cross-sectional study and the 
2 Neisseria strains isolated from the longitudinal study were screened for the 
merA gene using the BAMERA and M erAl primers. The MerAl primers 
produced amplicons o f approximately 1246 base pairs and the BAMERA primers 
produced products o f 532 base pairs. Isolates that produced amplicons of 
approximately these lengths were presumed to contain the merA gene (Table 6.2).
O f the 52 mercury-resistant S. oralis tested, 46 (88%) contained the merA gene, 
while of the 15 S. mitis tested, 9 o f the organisms contained the gene (60%). The 
only streptococcus species found to not contain the merA gene was S. sanguinis 
and S. vestibularis. However, very few isolates o f these species were tested 
(4 and 1 respectively).
The mercury-resistant Staph, aureus isolated from a patient without amalgam was 
found to not contain the merA gene when screened with the BAMERA and 
MerAl primers. However, o f the 4 mercury-resistant CNS tested, 2 contained the 
merA gene. One strain, which was unidentifiable and isolated from a patient 
without amalgam, was positive with both primers. The Staph, epidermidis,
isolated from a patient with amalgam, was positive with the MERA1 primer only.
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One R. dentocariosa strain, isolated from a patient with amalgam, was found to 
contain a merA gene when tested with the both the BAMERA and MerAl 
primers.
The P. stutzeri, isolated from a patient with amalgam fillings, did not contain the 
merA gene when tested with both sets o f primers.
The 2 N. sicca isolates, which were isolated during the longitudinal study from a 
patient pre- and post-amalgam, were found to contain the merA gene when tested 
with both the BAMERA and MerAl primers.
O f the two primers, the BAMERA primer produced more amplicons and thus 
detected more strains with merA than the MerAl primer (Table 6.3 & 6.4). O f the 
52 S. oralis tested, 81% were merA positive when screened with the BAMERA 
primers, but only 42% were found to possess the merA when tested using the 
MerAl primers.
One quarter o f the amplified products were sequenced and compared to the 
B. cereus RC607 merA gene using the BLAST database 
(www.ncbi.nlm.nih.gov/BLAST). All sequenced amplicons were found to be up 
to 95% identical to the B. cereus RC607 merA gene. The amplicons were also 
found to be very similar to merA genes from B. megaterium, B. macroides, 
B. licheniformis, B. sphaericus, Exiguobacterium species and 
Clostridium butyricum.
236
6.5 Discussion
Despite mercury resistance being discovered first in Staph, aureus, less is known 
about the mer operons o f Gram-positive bacteria than Gram-negative bacteria 
(Richmond & John, 1964). The work that has been published has focussed on 
environmental strains such as B. cereus (Wang et al, 1989, 
Bogdanova et al, 1998), B. megaterium (Narita et al, 2003), Exiguobacterium 
(Nikiforov et al, 1999) and Streptomyces (Sedlmeier and Altenbuchner, 1992). To 
date, there is little published information about the mer operon o f Gram-positive 
clinical isolates and there is no information in publications or the BLAST 
database about the mer operon in viridans streptococci and commensal Neisseria 
strains (Laddaga et al, 1987, Zscheck and Murray, 1990). Therefore, the aim of 
this study was to determine whether HgR bacteria isolated from saliva and plaque 
samples possessed the merA gene and, if  positive, a selection o f these genes were 
sequenced and compared to others on the BLAST database.
Of the mercury-resistant organisms isolated, members o f the genera 
Staphylococcus, Streptococcus, Rothia and Neisseria were found to contain the 
merA gene. The merA gene was not present in the P. stutzeri.
The BAMERA primers determined that 53% of the organisms tested contained
the merA gene, while only 33% of the strains contained the merA gene when
screened with the MerAl primers. However, it is possible that the PCR negative
strains contained the gene and the primers used were unable to amplify the merA
gene. The BAMERA primers amplified only the core region o f the merA gene,
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producing an amplicon o f 532bp in length. This area included the conserved 
regions o f Cys207, Cys212 and Tyr264. The MerAl primers were designed to 
amplify the second repeat o f the N-terminal domain and the core region of the 
RC607 merA gene, producing an amplicon o f 1246bp. This area includes the 
conserved regions o f Cys207, Cys212, Tyr265 and Tyr605 and a single
'y,
N-terminal cysteine, which is involved in delivery o f Hg to the catalytic core. O f 
the 113 streptococci tested, 65 (58%) were positive for the merA gene when 
screened with the BAMERA primers, while only 39 (35%) possessed the gene 
when tested with the MerAl primers. This suggests that the streptococci that 
were negative with the MerAl primer but positive with the BAMERA primer do 
not possess an N-terminal domain. However, taxonomically, streptococci, like the 
genus Clostridium and Bacillus, have a low G+C content. Previous work has 
shown that Gram-positive bacteria with a genomic G+C content less than 
50% possess a N-terminal domain (Bogdanova and Mindlin, 1991, 
Narita et al, 2003). Therefore, according to this rule, streptococci should contain 
an N-terminal repeat and the MerAl primer should amplify just as many genes as 
the BAMERA primer when used to amplify the merA gene in streptococci. It is 
possible that the streptococci tested do have an N-terminal domain but the 
nucleotides found within it differ significantly to RC607 and thus the MerAl 
primer is simply unable to amplify the streptococcal merA gene.
Of the 5 staphylococci tested (1 Staph, aureus and 4 CNS), only 2 were found to
contain the merA gene. Only one o f these strains appeared positive with the
MerAl primer suggesting it has an N-terminal domain. Staphylococci have a low
G+C content and high concentrations of cysteine and coenzyme A in the
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cytoplasm (Barkay et al, 2003). This suggests that the merA should possess an 
N-terminal domain. In fact, the mercuric reductase from Staph, aureus pI258 
contains a single repeat in the N-terminal domain (Laddaga et al, 1987).
Only one of the 6 R. dentocariosa strains isolated was found to contain the merA 
gene. This was positive using the MerAl primer, suggesting that the merA gene 
from this organism has an N-terminal domain. Rothia belong to the G+C rich 
branch of the Gram-positive bacteria and this may indicate that, like other bacteria 
with a high G+C content, the merA gene contains a single repeat at the N-terminal 
domain.
Three Gram-negative mercury-resistant bacteria were isolated from patients in the
cross-sectional (P. stutzeri) and longitudinal (N. sicca) studies. Using PCR, the
P. stutzeri was found to not contain the merA gene. However, the organism may
possess merA but the homology between the gene and primers may be low and
unable to amplify. Barkay isolated an environmental HgR P. stutzeri that
hybridised with a merA probe at a high stringency (Barkay et al, 2003). The
probe was developed from the merA gene of Tn501. The investigation did not
determine whether the strains possessed a merA gene with an N-terminal domain.
However, other studies have determined that pseudomonads synthesise
glutathione, which suggests that they have a single repeat in the MerA appendages
(Barkay et al, 2003). The two Neisseria isolates from a patient enrolled in the
longitudinal study were found to contain the merA gene when screened using both
the MerAl and BAMERA primers. This suggests that the gene has an N-terminal
domain. At present, no information has been published on mercury resistance and
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merA in Neisseria species, although other Gram-negative bacteria usually possess 
a single repeat in the N-terminal domain (Wang et al, 1989, Narita et al, 2003). 
The amplicons were sequenced and found to be up to 95% identical to the 
Bacillus, Exiguobacterium and Clostridium sequences on the BLAST database.
Amplicons from some o f the streptococci, both Neisseria and one o f the 
staphylococci were sequenced to determine their similarity to the RC607 merA 
gene. The amplicons from the R. dentocariosa were not sequenced. The 
amplicons that were sequenced were found to be identical to, or very closely 
related to, the merA gene o f B. cereus RC607.
O f the organisms tested, 28% of the organisms from the patients with amalgam 
and 52% of the bacteria from the amalgam-free patients were found to not contain 
the merA gene when screened using PCR. These strains may either contain a gene 
significantly divergent from the merA gene from B. cereus RC607 to preclude 
amplification or may not possess mercury reductase and have a different 
resistance system. Using a less specific technique such as low-stringent 
hybridisation may have resulted in detecting the merA gene in more o f the 
organisms tested. Hybridisation has been used in many studies where probes 
encoding fragments of merA from pI258 has detected the gene in Ent. faecalis and 
probes encoding fragments of Tn501 detected the gene in P. stutzeri, P. cepacia 
and P. vesicularis (Zscheck and Murray, 1990, Barkay et al, 2003). Low 
stringency hybridisation has permitted hybrid formation between the merA genes 
from Tn501, RC607 and pI258 (Barkay et al, 2003).
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In previous studies, many phenotypic mercury-sensitive bacteria have been shown 
to be genotypically mercury-resistant (Bogdanova et al, 1992,
Fleischmann et al, 1995). A collection of Gram-positive bacteria isolated from 
environmental samples were shown to possess merR and merA genes but were 
phenotypically mercury-sensitive (Bogdanova et al, 1992). Bogdanova concluded 
this was probably due to the absence or inactivation o f genes encoding transport 
functions. Such vestigual or cryptic operons have also been detected in 
Haemophilus influenzae where the genes for transport and regulation were 
separated by over 600kb o f DNA (Fleischmann et al, 1995). Cryptic operons 
have also been found in Staphylococcus species and Gram-negative bacteria. 
Micrococcus, Brevibacterium and Rhodococcus strains (G+C rich bacteria) also 
possess cryptic mer determinants (Summers et al, 1986, Bogdanova et al, 1992, 
Silver and Walderhaug, 1992).
Due to time constraints, this part o f the study was not completely finished and 
many questions have been left unanswered. Previous work has shown that most 
Gram-positive bacteria exhibit broad-spectrum resistance to mercury and this is 
especially common in bacteria with double repeats in their N-terminal domain 
(Bogdanova et al, 1998, Narita et al, 2003). The length o f the N-terminal domain 
can be determined by the decrease o f the molecular mass of mercury reductase in 
limited proteolysis experiments (Bogdanova and Mindlin, 1991). To continue the 
present study, testing for growth on agar containing an organomercurial would 
establish whether the mercury-resistant bacteria had broad-spectrum resistance. 
The isolates could be tested using PCR with different primers, which would
determine the type o f N-terminal domain that the organisms contain.
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Alternatively, proteolysis studies would determine whether the bacteria had single 
or double repeats at the N-terminal domain. Further work could also involve the 
determination o f whether the mer operons are found on the chromosome or a 
plasmid.
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F i g u r e  6 . 2 :  N u c l e o t i d e  (amino acid) s e q u e n c e  o f  merA (MerA) B. cereus R C 607
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F ig u r e  6 . 2  c o n t i n u e d :  N u c l e o t i d e  (amino acid) s e q u e n c e  o f  merA (MerA) B. cereus RC607
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A = Alanine I  = Isoleucine R = Arginine
B = Asparagine or Aspartic acid K = Lysine S = Serine
C = Cysteine L « Leucine T = Threonine
D = Aspartic acid M = Methionine V = Valine
E = Glutamic acid N = Asparagine W = Tryptophan
F = Phenylalanine P = Proline Y = Tyrosine
G = Glycine Q = Glutamine Z = Glutamine
H = Histidine * = Stop codon
F ig u r e  6 . 2 :  N u c l e o t i d e  (amino acid) s e q u e n c e  o f  merA (MerA) B. cereus R C607 ( a d a p t e d  fr o m  Wang e t  al, 1 9 8 9 )
N u c l e o t i d e s  a n d  a m in o  a c i d s  i n  l i g h t  g r e y  i n d i c a t e  t h e  N - t e r m i n a l  d o m a in , w h i l e  t h o s e  i n  d a r k  g r e y  a n d  b l a c k  i n d i c a t e  
t h e  c o r e  a n d  C - t e r m i n a l  r e s p e c t i v e l y .  N u c l e o t i d e s  b o x e d  i n  r e d  a n d  g r e e n  i n d i c a t e  t h e  M erA l a n d  BAMERA p r im e r s  
r e s p e c t i v e l y .  S h a d e d  c o d o n s  a n d  a m in o  a c i d s  a r e  t h e  c o n s e r v e d  r e s i d u e s  fo u n d  i n  t h e  a c t i v e  s i t e :  y e l l o w  i n d i c a t e s
T y r 2 6 4  a n d  T y r 6 0 5 ,  b l u e  i n d i c a t e s  C y s 2 0 7 ,  C y s 2 1 2 , C y s6 2 8  a n d  C y s6 2 9  (Wang e t  al, 1 9 8 9 ,  B a r k a y  e t  al, 2 0 0 4 ) .
Organism
No. (% ) isolates containing the merA gene
without amalgam fillings with amalgam fillings
Streptococcus oralis 13 (76) 33 (94)
Streptococcus mitis 3 (38) 6(86)
Streptococcus salivarius 2(25) 2(40)
Streptococcus parasanguis 1(17) 1(50)
Streptococcus sanguis 0(0) 0(0)
Streptococcus anginosus 1(50) -
Streptococcus vestibularis 0(0) -
Unidentified streptococci 8(62) 6(60)
Staphylococcus aureus 0(0) -
Coagulase-negative staphylococci 1(33) 1 (100)
Rothia dentocariosa 0(0) 1(20)
Pseudomonas stutzeri - 0(0)
Total 29 (48) 50 (72)
Table 6.2: Number (% ) of Mercury-resistant isolates (cross-sectional study) containing the merA gene
as determined using the BAMERA and MerAl primers
Organism No. of organisms 
tested
No. (% ) o f organisms containing the merA gene
BAMERA MerAl
Streptococcus oralis 52 42 (81) 22 (42)
Streptococcus mitis 15 8(53) 5(33)
Streptococcus salivarius 13 3(23) 2(15)
Streptococcus parasanguis 8 2(25) 0(0)
Streptococcus sanguis 4 0(0) 0(0)
Streptococcus anginosus 2 1(50) 0(0)
Streptococcus vestibularis 1 0(0) 0(0)
Unidentified streptococci 23 10(23) 10(43)
Staphylococcus aureus 1 0(0) 0(0)
Coagulase-negative staphylococci 4 1(25) 2(50)
Rothia dentocariosa 6 1(17) 1(17)
Pseudomonas stutzeri 1 0(0) 0(0)
Total 130 68 (52) 42 (32)
Table 6.3: Number (% ) o f mercury-resistant isolates (cross-sectional study) 
containing the merA gene as determined using the BAMERA and MerAl primers
Organism No. o f organisms tested  No. (% ) of organisms containing the merA gene
BAMERA only MerAl only MerAl and BAMERA Neither
Streptococcus oralis 50 26 (52) 6(12) 16 (32) 2(4)
Streptococcus mitis 15 5(33) 2(27) 3(20) 5(33)
Streptococcus salivarius 13 2(15) 1(8) 1(8) 9(69)
Streptococcus parasanguis 7 2(29) 0(0) 0(0) 5(71)
Streptococcus sanguis 4 0(0) 0(0) 0(0) 4(100)
Streptococcus anginosus 1 0(0) 0(0) 0(0) 1 (100)
Unidentified streptococci 23 4(17) 4(17) 6(4) 9(39)
Total 113 39 (35) 13 (11) 26 (23) 35 (31)
Table 6.4: Number (% ) o f mercury-resistant streptococci (cross-sectional study) 
containing the merA gene as determined using the BAMERA and MerAl primers
Chapter Seven 
Conclusions
7.0 Conclusions
7.1 Introduction
The oral flora o f humans is a potential reservoir o f antibiotic-resistant bacteria and 
studies have shown a correlation between consumption o f antimicrobial agents 
and the emergence o f resistance to these drugs. Additional factors in the 
environment may also give rise to selective pressure, resulting in an increase in 
drug resistance. Detergents containing organomercurials have been shown to 
promote mercury resistance. Mercury resistance genes are often found on 
transferable elements, which are able to carry other resistance genes, conferring 
resistance to other antimicrobials such as antibiotics. It is feasible that 
environmental mercury could promote the emergence and spread o f both mercury 
and antibiotic resistance in the commensal flora o f humans. The most prevalent 
source o f intentional mercury exposure for the general population in developed 
countries is dental amalgam.
A small number o f previous studies have investigated whether the dental amalgam 
used to repair caries can provide enough selective pressure to promote the 
emergence and spread o f mercury and antimicrobial resistance in the normal flora 
of humans and monkeys (Summers et al, 1993, Osterblad et al, 1995, 
Edlund et al, 1996). However, from the limited number of studies carried out, the 
results have been inconclusive. Summers found a link between amalgam fillings 
and an increase in mercury and antibiotic resistance in the oral and faecal flora of 
primates (Summers et al, 1993). By contrast, Edlund found that, in human adults,
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there was no link between the presence o f mercury amalgam fillings and the 
prevalence o f mercury-resistant oral bacteria (Edlund et al, 1996). The results of 
a study by Osterblad also supports the theory that amalgam fillings do not provide 
selective pressure (Osterblad et al, 1995).
The primary objective o f the current study was to determine whether mercury 
released from amalgam fillings could select for mercury-resistant bacteria in the 
oral flora of children. This was achieved through both a cross-sectional and a 
longitudinal study. The second aim was to determine whether changes in mercury 
resistance in the oral flora correlated with changes in the incidence of antibiotic 
resistance. The final aim was to determine whether individual mercury-resistant 
isolates contained the merA gene.
7.2 Effect o f Medium Composition on the Susceptibility of Oral
Streptococci to Mercuric Chloride
Unlike antibiotic susceptibility testing, where the MIC of the antibiotic against an 
organism can be determined using standardised methods, mercury susceptibility 
testing cannot be carried out in this manner. This has led to the use of a wide 
range of methods to determine whether organisms are ‘resistant’ to mercury.
The current study has shown that the culture medium used in mercury 
susceptibility testing plays a very important role and can have a significant 
influence on the MIC. Significant interactions between mercuric chloride and test 
media were observed and adding blood to solid media strongly decreased the
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antibacterial activity o f mercury. The study highlighted that before undertaking 
studies of mercury resistance it is important to choose the correct agar. Not only 
must the agar support the growth of the organisms tested but also its interaction 
with mercury must be determined, so that the correct concentration o f mercury is 
incorporated.
7.3 A Cross-sectional Study -  Resistance o f the Commensal Oral
Microflora to Mercury and Antibiotics in Subjects With and Without 
Dental Amalgam Fillings
In the cross-sectional study, samples were taken from 2 sets o f patients, one with 
amalgam fillings and one without, to determine whether children with fillings 
harboured a higher proportion o f mercury-resistant bacteria in their oral flora than 
those without. The mercury-resistant bacteria were identified and differences in 
the types of organism isolated from individuals with and without amalgam fillings 
were noted. Finally, the MIC of 6 frequently-used antibiotics for the 
mercury-resistant organisms were determined in order to investigate a possible 
correlation between antibiotic and mercury resistance.
It was observed that similar numbers of children without and with amalgam 
fillings harboured mercury-resistant bacteria in their oral flora and these 
differences were not statistically significant. However, the proportion o f 
mercury-resistant oral bacteria as a fraction o f the total sample population showed 
a significant correlation with the number of amalgam surfaces in the children’s 
mouths.
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There was little difference between the two groups in terms o f the number of 
different mercury-resistant species isolated. Mercury-resistant organisms isolated 
included Streptococcus species, Staph, aureus, coagulase-negative staphylococci 
(CNS), Rothia dentocariosa and Pseudomonas stutzeri. No mercury-resistant 
obligate anaerobes were isolated from either group. Most o f the mercury-resistant 
bacteria isolated were streptococci and previous studies have shown that 
streptococci are the predominant cultivable oral flora in children between the ages 
of 2 and 10 years (Chen et al, 1997, Kamma et al, 2000). O f those streptococci 
that could be identified, the majority were S. oralis in both groups. 
Mercury-resistant S. oralis was isolated more often from the amalgam group and 
this was found to be statistically significant. In the non-amalgam group, the 
mercury-resistant streptococci showed a greater species diversity with no 
particular streptococcal species being dominant in terms of frequency o f isolation.
Forty one percent and 33% o f the mercury-resistant bacteria isolated from the 
groups with and without amalgam fillings respectively were also resistant to at 
least one o f the antibiotics tested. The mercury-resistant organisms were most 
often resistant to tetracycline and to a lesser extent, erythromycin. Ampicillin and 
vancomycin resistance was not observed in any o f the Gram-positive organisms 
isolated. A greater number o f S. oralis strains isolated from patients with 
amalgam were resistant to tetracycline compared with the number o f S. oralis 
strains from the non-amalgam patients. These results were statistically 
significant.
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7.4 A Longitudinal Study -  Resistance of the Commensal Oral Microflora
to Mercury and Antibiotics in Subjects before and after the placement 
of Amalgam Fillings
The first aim o f the longitudinal study was to determine whether placement of 
mercury amalgam fillings in children’s teeth resulted in an increase in oral 
bacteria resistant to mercury and various antibiotics. This was achieved by 
measuring the proportion o f mercury- and antibiotic-resistant bacteria over three 
visits before and after amalgam placement. A comparison of the results 
demonstrated no significant difference in the proportion o f bacteria resistant to 
either mercury or to any o f the antibiotics between the three visits.
The second aim was to determine whether there were any differences in the types 
of organisms isolated from the pre- and post-amalgam samples. In general, the 
number o f mercury-resistant species isolated did not differ greatly pre- and 
post-amalgam. Mercury-resistant organisms isolated included Streptococcus 
species, coagulase-negative staphylococci (CNS), Rothia dentocariosa and a 
Neisseria species. Ninety one percent o f the organisms isolated from the children 
pre- and post-amalgam were identified as streptococci. Streptococcus oralis was 
the most commonly isolated streptococcal species and was more frequently 
isolated from post-amalgam patients. However, unlike in the cross-sectional 
study, this difference was narrowly not significant.
The final aim was to investigate whether the mercury-resistant organisms were 
also resistant to any o f 5 antibiotics and to determine whether there were
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differences pre- and post-amalgam placement. Twenty seven percent and 40% of 
the mercury-resistant bacteria isolated from the pre- and post-amalgam patients 
were also resistant to at least one of the antibiotics tested -  however, this 
difference was not statistically significant. None of the mercury-resistant bacteria 
exhibited resistance to ampicillin or vancomycin. The mercury-resistant 
organisms were most often resistant to erythromycin and to a lesser extent, 
tetracycline. This is in sharp contrast to the cross-sectional study where more 
mercury-resistant isolates were resistant to tetracycline than to erythromycin.
7.5 Mercury Reductase (merA) Genes in Oral Flora
For the final part of this study, the polymerase chain reaction was used to 
determine whether the mercury-resistant bacteria isolated from the cross-sectional 
study and the Neisseria from the longitudinal study possessed the merA gene.
Of the mercury-resistant organisms isolated, members o f the genera 
Staphylococcus, Streptococcus, Rothia and Neisseria were found to contain the 
merA gene. The merA gene was not amplified from the P. stutzeri as the 
homology between this gene and the merA gene from B. cereus RC607 may be 
low. Sequencing a selection of the amplicons found that they were up to 
95% identical to the Bacillus, Exiguobacterium and Clostridium sequences on the 
BLAST database.
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7.6 Concluding Remarks
In conclusion, mercury and antibiotic resistance in the oral flora is widely 
distributed among healthy children and dental amalgam alone does not appear to 
be a key factor in promoting spread. This study has shown that antibiotic and 
mercury resistance is commonly encountered in viridans streptococci which can 
act as genetic reservoirs. Resistance to commonly used antimicrobial agents 
suggests the need for comprehensive surveillance programmes to monitor 
resistance in these and other commensal organisms.
7.7 Parallel Work
Many viridans streptococci such as S. mutans, S. mitis, S. oralis, S. sanguinis and 
S. infantis are naturally competent (Gaustad, 1985, Ronda et al, 1988, 
Whatmore et al, 2000, Cvitkovitch, 2001, Ween et al, 2002). Additional work 
was carried out by a final year undergraduate where DNA was extracted from 4 
mercury- and antibiotic-resistant streptococci and used in transformation 
experiments. However, no transformants were obtained. Mercury- and 
antibiotic-resistant streptococci were also used in plate and filter matings 
(conjugation) which failed to produce mercury-resistant transconjugants but 
which created tetracycline-resistant transconjugants (Stapleton et al, 2004).
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7.8 Suggestions for Further Work
Due to time limitations, many questions remain unanswered. Previous work has 
shown that most Gram-positive bacteria exhibit broad-spectrum resistance to 
mercury and testing for growth on agar containing an organomercurial would 
establish whether bacteria possess broad-spectrum resistance to mercury. 
Broad-spectrum mercury resistance is especially common in bacteria with double 
repeats in the N-terminal domain of the merA protein and the length of the 
N-terminal can be determined by the decrease of the molecular mass of mercury 
reductase in proteolysis experiments (Bogdanova & Mindlin, 1991, 
Bogdanova et al, 1998, Narita et al, 2003). Alternatively, testing the isolates 
using PCR with different primers would determine the type o f N-terminal that the 
organisms possess. It would also be interesting to determine whether the mer 
operons are found chromosomally or on a plasmid.
Many phenotypic mercury-sensitive bacteria have been shown to be genotypically 
mercury-resistant and possess the merA and merR gene (Bogdanova et al, 1992, 
Fleischmann et al, 1995). Such vestigial or cryptic operons have also been 
detected in Haemophilus influenzae, Staphylococcus, Micrococcus, 
Brevibacterium and Rhodococcus species and Gram-negative bacteria 
(Summers et al, 1986, Bogdanova et al, 1992, Silver & Walderhaug, 1992). It 
would be interesting to screen mercury-sensitive streptococci for the merA gene.
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To date, very little information has been published on mercury resistance in 
Neisseria, especially N. sicca, which was isolated in the current study. It would 
be interesting to continue working further on this organism by sequencing the 
merA gene and determining whether it is plasmidal or chromosomal.
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